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Stress and Cognition
Cognition refers to the acquisition, transformation, storage and use of knowledge 
and  includes  many  di erent  mental  processes  such  as  attention,  memory, 
language, perception, reasoning and decision-making. Cognition allows us to 
interpret the world in which we are living, learn from the past and communicate 
with  others  and  thereby  make  adaptive  changes  when  our  environment  is 
changing or suddenly becomes a threat. It is well established that stress induced 
by environmental challenges (i.e., a stressor) can have pronounced e ects on 
cognition at many di erent levels (Lupien et al., 2009; Roozendaal et al., 2009; 
Campeau et al., 2011). Stress invokes behavioral and physiological changes that 
help the organism to cope with the situation and thereby promotes survival. This 
thesis will investigate the e ects of stress on two di erent aspects of cognition 
in rats, namely social cognition and memory. Part I will investigate the role of 
social information as a valuable trigger of stress, studied in a rodent model of 
empathy and Part II will focus on the involvement of the endocannabinoid system 
in regulating the e ects of stress hormones on memory. 
Empathy: A focus on rodent models
While the study of empathy has had a di cult history, marked by many di erent 
de nitions of the concept (Preston and de Waal 2003; de Vignemont and Singer 
2006;  Leiberg  and  Anders  2006;  Decety  and  Meyer  2008),  empathy-related 
responding  is  thought  to  play  a  key  role  in  prosocial  behavior,  altruism  and 
moral reasoning (Eisenberg 2000; de Waal 2008; Decety 2010). Several theoretical 
models  have  described  distinct  emotional  and  cognitive  facets  of  empathy 
(Preston and de Waal 2003; Decety and Jackson 2004; Leiberg and Anders 2006; 
de Waal 2008). Although empathy is not unique to humans, humans are particular 
for high-level cognitive abilities such as executive function, language, theory of 
mind that are layered on top of the phylogenetically older social and emotional 
capacities (Preston and de Waal 2003; de Waal 2008; Decety and Meyer 2008; 
Decety  2010).  According  to  Panksepp  and  Lahvis  (2011),  emotional  empathy 
requires that two conspeci cs share an a ective state, however the degree of 
empathy can be modulated by cognitive processes, such as the integration of 
information related to past experience of the subject, familiarity or similarity with 
the object. Some views of empathy consider it as an evolutionarily continuous 
phenomenon across species that exists in all social animals in varying degrees 
(Preston and de Waal 2003; Panksepp and Lahvis 2011). For example, Preston and 9
de Waal (2003) suggested that both emotional and cognitive processes involved 
in empathy could be uni ed into an ancient perception-action mechanism. These 
authors view empathy as any process where the attended perception of the 
object’s state automatically generates a similar state in the subject. A perception-
action model makes empathy a superior category that includes all subclasses 
of phenomena that share the same mechanism such as emotional contagion, 
sympathy, cognitive empathy, helping behavior, et cetera. These phenomena all 
share aspects of their underlying process and cannot be totally disentangled. For 
instance, emotional contagion, a change in an individual’s emotional state as a 
result of the perception of the other individual’s similar emotional state, might be 
the lowest common dominator of all empathic processes (Preston and de Waal 
2003; de Waal 2008). 
The recent discovery of mirror neurons in the ventral premotor cortex of monkey 
that are active both during execution and observation of action (Gallese et al., 
1996; Rizzolatti et al., 1996; Rizzolatti and Craighero 2004) prompted a series of 
studies in humans. These studies have shown that brain regions responsible for 
our own actions, sensations and emotions are recruited when we observe the 
actions, sensations and emotions of others (Iacoboni et al., 1999; Buccino et al., 
2001; Wicker et al., 2003; Keysers et al., 2004; Singer 2004; Keysers and Gazzola 
2006; Keysers and Gazzola 2009; Keysers et al., 2010). These  ndings led to an 
understanding of the neural basis of empathy: seeing states of others triggers 
the representation of corresponding states in our brain. Although empathy has 
been exhaustively studied in higher primates and humans, studies focusing on 
the existence of this phenomenon in low-order social animals, e.g. rats and mice, 
have largely remained missing until recent years. However, further understanding 
of the neural circuits underlying empathy would require the usage of invasive 
techniques such that manipulations of neural activity in targeted brain regions by 
intracranial drug infusions or by using combination of genetic and optical tools 
as referred together as optogenetics in behaving animals. These methods have 
been established and commonly used in rodents but currently not applicable 
in humans and have limited practice in non-human primates (but see (Diester 
et al., 2011)). Thus, establishing rodent models of empathy is timely and would 
present a valuable tool in this  eld. A small number of studies performed more 
than four decades ago evidenced that rodents are attentive to the a ective state 
of conspeci cs; however, a further interest in this  eld was not pursued for a 
long time (Church 1959; Rice and Gainer 1962). Recently, Langford et al. (2006) 
demonstrated that pain sensitivity of mice is modulated by the observation of a 10
cagemate’s similar pain response in a way that a mouse that observes the other 
in pain also displays more pain response, suggesting the existence of true adult-
adult empathy in mice. Further evidence stemmed from studies that tested the 
social transfer of fear in rodents. Some of these studies indicated that animals 
that  observe  the  conditioned  fear  responses  of  demonstrators  to  cue,  either 
express freezing behavior (fear response in rodent) during the observation of fear 
responses of demonstrators to the cue or display freezing when they are only 
tested with the cue or context that predicted the distress of the demonstrator 
(Chen et al., 2009; Bruchey et al., 2010; Jeon et al., 2010; Kim et al., 2010). Response 
to the observation of fear behavior of the demonstrator required observers to 
have a prior experience with the aversive stimuli that was associated with the cue 
(Bruchey et al., 2010; Kim et al., 2010) whereas in other studies, observers were 
naïve and did not require the presence of demonstrator expressing freezing to 
the cue (Bruchey et al., 2010; Jeon et al., 2010). Jeon et al. (2010) also found that 
observers express freezing when they are adjacent to the demonstrator mouse 
receiving repeated footshocks. This latter e ect is consistent with the emotional 
contagion phenomenon since the freezing behavior of the demonstrator and 
observer mice occurred at the same time.
Other evidence for rodent empathy originated from studies that focused on the 
modulation of learning by social cues in rodents,  ndings of these studies showed 
that a brief social interaction with a distressed conspeci c a ects the subsequent 
fear learning, retention and extinction (Bredy and Barad 2009; Bruchey et al., 
2010; Knapska et al., 2010; Panksepp and Lahvis 2011). For instance, Knapska et 
al. (2010) showed that an interaction with a distressed conspeci c, shortly after it 
underwent a fear-conditioning paradigm, facilitated the acquisition and retrieval 
of  contextual  fear  conditioning  in  observers.  Interestingly,  in  another  study, 
Knapska et al. (2006) reported that the interaction with a distressed conspeci c 
induces the expression of the neuronal activity-dependent transcription factor 
c-fos in many regions of the amygdala in observers similar to that in the distressed 
conspeci c. These  ndings suggested that a speci c pattern of amygdala activation 
occurs following the experience of self-distress and the experience of distress in 
others. The amygdala contributes to cognitive processes such as emotion, reward, 
learning, memory and attention (Davis and Whalen 2001; Adolphs 2003; Murray 
2007). Its role in aversive learning and fear expression is well established (LeDoux 
1996; LeDoux 2000; Davis and Whalen 2001; Maren 2001; Phelps and LeDoux 
2005). Lesion and functional neuroimaging studies in humans that used pictures 
of emotional facial expressions as social signals also indicated that the amygdala 11
participates in processing of information about basic emotions of others (Adolphs 
2003; Phelps and LeDoux 2005).
Empathy is modulated by some factors such as familiarity or similarity with the 
conspeci c (species, age, gender), past experience (with the situation of observed 
distress) and salience of the stimulus from the conspeci c (Preston and de Waal 
2003). Few studies of rodent models of empathy focused on the modulation 
of  empathy  by  familiarity  with  the  conspeci c  or  past  experience  with  the 
observed distressing situation. Langford et al. (2006) found that familiarity is 
strictly  necessary  for  empathic  response  in  mice,  whereas  Jeon  et  al.  (2010) 
showed that the empathic response was only enhanced by familiarity but was 
not necessary for the response, per se. Most rodent empathy studies reported 
that exposing observers to a prior similar distressing experience is required for 
empathic response (Langford et al., 2006; Bredy and Barad 2009; Kiyokawa et al., 
2009; Knapska et al., 2010) but some found e ects also in naïve animals (Bruchey 
et al., 2010; Jeon et al., 2010). The channel or sensory modality that is vital to 
convey the information between conspeci c have been examined by a number 
of studies, these demonstrated a role for visual (Langford et al., 2006; Jeon et 
al., 2010), olfactory (Bredy and Barad 2009; Kiyokawa et al., 2009) and auditory 
channels (Chen et al., 2009; Kim et al., 2010), suggesting that sensory modality 
seems to depend on the nature of the employed paradigm and the expression of 
the distress response. 
Outline of this thesis
The overall aim of this thesis is to examine the multifaceted e ects of stress on 
cognition. The thesis consists of two parts, Part I comprises of a single chapter 
with its own introduction and discussion. This part explores whether a rat’s stress 
response can a ect the behavior of other rats, which can represent a simple form 
of empathy. Part II, which consists of a separate introduction, four empirical and 
discussion chapters, deals with the neurobiological mechanism of stress hormone 
e ects on di erent memory functions. In particular, this part examines the role 
of the endocannabinoid system in regulating the e ects of glucocorticoids on 
di erent memory processes.12
REFERENCES
Adolphs R (2003). Is the human amygdala specialized for processing social information? 
Ann N Y Acad Sci 985: 326-340.
Bredy T, Barad M (2009). Social modulation of associative fear learning by pheromone 
communication. Learn Mem 16: 12-18.
Bruchey AK, Jones CE, Mon ls MH (2010). Fear conditioning by-proxy: social transmission 
of fear during memory retrieval. Behav Brain Res 214: 80-84.
Buccino G, Binkofski F, Fink GR, Fadiga L, Fogassi L, Gallese V, Seitz RJ, Zilles K, Rizzolatti 
G, Freund HJ (2001). Action observation activates premotor and parietal areas in a 
somatotopic manner: an fMRI study. Eur J Neurosci 13: 400-404.
Campeau S, Liberzon I, Morilak D, Ressler K (2011). Stress modulation of cognitive and 
a ective processes. Stress 14: 503-519.
Chen Q, Panksepp J, Lahvis G, Bartolomucci A (2009). Empathy Is Moderated by Genetic 
Background in Mice. PLoS One 4: e4387.
Church RM (1959). Emotional reactions of rats to the pain of others. Journal of comparative 
and physiological psychology 52: 132-134.
Davis M, Whalen PJ (2001). The amygdala: vigilance and emotion. Mol Psychiatry 6: 13-34.
de Vignemont F, Singer T (2006). The empathic brain: how, when and why? Trends Cogn 
Sci 10: 435-441.
de Waal FB (2008). Putting the altruism back into altruism: the evolution of empathy. 
Annual review of psychology 59: 279-300.
Decety J (2010). The neurodevelopment of empathy in humans. Dev Neurosci 32: 257-
267.
Decety J, Jackson PL (2004). The functional architecture of human empathy. Behav Cogn 
Neurosci Rev 3: 71-100.
Decety J, Meyer M (2008). From emotion resonance to empathic understanding: a social 
developmental neuroscience account. Develop. Psychopathol. 20: 1053-1080.
Diester I, Kaufman MT, Mogri M, Pashaie R, Goo W, Yizhar O, Ramakrishnan C, Deisseroth 
K, Shenoy KV (2011). An optogenetic toolbox designed for primates. Nat Neurosci 14: 
387-397.
Eisenberg  N  (2000).  Emotion,  regulation,  and  moral  development.  Annual  review  of 
psychology 51: 665-697.
Gallese V, Fadiga L, Fogassi L, Rizzolatti G (1996). Action recognition in the premotor 
cortex. Brain 119 ( Pt 2): 593-609.
Iacoboni M, Woods RP, Brass M, Bekkering H, Mazziotta JC, Rizzolatti G (1999). Cortical 
mechanisms of human imitation. Science 286: 2526-2528.
Jeon D, Kim S, Chetana M, Jo D, Ruley H, Lin S, Rabah D, Kinet J, Shin H (2010). Observational 
fear learning involves a ective pain system and Cav1.2 Ca2+ channels in ACC. Nat 
Neurosci 13: 482-488.13
Keysers C, Gazzola V (2006). Towards a unifying neural theory of social cognition. Prog 
Brain Res 156: 379-401.
Keysers C, Gazzola V (2009). Expanding the mirror: vicarious activity for actions, emotions, 
and sensations. Curr Opin Neurobiol 19: 666-671.
Keysers C, Kaas JH, Gazzola V (2010). Somatosensation in social perception. Nat Rev 
Neurosci 11: 417-428.
Keysers C, Wicker B, Gazzola V, Anton JL, Fogassi L, Gallese V (2004). A touching sight: SII/
PV activation during the observation and experience of touch. Neuron 42: 335-346.
Kim E, Kim E, Covey E, Kim J, Chapouthier G (2010). Social Transmission of Fear in Rats: The 
Role of 22-kHz Ultrasonic Distress Vocalization. PLoS One 5: e15077.
Kiyokawa Y, Takeuchi Y, Nishihara M, Mori Y (2009). Main olfactory system mediates social 
bu ering of conditioned fear responses in male rats. Eur J Neurosci 29: 777-785.
Knapska E, Mikosz M, Werka T, Maren S (2010). Social modulation of learning in rats. Learn 
Mem 17: 35-42.
Langford DJ, Crager SE, Shehzad Z, Smith SB, Sotocinal SG, Levenstadt JS, Chanda ML, 
Levitin DJ, Mogil JS (2006). Social modulation of pain as evidence for empathy in 
mice. Science 312: 1967-1970.
LeDoux J (1996). Emotional networks and motor control: a fearful view. Prog Brain Res 
107: 437-446.
LeDoux JE (2000). Emotion circuits in the brain. Annu Rev Neurosci 23: 155-184.
Leiberg  S,  Anders  S  (2006). The  multiple  facets  of  empathy:  a  survey  of  theory  and 
evidence. Prog Brain Res 156: 419-440.
Lupien S, Mcewen B, Gunnar M, Heim C (2009). E ects of stress throughout the lifespan 
on the brain, behaviour and cognition. Nat Rev Neurosci 10: 434-445.
Maren S (2001). Neurobiology of Pavlovian fear conditioning. Annu Rev Neurosci 24: 897-
931.
Murray EA (2007). The amygdala, reward and emotion. Trends Cogn Sci 11: 489-497.
Panksepp JB, Lahvis GP (2011). Rodent empathy and a ective neuroscience. Neurosci 
Biobehav Rev 35: 1864-1875.
Phelps EA, LeDoux JE (2005). Contributions of the amygdala to emotion processing: from 
animal models to human behavior. Neuron 48: 175-187.
Preston S, de Waal F (2003). Empathy: Its ultimate and proximate bases. Behavioral and 
Brain Sciences 25: 1-20.
Rice  GE,  Gainer  P  (1962).  “Altruism”  in  the  albino  rat.  Journal  of  comparative  and 
physiological psychology 55: 123-125.
Rizzolatti G, Craighero L (2004). The mirror-neuron system. Annu Rev Neurosci 27: 169-
192.
Rizzolatti G, Fadiga L, Gallese V, Fogassi L (1996). Premotor cortex and the recognition of 
motor actions. Brain Res Cogn Brain Res 3: 131-141.
Roozendaal B, Mcewen B, Chattarji S (2009). Stress, memory and the amygdala. Nat Rev 14
Neurosci 10: 423-433.
Singer T (2004). Empathy for Pain Involves the A ective but not Sensory Components of 
Pain. Science 303: 1157-1162.
Wicker B, Keysers C, Plailly J, Royet JP, Gallese V, Rizzolatti G (2003). Both of us disgusted 
in My insula: the common neural basis of seeing and feeling disgust. Neuron 40: 655-
664.15Experience Modulates 
Vicarious Freezing in Rats: A 
Model for Empathy
1





	

Piray Atsak1, Marie Orre1,2, Petra Bakker1, Leonardo Cerliani1,2, Benno 
Roozendaal1, Valeria Gazzola# 1,2, Marta Moita# 3, Christian Keysers# 1,2.
1.  Department of Neuroscience, University Medical Center Groningen, 
Groningen, The Netherlands.
2.  Netherlands Institute for Neuroscience, An institute of the KNAW, 
Amsterdam, The Netherlands 
3.  Champalimaud Neuroscience Programme at Instituto Gulbenkian 
de Ciência, Oeiras, Portugal
# These authors contributed equally to this work.
PLoS One  (2011) 6 :e21855.18
C
h
a
p
t
e
r
 
1
Experience modulates vicarious freezing in rats: a model for empathy
ABSTRACT 
The study of the neural basis of emotional empathy has received a surge of interest 
in recent years but mostly employing human neuroimaging. A simpler animal 
model would pave the way for systematic single cell recordings and invasive 
manipulations of the brain regions implicated in empathy. Recent evidence has 
been put forward for the existence of empathy in rodents. In this study, we describe 
a potential model of empathy in female rats, in which we studied interactions 
between two rats: a witness observes a demonstrator experiencing a series of 
footshocks. By comparing the reaction of witnesses with or without previous 
footshock experience, we examine the role of prior experience as a modulator 
of empathy. We show that witnesses having previously experienced footshocks, 
but not naïve ones, display vicarious freezing behavior upon witnessing a cage-
mate experiencing footshocks. Strikingly, the demonstrator’s behavior was in turn 
modulated by the behavior of the witness: demonstrators froze more following 
footshocks if their witness froze more. Previous experiments have shown that rats 
emit ultrasonic vocalizations (USVs) when receiving footshocks. Thus, the role of 
USV in triggering vicarious freezing in our paradigm, is examined. We found that 
experienced witness-demonstrator pairs emitted more USVs than naïve witness-
demonstrator  pairs,  but  the  number  of  USVs  was  correlated  with  freezing  in 
demonstrators, not in witnesses. Furthermore, playing back the USVs, recorded 
from  witness-demonstrator  pairs  during  the  empathy  test,  did  not  induce 
vicarious freezing behavior in experienced witnesses. Thus, our  ndings con rm 
that vicarious freezing can be triggered in rats, and moreover it can be modulated 
by prior experience. Additionally, our result suggest that vicarious freezing is 
not triggered by USVs per se and it in uences back onto the behavior of the 
demonstrator that had elicited the vicarious freezing in witnesses, introducing a 
paradigm to study empathy as a social loop.19
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INTRODUCTION
The study of the neural basis of empathy has received a surge of interest in the last 
years following the description of brain activity in humans that suggests that the 
representations of a subjects’ own emotional states and sensations are partially 
activated when witnessing the disgust, pain or pleasure of others (Hutchison et 
al., 1999; Carr et al., 2003; Wicker et al., 2003; Keysers et al., 2004; Morrison et al., 
2004; Singer, 2004; Avenanti et al., 2006; Decety and Jackson, 2006; Decety and 
Lamm, 2006; Keysers and Gazzola, 2006; Jabbi et al., 2007; Jabbi et al., 2008). In 
particular, this evidence has been taken to suggest that a neural mechanism, 
similar to the mirror neurons found in the ventral premotor and inferior parietal 
lobe of the monkey, which respond both during the execution of goal directed 
actions and the observation of the same actions executed by others (Gallese et 
al., 1996; Umiltà et al., 2001; Kohler et al., 2002; Keysers et al., 2003; Fogassi et 
al., 2005; Fujii et al., 2008; Rozzi et al., 2008; Caggiano et al., 2009), could be at 
work in emotional and somatosensory brain circuits as well (Bastiaansen et al., 
2009; Keysers et al., 2010). Testing this idea would require single cell recordings 
and experimental manipulations of the brain regions involved in empathy. Such 
invasive techniques are not readily applicable in humans (but see (Hutchison et 
al., 1999; Mukamel et al., 2010)); therefore an animal model of emotional empathy 
would be essential to further our understanding of empathy. 
It has been proposed that empathy exists in social animals because the detection 
of discomfort, distress or fear in conspeci cs carries information of high survival 
value (Preston and de Waal, 2003). In the context of developing an animal model 
of empathy, here we will focus on whether rats and mice, the two most readily 
available laboratory mammals, show such social transmission of distress cues. 
Social transmission of information in rats does occur in a wide range of behaviors 
such as food preference (Galef, 1985; Galef and Beck, 1985), motor (Kohn and 
Dennis, 1972; Zentall and Levine, 1972) and avoidance behaviors (Masuda et al., 
2009). Moreover, rats, can respond with fear and learn from fear reactions of others; 
for instance, a neutral stimulus can acquire aversive value after an observation of 
conditioned responses of another rat (Church, 1959; Bruchey et al., 2010; Kim et 
al., 2010). Additionally, interactions with a distressed conspeci c seem to recruit 
the amygdala that is also active when experiencing  rst hand distress (Knapska et 20
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al., 2006). Also mice show evidence of similar social transmission: the observation 
of a conspeci c being shocked has been shown to induce vicarious freezing in 
mice (Jeon et al., 2010) and to enhance subsequent fear learning in this species 
(Chen et al., 2009a). Vicarious behavior in mice seems to be regulated by the 
degree of relatedness between the interacting individuals (Langford et al., 2006; 
Jeon et al., 2010). Together, these evidences suggest that rodents are sensitive 
to what happens to other rodents. Rodents might therefore provide a powerful 
animal model for studying and manipulating the neural mechanisms of empathy.
In the e ort to develop animal models of empathy, it is important to determine 
what aspect of empathy can actually be modeled. Current conceptualizations of 
empathy de ne it as being composed of two components/processes. First, if an 
individual has an a ective reaction that resembles that of another and is triggered 
by perceiving or imagining the state of that other individual, the individual is said 
to experience ‘emotional contagion’ (de Vignemont and Singer, 2006; Singer and 
Lamm, 2009). Emotional contagion occurs early in human development: babies 
are more likely to cry if they hear other babies cry. Second, if that individual is 
also aware of the fact that its emotional reaction is triggered by that of another, it 
experiences true empathy. This distinction is important, because empathy proper 
is more likely to trigger prosocial behavior than emotional contagion. In animals, 
it is however often impossible to assess whether they are aware of the source of 
their emotions, and accordingly to disentangle models of emotional contagion 
from models of empathy. 
Since empathy in humans has been shown to be modulated by experience (see 
Refs. (Preston and de Waal, 2003; de Vignemont and Singer, 2006; de Waal, 2008; 
Bastiaansen et al., 2009) for reviews) in this study we aimed at establishing a 
paradigm to study both empathy/emotional contagion itself and its modulation 
by prior experience. A vast number of studies in the literature reported gender 
di erences  in  empathy  and  social  perception  (Ho man,  1977;  Eisenberg  and 
Lennon, 1983; Connellan et al., 2000; Alexander and Hines, 2002; Baron-Cohen 
and Wheelwright, 2004; Baron-Cohen et al., 2005), moreover, gender di erences 
in social modulation of behaviors have been reported in rats (Westenbroek et al., 
2003; Westenbroek et al., 2005; Yee and Prendergast, 2010) with stronger e ects 
in females. We therefore use female rats in this study.  21
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In Experiment 1, we examined the behavior of two interacting female rats while 
one of them, the demonstrator, experiences a series of unconditioned aversive 
stimulus (5 footshocks) while the other, the witness, can hear, see and smell 
the reaction of the demonstrator. To investigate whether prior experience with 
a  similar  aversive  stimulus  would  modulate  the  reaction  of  the  witness,  we 
compared the behavior of witnesses that had previously experienced footshocks 
with that of witnesses that had not. Finally, we also quanti ed the relationship 
between the witnesses’ behavior and that of the demonstrators to examine if the 
way that the witness responds to the behavior of the demonstrator might in turn 
in uence the behavior of the demonstrator.
We predicted that witnessing the distress reactions of the demonstrator would 
alter  the  behavioral  pattern  of  the  witness  and  make  the  witness’  behavior 
resemble that of the demonstrator, for instance by showing an increased freezing 
or by expressing other distress-related behaviors. Moreover, we expected such 
vicarious fear responses to be more pronounced in witnesses that had previously 
experienced  footshocks.  Finally,  it  is  reported  that  rats,  when  paired  with  a 
conspeci c, express less conditioned fear responses, suggesting the existence of 
social bu ering e ects (Kiyokawa et al., 2004). Furthermore, the stress status of 
the partner plays an important role in social bu ering e ects, e.g. a non-shocked 
partner (not pre-exposed to footshocks) is more e ective in attenuating fear 
responses  than  a  shocked  partner  (pre-exposed  to  footshocks)  (Kiyokawa  et 
al., 2004). These  ndings led us to expect that demonstrators paired with naïve 
witnesses  show  less  distress  than  those  paired  with  experienced  witnesses, 
because of the di erential social bu ering by their paired witness group. 
Next,  we  set  out  to  explore  the  contribution  of  various  components  of  the 
auditory channel in triggering the vicarious freezing in the experienced witness 
rats.  It  is  well  documented  that  rats  emit  ultrasonic  vocalizations  (USVs)  and 
that the frequency and temporal pattern of such vocalizations are determined 
by speci c environmental factors (Brudzynski, 2005; Burgdorf et al., 2005; Ehret, 
2005; Brudzynski, 2007). USVs have been thought to play an important role in 
the  communication  between  conspeci cs  but  their  exact  function  remains 
unclear. It has been proposed that they can serve to: localize conspeci cs, transfer 
emotionally valenced information across conspeci cs and warn other individuals 22
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of external dangers to promote escape or dispersion. (see Refs. (Burgdorf et al., 
2005; Ehret, 2005; Brudzynski, 2007) for review). Furthermore it has been previously 
shown that rats emit USVs at a certain frequency (~22 kHz) in aversive conditions 
(e.g. during fear conditioning) and in the presence of cues that predict danger 
(Blanchard et al., 1991; Wohr et al., 2005). Additionally, a recent study showed that 
USVs can modulate social transmission of fear in rats (Kim et al., 2010), however 
not many studies in the literature examined the role of USVs in potential empathy 
paradigms. Thus, we set out to test the role of USVs in our potential model of 
empathy. First, we recorded the USVs produced during the social interactions 
in Experiment 1 in order to establish the degree of communication between 
witness and demonstrator pairs. Second, in Experiment 2, we used these recorded 
vocalizations and played them back to separate groups of naïve and experienced 
animals while monitoring their behavior, freezing in particular. We produced two 
kinds of auditory stimuli from the recordings of Experiment 1: i) 22 kHz ultrasonic 
vocalizations (all other recorded sound were  ltered out) ii) 2-4 kHZ control sound 
that share same temporal characteristics with USVs. 
METHODS
Subjects. Female Long-Evans rats (250-300 g) from Harlan US Davis were kept in 
a temperature controlled (22 ºC) room and maintained on a reversed 12-h light: 
12-h dark cycle (07:00 lights o  - 19:00 lights on). Rats were socially housed as 
2-4 rats per cage and had ad libitum access to food and water. All experiments 
are conducted during the dark cycle between 09:00 and 13:00 h. All experiments 
were conducted in strict accordance with the European Community’s Council 
Directive (86/609/EEC) and all experimental procedures were approved by The 
Institutional Animal Care and Use Committee of the University of Groningen 
(IACUC-RuG, approval number: 4669). 
Experiment 1
Groups. Adult female rats were randomly assigned to one of the witness or one of the 
demonstrator groups, each witness and demonstrator pair is composed of cage-
mates and therefore housed together from arrival till the end of the experiment. 
Witnesses and demonstrators were divided into the following subgroups: Witness 
groups - Naïve Control Witness, Naïve Shock Witness, Experienced Control Witness 23
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and Experienced Shock Witness; Demonstrator groups - Demonstrator paired 
with  Naïve  Control  Witness,  Demonstrator  Paired  with  Naive  Shock  Witness, 
Demonstrator paired with Experienced Control Witness, Demonstrator paired with 
Experienced Shock Witness (see table 1 for the explanation and abbreviations of 
the experimental groups and pairs). Rats were handled and habituated 3 minutes 
to the experimenter everyday for 10 days preceding the experiment. All rats were 
habituated to the transportation and experimental room for 20 minutes/day for 3 
days prior to the experiment. 
Apparatus.  To  ensure  that  experienced  witnesses  could  be  familiarized  with 
footshocks prior to the Empathy Test without generating conditioned fear for 
the context of the Empathy Test, two di erent chambers (context A and B) were 
used for the Pre-Exposure and Empathy Test in a counterbalanced fashion. Each 
chamber consisted of two adjacent animal compartments - witness compartment 
and demonstrator compartment (each D24cm x W25cm x H34cm) divided by a 
perforated transparent Plexiglas divider.  The dimensions of the two chambers 
were identical but the two contexts (A and B) were modi ed to maximize their 
discriminability by the animals. Context A had metal-coated sides, a transparent 
front door and lid, and was illuminated using a dim red light. Context B had side 
panels coated with a striped pattern using latex-based colors, a patterned solid 
front door and lid, and was illuminated using a bright white light. In both contexts 
(A and B), the demonstrator area had a stainless steel rod  oor to deliver shocks 
while a solid Plexiglas sheet covered the witness area’s  oor. The demonstrator 
Table 1: Conditions and Groups in Experiment 1  
  Each row indicates the Witness group and its paired Demonstrator group. 
 
Condition  Witness  Demonstrator 
Control 
NcW 
         Naive control Witness 
D(NcW) 
EcW 
    Experienced control 
Witness 
D(EcW) 
Shock 
NsW 
           Naive shock Witness 
D(NsW) 
EsW 
     Experienced shock 
Witness 
D(EsW) 24
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Figure 1. Illustration of experimental design of Experiment 1. Pairs of rats were exposed to the 
Empathy Test context for 15 minutes (Habituation). Twenty-four hours later, witnesses were placed 
in the other context, and either received or not a number of footshocks (Pre-Exposure Training). 
Twenty four hours later, the witnesses were tested for long-term retention of this experience by 
replacing them in the pre-exposure context and measuring freezing (Pre-Exposure Test). Twenty-
four hours later, demonstrator - witness pairs were placed again in the 2 compartments of the 
Empathy context. This time, the demonstrator (right) receives shocks through the  oor grid while 
the witness (left) can hear, see and smell the demonstrator through a perforated Plexiglas dividing 
screen. The lowest panel schematizes the time course of the Empathy Test session.25
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area of each chamber (context A or B) was used for the Pre-Exposure training of 
the experienced witnesses. Experienced witnesses that received the footshock in 
context A, were then tested in context B in the Empathy Test or vice-versa. Between 
animals, chambers were wiped twice with di erent substances to ensure the 
contexts di ered in odor: context A- 7  0% alcohol and then 3% mint soap solution 
and context B- 3% vinegar and then antibacterial soap solution. 
Pre-Exposure.  All  witnesses  were  placed  in  the  Pre-Exposure  environment 
individually and after 15 minutes of exploration, only experienced witness groups 
received 4 footshocks (1 second each, 0.8 mA) separated by random intervals 
ranging between 240 and 360 seconds (Fig. 1). The pre-exposed rats were housed 
individually for 1h after pre-exposure before being returned to their home cages. 
Twenty-four hours later, both naïve and experienced witness rats were individually 
tested in the same Pre-Exposure context for 5 minutes (this session will be referred 
as Pre-Exposure test) and freezing behavior was scored during the last 3 minutes. 
As this test session could lead to extinction of the acquired fear, at the end of 
the 5 minutes of Pre-Exposure test, experienced witnesses received one reminder 
footshock (1 second, 0.8 mA) before they were taken out of the chamber. Again, 
the rats were then housed individually for 1h before returning to their home cage. 
Empathy Test. All witness-demonstrator pairs were habituated to the Empathy 
Test environment a day prior to the Pre-Exposure training of witnesses. In the 
Empathy Test, the witness and demonstrator constituting a pair were placed in 
the two adjacent areas of the Empathy Test chamber for a total time of 40 minutes 
(Fig. 1). After 10 minutes of baseline, in the shock condition,  ve footshocks (each 
footshock 5 seconds, 0.8 mA) separated by random intervals of either 2 or 3 m, 
were delivered to the demonstrator rat only (Fig. 1). In the control condition, 
the exact same procedure was used, except that a Plexiglas  oor separated the 
demonstrator rat from the metal grid through which the shocks were delivered. 
This ensured that any sounds or vibrations generated by the shock device would 
be identical between the shock and control conditions, but the actual footshocks 
would  only  reach  the  experimental  but  not  the  control  demonstrators.  Any 
di erences in freezing rate between the two conditions therefore cannot be due 
to classical conditioning to the sound of the shock device. After the last shock 
delivery, rats were left in the box for an additional 20 minutes. 26
C
h
a
p
t
e
r
 
1
Experience modulates vicarious freezing in rats: a model for empathy
Behavioral Scoring and Analysis. The entire test sessions were videotaped with a 
CCD black and white camera (Model SSC-M370 CE, Sony, Japan) mounted on the 
chamber and connected to an MPEG-encoder PC. Movies were stored in MPEG-
2 digital format for later behavioral scoring. Live image from the same camera 
was transferred to a PC running a video-tracking system (Ethovision 3.1; Noldus 
information technology, Wageningen, Netherlands) for quanti cation of general 
movement  and  locomotor  activity  of  the  witness  groups.  Locomotor  activity 
of witnesses is sampled as 5 minute time-bins and the percentage change in 
locomotion was calculated by subtracting the locomotor activity measured in 
the  rst 5 minutes (taken as a baseline) from the locomotor activity sampled in 
the subsequent 5 minute time-bins (in total 8 time-bins were used: 1st and 2nd 
-before shock, 3rd and 4th -shock period, 5th and 6th -after shock and 7th and 8 th 
recovery period, Fig. 2b illustrates only the  rst 6 time-bins). Additional video-
tracking analysis was run to quantify the amount of time spent by witnesses in 
close distance to the demonstrator. For this analysis, the observer’s compartment 
was divided in a far and a close half, relative to the screen dividing the two rats 
(each zone is 12.5 cm wide) and time spent in the zone close to the demonstrator’s 
compartment (window zone) is calculated in three 10 minute time periods, each 
corresponding to before shock, shock and after shock periods, respectively. 
Freezing behavior was scored in the Pre-Exposure training, Pre-Exposure test 
and in the Empathy Test sessions. A trained researcher that was blind to the 
experimental condition, performed the behavioral scoring from the digital movies 
using Observer XT (Noldus information technology, Wageningen, Netherlands) 
and Jwatcher (http://www.jwatcher.ucla.edu/). A rat was considered to be freezing 
if it was (i) in the stereotypical crouching posture and (ii) not moving except for 
respiration related movements. In the Empathy Test, total time of freezing scoring 
consisted of 14 minutes divided in 6 time-bins per rat. The  rst time bin lasted 
from -2 minute to 0 relative to the onset of the  rst shock. The other  ve time-bins 
corresponded to the time following each of the 5 shock trials (since the inter-
shock interval was either 3 or 2 minutes, the time-bins used corresponded to 3 
time-bins of 2 minutes and 2 time-bins 3 minutes). For control groups, the same 
scoring schedule was used. Freezing scores were calculated as the percentage of 
time during each bin that the rats spent freezing. Average percentage freezing 
in shock period was calculated by averaging the freezing scores in 5 time bins 27
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following the footshock trials. 
Ultrasonic  Vocalization  Recordings  and  Analysis.  Sounds  were  recorded  with  a 
high-frequency omnidirectional microphone (Earthworks M30, frequency range 
5-30kHz, Earthworks Inc., Milford NH) mounted on the chamber, and ampli ed 
(Edirol FA-66, Roland Corporation, Los Angeles, CA).  Sounds were digitized at 
96 kHz, 16 bits and stored in wav format using Adobe Soundbooth CS3 (Adobe 
Inc.) on a Macintosh computer. In order to count the number of USVs emitted by 
witness-demonstrator pairs, wav  les were processed in Matlab (Mathworks Inc.) 
to create sound spectrograms using short-time fast Fourier transform (sFFT) with 
a window of 256 time points and an overlap of 75%, resulting in a  nal frequency 
resolution of 1.5 kHz and time resolution of 0.6 ms. Frequencies outside 15-30 
kHz were truncated. Time points containing USVs were separated from those 
containing only environmental noise by considering the standard deviation of 
the ( ltered) power spectrum of each time point. 
Time points containing USVs were clearly identi able as having a higher standard 
deviation in the power spectrum with respect to time points containing only 
environmental noise. We therefore set the time points containing only noise to 0 
dB, and summed the power of each time point across frequencies. The resulting 
vector was smoothed with a moving average of 100 time points (corresponding 
to approximately 66.67 ms) to increase the signal-to-noise ratio. The nonzero time 
points of this vector were used to calculate the number of calls, and to compute 
the distribution of the estimated number of calls for di erent durations. Only 
the number of emitted USV in the time frame of freezing scores (6 time bins, see 
behavioral scoring and analysis for details) was taken into consideration. In order 
to check the accuracy of the algorithm, the number of USVs in the recording of 5 
di erent demonstrator-witness pairs was quanti ed both by the algorithm and 
manually. The number of calls detected by algorithm matched the number of 
manually counted calls during the same interval.
Experiment 2
Groups, Chambers and Experimental Design. Rats were handled and habituated 
3 minutes to the experimenter everyday for 10 days preceding the experiment. 
All rats were accustomed to the transportation and experimental room for 20 28
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minutes/day for 3 days prior to the experiment. On the  rst day of the experiment, 
all rats were habituated to the Sound Test chamber (D25xW40xH40) for 15 minutes. 
Then, rats were divided into two groups: Experienced and Naïve. Experienced 
animals were trained with footshocks according to the Pre-Exposure training 
schedule described in Experiment 1, whereas the other animals were kept naïve to 
footshock. On the following day, animals were placed in the Sound Test chamber 
and Control sounds or USV sounds were played back from a high frequency 
loudspeaker (Precision 8D Studio Monitor, Tannoy Ltd., Scotland, UK) through 
the holes in the Plexiglas divider also used in Experiment 1. In pilot experiments, 
playback loudness was adjusted to lead to the same sound intensities in the 
chamber of the witness rats as in Experiment 1. Since the distance between the 
speaker and the animal depends on the place preference of the animal, we set 
the distance of the speaker such that the maximal distance (45 cm) or minimal 
distance  (5  cm)  between  rat  and  speaker  corresponded  to  the  maximum  or 
minimum distance between the witness and demonstrator pairs in the Empathy 
Test. The total duration of the Sound test was 40 minutes, however only the time 
window of interest is analyzed (see below for detailed explanation). 
Auditory Stimulus and Playback. In this experiment two di erent sounds (USV 
and Control sounds) were played back to naïve and experienced rats. In order to 
prepare the USV stimuli for playback, the sound tracks recorded from the EsW-
D(EsW) pairs during Experiment 1 were band-pass  ltered in the range between 
17 and 25 kHz in Adobe Soundbooth CS3 (Adobe, San Jose, CA).  No USVs outside 
this frequency range were observed. Control sounds were generated from the 
same sound track recorded in Experiment 1 by using the SOX software (http://sox.
sourceforge.net/). USVs in each recorded  le were pitched down 35 semitones to 
a range of 2.6 - 4 kHz, while intensity and temporal characteristics were preserved. 
This range for the control sound was selected on the basis of the previous  ndings 
in the literature that rat e ectively discriminates 4 kHz sounds from USVs (Bang 
et al., 2008). Sound presentation started after 10 minutes of baseline at the point 
in which the  rst electroshock was given in the recording session (Experiment 1), 
so as to lead to a similar timing as in the Empathy Test in Experiment 1 (footshock 
exposure of demonstrator started after 10 minutes of baseline). In addition to this 
main auditory experiment (Experiment 2) we also conducted a pilot experiment 
to explore the contribution of other auditory signals contained in the sound track 29
C
h
a
p
t
e
r
 
1
Experience modulates vicarious freezing in rats: a model for empathy
recorded in Experiment 1. In this pilot experiment, the same rats that had only 
been exposed to the control sound in Experiment 2 were place in the test chamber 
once  more  and  exposed  to  a  playback  of  the  un ltered  recording  (USV  and 
audible sounds) of the Empathy Test. In Experiment 2 and in the pilot experiment, 
freezing behavior was scored and analyzed using the same time window as in 
Experiment 1 but only in 2 time-bins corresponding to 2 minutes before the onset 
of the playback and 12 minutes during sound playback, respectively.
Behavioral  Scoring  and  Analysis.  Behavioral  scoring  was  performed  live  with 
Ethovision 3.1. (Noldus information technology, Wageningen, Netherlands). 20% 
of the animals were also scored blindly and the correlation coe cient between 
blind and live scoring was found to be nearly perfect (pearson correlation, rp=0.96, 
p<0.05).
Statistical  Analysis.  A  separate  analysis  was  performed  on  witnesses’  and 
demonstrators’ freezing levels. In both cases, we analyzed between and within 
group changes in freezing behavior using a two-way mixed e ect analysis of 
variance (ANOVA) with time (before and after shock) as a within factor and group 
(either witness or demonstrator groups) as a between factor. In the analysis of 
the dynamics of interaction between demonstrator and witness, we analyzed 
the freezing behavior of demonstrators and witnesses separately.  In both cases, 
we analyzed changes in freezing behavior using a two-way ANOVA with time (6 
time bins) as within factor and group (2 shock groups) as between factor. Planned 
comparisons were conducted using unpaired t-tests to compare the di erences 
between groups, while planned comparisons using paired t-tests were performed 
to compare the di erences between time bins. A two-way mixed e ect ANOVA 
model was used, with factors for time bins (within) and group (between) for the 
analysis of locomotor activity of witnesses. Further post hoc tests were performed 
for more detailed comparisons between witness groups and time bins. Similarly, 
di erences in the time spent in the window zone were tested with a two-way 
mixed e ect ANOVA with time bins as within and group as between factors, 
followed by post hoc tests. The p values resulting from the latter two analyses 
were corrected for multiple comparisons with the Bonferroni method. Pearson’s 
correlation was used to calculate the relationship between freezing of EsW and 
freezing of D(EsW), and between USV and average freezing of demonstrators and 30
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Figure 2. Behavior of 4 witness groups in Empathy Test. Naïve control witness (NcW), experienced 
control witness (EcW), naïve shock witness (NsW), experienced shock witness (EsW). (A) % Average 
freezing before shock and during shock period by witnesses. ***p<0.001 EsW compared to all the 
other witness groups. (B) % Change in locomotor activity before shock, shock and after shock 
periods. % Change in locomotion is relative to the  rst time bin that served as baseline and thus 
has a value of zero by de nition. $p<0.05, $$p<0.01 EsW compared to EcW; ##p<0.01, ###p<0.01 
EsW compared to NcW ; ***p<0.001 EsW compared to NsW. (C) % Time spent in window zone by 
witnesses. $p<0.05, $$p<0.01 EsW compared to EcW ;  ##p<0.01 EsW compared to NcW; *p<0.05,   
**p<0.01 EsW compared to NsW. All data is presented as mean ± S.E.M (n = 11-15 per group).31
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as well as between USV and average freezing of witnesses. In the analysis of USV, 
the percentage of pairs that emitted USV was calculated and compared between 
NsW-D(NsW) and EsW-D(EsW) pairs with t-test. 
Figure 3. Social modulation of freezing in witnesses and demonstrators. (A) % Average freezing 
before shock and during shock period by demonstrators paired with naive (D(NsW) and experienced 
(D(EsW) witnesses. (B) Correlation between freezing levels of experienced shock witness (EsW) 
and their paired demonstrator (D(EsW)). (C) % Freezing levels of naïve (NsW) and experienced 
shock witness (EsW) before shock (BS) and during footshock trials (1st to 5th). (D) % Freezing of 
demonstrator group paired with naïve (D(NsW) and experienced (D(EsW)) witnesses before shock 
(BS) and during footshock trials (1st to 5th). **p<0.01, ***p<0.001 compared to respective groups . All 
data is presented as mean ± S.E.M (n = 11-15 per group).32
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RESULTS
As  we  were  interested  in  the  e ect  of  prior  experience  with  footshock  on 
vicarious fear, we  rst veri ed whether Pre-Exposure training with footshock led 
to the formation of a long-term memory for the aversive event in experienced 
witnesses. To this end, we compared the freezing behavior of experienced and 
naïve witnesses in the Pre-Exposure test. We found that experienced witness rats, 
that received footshocks on the Pre-Exposure training, froze signi cantly more 
than naïve witnesses (36.6  5.2 %, vs. 1.2 ± 0.7 % (mean±SEM)) in the Pre-Exposure 
test (t (20) = -3.276, p<0.001). This  nding con rmed that a long-term memory of 
the Pre-Exposure event was formed in the experienced witnesses.    
Vicarious fear
To investigate whether rats display vicarious fear when observing a conspeci c 
receiving  footshocks,  freezing  behavior  was  compared  across  witness  groups 
(Fig. 2a). A 4 Groups (NsW, EsW, NcW, EcW) x 2 time period (before shock vs. 
shock period) mixed e ect ANOVA for freezing levels revealed a signi cant main 
e ect of group (F3,96=12.519, p<0.0001), time period (F1,96=45.201, p<0.0001) and 
interaction of group by time period (F3,96=14.939, p<0.0001). Following planned 
comparisons  showed  that  EsW  displayed  higher  freezing  levels  in  the  shock 
period compared to all other witness groups (p<0.0001 compared to NsW, NcW, 
EcW). These results indicate that in our experiment, rats express vicarious freezing 
behavior when observing a conspeci c being shocked but only when they have 
had prior experience with footshock.
We also analyzed the locomotor activity of the four witness groups using video-
tracking.  This  data  provides  an  overall  measure  of  the  witnesses’  locomotor 
activity throughout the whole Empathy test period (Fig. 2b).  A 4 Groups (NsW, 
EsW, NcW, EcW) x 7 time bins (each consists of 5 minutes) mixed e ect ANOVA 
for locomotor activity, indicated a signi cant main e ect of group (F3,48=7.84, 
p<0.0001)  and  e ect  of  time  bins  (F6,288=19.748,  p<0.0001),  and  a  signi cant 
e ect  of  interaction  between  group  and  time  bins  (F18,288=2.983,  p<0.0001). 
Further post-hoc analyses pointed out that EsW exhibited a signi cantly larger 
reduction of locomotor activity in time bins corresponding to shock period and 33
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to after shock period (see Fig. 2b for the signi cant di erences relative to other 
groups). This con rmed the results derived from the analysis of freezing behavior. 
Locomotion of the four witness groups reconverged during the last 10 minutes 
of the Empathy Test when all groups showed a similar level of activity (Data not 
shown). Additionally, by using the video-tracking system, we could also assess 
whether the witness rats preferred to be close to the demonstrator during the 
Empathy test session (Fig. 2c). To this end, we divided the witnesses’ compartment 
Figure 4. (A) Example sound spectrograms illustrating (1) a 40 min sound track containing USVs 
recorded in Experiment 1, (2) USVs in a 10 second time window detail, (3) the result of the automated 
detection of USVs in Matlab, with epochs containing a single 22 kHz-USV shown in yellow. (B) % of 
naïve shock witness (NsW)-demonstrator (D(NsW) pairs and % experienced shock witness (EsW) 
and Demonstrator (D(EsW) pairs that emitted USVs. (C) Correlation between the number of emitted 
USVs and % average freezing response in shock period by both demonstrator groups (paired with 
naïve shock witness D(NsW) and paired with experienced shock witness D(EsW) together). (D) 
Correlation between the number of USVs and % average freezing behavior in shock period by naïve 
shock witness (NsW) and experienced shock witness (EsW) groups.34
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in 2 equal zones: a window zone close to demonstrator and a wall zone far from the 
demonstrator. A 4 Groups (NsW, EsW, NcW, EcW) x 3 time periods (before shock, 
shock, after shock) mixed e ect ANOVA comparing the proportion of time spent 
in the window zone revealed a signi cant e ect of group (F3, 48=3.063, p<0.05) 
and e ect of time period (F2, 96=26.394, p<0.0001) and as well as signi cant e ect 
of interaction between group and time period (F6, 96=5.846, p<0.0001). Following 
post hoc comparisons showed that the EsW group spent signi cantly more time 
in the window zone close to their demonstrator than all the other witness groups 
during shock period and after shock period (see Fig. 2c for signi cant di erences 
relative to other groups).
E ect of social interaction on freezing behavior of demonstrators 
A two by two mixed e ects ANOVA, demonstrator groups ((D(NsW) vs D(EsW)) 
and  two  time  periods  (before  shock  and  shock  period),  for  freezing  levels 
showed a signi cant main e ect of group (F1,24=35.619, p<0.0001), of time period 
(F1,24=227.615, p<0.0001) and a signi cant interaction between group and time 
period (F1,24=29.890, p<0.0001). Planned comparisons show that before shock 
trials both groups displayed low levels of freezing that did not signi cantly di er 
from each other (p = 0.658, Fig. 3a), and that footshock delivery led to signi cantly 
higher levels of freezing in all demonstrators exposed to footshock (comparison 
of  freezing  before  shock  period  vs  during  shock  trials,  p<0.0001  for  D(NsW), 
p<0.0001 for D(EsW)). However, D(EsW) expressed signi cantly more freezing 
behavior than D(NsW) (p<0.0001, Fig. 3a) during the shock period. To further 
explore the relationship between freezing displayed by the demonstrator and 
the witness rats, we examined the correlation between freezing levels displayed 
by D(EsW) and EsW rats (the group of witness rats which displayed vicarious 
freezing). We found no signi cant correlation (Pearson r=0.247 p=0.394, Fig. 3b), 
suggesting that prior experience, rather than di erences in freezing displayed 
by demonstrators (D(EsW) vs. D(NsW)), underlies the di erences observed in the 
behavior of the two shock witness groups.  
To further investigate the dynamics of the demonstrator – witness interaction, 
we conducted analyses to look at the e ect of time on the di erence of freezing 
between  the  demonstrator  and  witness  groups  separately  (Fig  3c,  3d).  A  2 
shock witness groups (NsW, EsW) x 6 time bins (before shock, 1st to 5th shock 35
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trials) mixed e ect ANOVA for freezing behavior indicated a signi cant e ect 
of group (F1,24=11.259, p<0.01) and e ect of time (F5,120=3.594, p<0.01). Planned 
comparisons further unveiled that a signi cant increase in freezing behavior of EsW 
relative to the baseline emerged after the 1st footshock trial (p=0.041 compared 
to baseline) and that after this initial increase, freezing levels remained stable in 
the following footshock trials (no di erence between 1st shock trial compared to 
2nd – 5th, p>0.05). Freezing levels of EsW signi cantly di ered from NsW in some 
of the footshock trials, but the di erence was not signi cant in all cases (Fig. 3c). 
A 2 shock demonstrator groups (D(NsW), D(EsW)) x 6 time bins (before shock, 
1st  to  5th  shock  trials)  mixed  e ect  ANOVA  for  freezing  behavior  revealed  a 
signi cant e ect of group (F1,24=34.585, p<0.00001), e ect of time (F5,120=36.406, 
p<0.00001) and as well as signi cant interaction of group and time (F5,120=4.052, 
p<0.01). Planned comparisons showed that freezing displayed by both groups 
of demonstrators (D(NsW) and D(EsW)) increased gradually over footshock trials: 
Freezing  levels  of  the  D(EsW)  showed  a  signi cant  increase  on  the  1st  shock 
trial relative to baseline (p=0.004), and increased again after the 2nd shock trial 
(p=0.001 relative to the 1st). Importantly, the signi cant di erence in freezing 
levels between D(EsW) and D(NsW) only emerged after the 2nd shock trial and 
remained signi cant in the all subsequent shock trials (Fig. 3d). Collectively, these 
 ndings show that the di erences in freezing between NsW-D(NsW) and EsW-
D(EsW) have a di erent time course for the demonstrators and witnesses. This 
Figure  5.  %  Freezing  behavior  of  Naïve  (Naïve-Control,  Naïve-USV)  and  Experienced  groups 
(Experienced-Control and Experienced-USV) before and during control and USV sound stimulus in 
Experiment 2. All data is presented as mean ± S.E.M (n = 10-11 per group).36
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di erence peaked around the 1st shock trial for EsW, but after the 2nd in both 
demonstrator groups (D(NsW) and D(EsW)). 
Alarm calls during the Empathy Test
Analyses of the USVs revealed that not all pairs of rats submitted to shocks emitted 
USV, and that a larger proportion of EsW-D(EsW) than NsW-D(NsW) pairs emitted 
USVs (86% versus 45%, p<0.05, Fig. 4b). Separate correlation analysis between 
the number of USVs emitted and proportion of freezing displayed by witness 
groups (EsW and NsW) and demonstrator groups (D(EsW) and D(NsW)) show 
a signi cant correlation between emitted USVs and mean percentage freezing 
for the demonstrator groups (r=0.602, p=0.001, Fig. 4c), but not for the witness 
groups (r=0.254, p=0.210, Fig. 4d). This shows that di erences in the number 
of USVs emitted by each pair is mainly explained by di erences in the freezing 
behavior of the demonstrators, suggesting that they might be the prime source 
of USVs. 
Next,  we  examined  whether  these  alarm  calls  induced  freezing  in  naïve  or 
experienced rats, to which end we performed Experiment 2, a sound playback 
experiment. Analysing Experiment 2 using a mixed e ects ANOVA with freezing as 
the dependent variable and a 4 groups (Naïve-Control, Naïve-USV, Experienced-
Control, Experienced-USV) x 2 time periods (before sound stimulus and during 
sound stimulus) design revealed a signi cant e ect of time period (F1,37=18.480, 
p<0.0001),  but  no  signi cant  e ect  of  group  (F3,37=1.006,  p=0.401)  and  no 
signi cant interaction of group and time period (F3,37=1.361, p=0.270). Although 
there was a signi cant increase in freezing levels in both experienced and naïve 
rats during the presentation of any sounds (USV and control sound stimuli), the 
playback of USVs did not increase the freezing levels above and beyond that of 
the control sounds in experienced or naïve listeners (Fig. 5). 
Finally, to examine if auditory information other than USVs could have triggered 
freezing in our experiment, we performed a pilot experiment in which we played 
back the un ltered recording of Empathy test (USV together with other audible 
sounds) and we found that the listening rats did displayed freezing behaviour 
when faced with the combination of USVs and environmental sounds, and that 
this freezing was stronger in experienced than naïve listeners (t (17) = 2.177, 37
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p<0.05, Fig. S1). Importantly, although these rats were not experimentally naïve, 
we did not observe any di erence in freezing behavior before the onset of the 
sound stimulus (Fig. S1). 
DISCUSSION 
In this study, we describe a paradigm to potentially study empathy in rats and, 
in particular, the role of prior experience in modulating the empathic response: 
a demonstrator rat was exposed to footshocks while a cage mate witnesses its 
distress. We found that demonstrator rats receiving footshocks displayed typical 
fear responses to this distressing experience, including freezing and emission of 
USVs and that witness rats that had previously experienced shocks themselves 
(EsW) displayed similar, albeit less intense, fear responses, including augmented 
freezing and reduced locomotion. Thus, our experiments con rm that rats can 
express vicarious fear responses even though not experiencing  rsthand pain 
or  distress. This  vicarious  response  was  signi cantly  reduced  (and  no  longer 
signi cant) in witness rats that had not experienced electroshocks in the past. We 
further found that the di erence in vicarious behavior of the witnesses fed back 
onto the behavior of the demonstrators that had triggered it in the  rst place: 
D(EsW) that were shocked in the company of experienced witnesses progressively 
froze more than D(NsW) that were exposed to footshocks of the same intensity 
in the company of naïve witnesses. Finally, the playback of USVs alone did not 
trigger such vicarious freezing more than control sounds. 
Prior Experience modulates vicarious freezing in rats
Recent studies put forward that mice can display empathic behaviors. In one study, 
the writhing behavior of a mouse in response to abdominal pain was enhanced if 
witnessing another mice writhe (Langford et al., 2006). The second study showed 
that mice express freezing when observing a conspeci c being shocked (Jeon et 
al., 2010). The fact that we found a signi cant elevation of freezing in EsW rats 
while observing demonstrator rat receive shocks con rms that a similar form of 
vicarious distress behavior can be observed in another species of social rodents, 
the rat. Moreover, that vicarious freezing was lower in NsW compared to EsW 
adds to our understanding of this phenomenon by showing that having prior 
experience with footshock can modulate this vicarious reaction. Our  ndings are 38
C
h
a
p
t
e
r
 
1
Experience modulates vicarious freezing in rats: a model for empathy
in line with the study indicating that conditioned fear responses elicit signi cant 
freezing in rats that previously experienced an aversive event but not in naïve rats 
(Kim et al., 2010).   
The fact that vicarious freezing in NsW was not only lower but also failed to di er 
signi cantly from baseline apparently contrasts with the study reporting strong 
vicarious freezing behavior displayed by naïve mice (Jeon et al., 2010). Many 
di erences between the two experiments could account for this discrepancy. For 
example, the intensity and the frequency of the aversive stimulus (footshock) that 
the witnesses observe seem to play a very important role in modulating empathic 
responses ((Jeon et al., 2010)supplementary material). Therefore it is reasonable 
to think that NsW in our experiment might have shown more vicarious freezing if 
demonstrators had been exposed to more intense or frequent footshocks. Future 
experiments will be required to determine the adequate intensity and frequency 
of the footshock to elicit empathic response in naïve witnesses and examine how 
much prior experience can further augment this response. Moreover, because 
most other developed empathy models in rodents used male mice (Langford, 
2006; Chen et al., 2009a; Jeon et al., 2010) whereas in our study we used female rats, 
it is plausible that there might be species and/or gender di erences in vicarious 
fear  behaviors.  Species  di erences  have  been  suggested  by  studies  reported 
con icting  ndings in social modulation of learning between mice and rats. For 
example, one study indicated that brief social interaction with a recently fear-
conditioned conspeci c improves the subsequent fear learning in rats (Knapska 
et al., 2010), whereas similar social interaction impairs fear learning in mice (Bredy 
and Barad, 2009). Gender di erences, on the other hand, would dove-tail with 
gender di erences in social support (Westenbroek et al., 2003) in rats and in social 
interest in human infant (Connellan et al., 2000) and chimpanzees (Alexander and 
Hines, 2002). Additionally, gender di erences in self reported human empathy and 
in functional activity associated with the human mirror neuron system have been 
also reported (Cheng et al., 2008; Cheng et al., 2009). Nonetheless, it was recently 
found, with a paradigm somewhat di erent form the one used in our study, that 
prior experience plays a crucial role in social transmission of fear between male 
rats as well (Kim et al., 2010). Future experiments testing rats and mice of both 
sexes in the same paradigms will be necessary to examine the presence of gender 
and species di erences in vicarious freezing. 39
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In our study, we did not examine the e ects of the estrous cycle on the vicarious 
freezing behavior, therefore variance in our data could in part be due to di erences 
in estrous cycle. There is evidence that estrous cycle could a ect anxiety and fear 
responses and therefore a ect freezing behavior in female rats (Frye et al., 2000; 
Marcondes et al., 2001; Chen et al., 2009b), however other studies reported no 
in uence of estrous cycle on anxiety levels, fear responses or social interaction in 
female rats (Hiroi and Neumaier, 2006; Stack et al., 2010).  
Other animal studies reported that past experience play a role in reinforcing 
social  transmission  of  fear  and  avoidance  behavior  in  rats  and  empathy  in 
pigeons (Church, 1959; Watanabe and Ono, 1986; Masuda et al., 2009; Kim et al., 
2010). Moreover, there is evidence of prior experience dependent modulation of 
empathic behavior in humans (see Ref. (Preston and de Waal, 2003) for a review). 
In particular, functional magnetic resonance imaging studies reported that in 
humans, hearing piano does not activate the premotor cortex, if one has never 
played the piano. Five lessons of piano playing, however, are su cient for the 
sound of piano to activate areas of the premotor cortex involved in playing the 
piano (Lahav et al., 2007). These results have been interpreted as evidence for 
Hebbian learning: a particular set of sounds (piano notes) becomes associated 
with a particular inner state (premotor activity required to play the piano) because 
each time the premotor neurons  re, the participant can hear the consequences 
of this action, namely the piano notes (Keysers and Perrett, 2004; Keysers and 
Gazzola, 2009).
Our results are compatible with a Hebbian learning account for the modulation 
of  empathic  behaviors  by  prior  experience.  When  experiencing  footshocks, 
rats will experience their own pain together with the sound and smell of their 
own reactions (emission of vocalizations, release of pheromones, and sound of 
running during the shocks alternated with the silence associated with freezing). 
The sensory consequences of these pain responses could become associated with 
the experience of pain during footshocks. Once this association is established, 
perceiving similar sounds and smells while a demonstrator is shocked and reacts 
accordingly,  would  trigger,  by  association,  a  vicarious  form  of  the   rst-hand 
experience of being shocked, including vicarious freezing. Rats that have not 
experienced this particular type of distress would be expected to have some, albeit 40
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weaker associations between the sensory consequences of the demonstrators 
distress and their own distress. Such weaker associations would originate from 
the naïve rats experience with other forms of stressors ( ying in from the US, 
grabbing from their home cage, handling by unknown humans etc). These other 
stressors  have  probably  led  to  somewhat  similar/overlapping  behaviors  (e.g. 
squeaking, trying to run away, USVs), that could have been Hebbianly associated 
with the similar states of distress in these rats. Indeed, in our experiment, there is 
a trend for NsW to demonstrate more freezing than the NcW. In addition, because 
sensing the distress of others is such a valuable source of information about 
dangers, one might suspect that certain expressions of distress may be inborn 
triggers of vicarious emotions and behavior, and thereby cause some vicarious 
freezing without any need for Hebbian learning.  
 
There  might  however  be  other,  less  speci c  routes  for  prior  experience  to 
in uence vicarious freezing. The prior experience of stress in experienced witness 
groups might have altered their emotional and cognitive state. For instance, the 
distress during Pre-Exposure could have generated a state of heightened anxiety 
that would prime these animals to be more sensitive to distress signals in the 
empathy test or to express their own distress-behavior more readily upon sensing 
the distress of others (Li et al., 2008; Masuda et al., 2009). Or, the prior experience 
might modulate the attentional and motivational states of the witnesses towards 
the behavior of their conspeci cs, including their demonstrators. More attention 
to the demonstrators would then increase vicarious freezing. In support of that 
possibility, EsW spent more time close to the demonstrator during and after the 
shock trials. 
One of the core bene ts of developing a potential rodent model of experience-
dependent empathy is that it will a ord us the possibility to disentangle these 
alternative accounts. For instance, repeating Experiment 1 with the addition of 
a group that would have experienced a di erent, but similarly intense, stressor 
during Pre-Exposure (e.g. immersion in ice water) would be highly instructive: a 
Hebbian account would predict this new group to freeze less, anxiety or attention 
accounts, as much, as the electroshock-pre-exposed group.
Prior experience of witnesses in uence the demonstrator’s response
We also found that during the shock exposure, D(EsW) expressed more freezing 41
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than D(NsW). Given that demonstrator rats were randomly assigned to these two 
groups and received the exact same treatment throughout the experiment, the 
only systematic di erence between these groups has to originate from systematic 
di erences in the treatment received by their witnesses.  The possible explanation 
for the di erence in freezing behaviors of two demonstrator groups might be due 
to di erential social bu ering e ects by their paired witness groups. Kiyokawa 
et  al  showed  that  the  stress  status  of  a  partner  could  in uence  the  social 
bu ering e ect in rats. In particular, rats paired with a naïve partner expressed 
less fear responses in a conditioning context than animals paired with previously 
shock-exposed partners (Kiyokawa et al., 2004). Our  nding is in line with this 
observation: demonstrators paired with naïve witnesses showed signi cantly less 
freezing responses compared with demonstrators paired with shock pre-exposed 
witnesses. Issues requiring further study include the channel that is responsible 
for the in uence exerted by the witnesses on the demonstrators and whether the 
di erence in freezing between the demonstrators represents (i) a di erences in 
their distress (Keysers and Perrett, 2004; Wohr et al., 2005; Brudzynski, 2007) or (ii) 
a di erence in the propensity to display signs of distress. An analogy to human 
behavior might clarify these latter alternatives. Would we be genuinely more 
distressed by a shock if the people around us showed more signs of concern or 
would we simply be more encouraged to show our distress? Disentangling these 
possibilities will be an interesting challenge for future research. Importantly, this 
 nding begs us to remember that social interactions are not one-way streets: 
the demonstrators in uenced the witnesses, but the witnesses also in uenced 
the demonstrators. While this conclusion may seem trivial, it actually brakes new 
grounds in the context of empathy research: most current models of empathy 
for pain or distress in human neuroscience used prerecorded stimuli (Wicker et 
al., 2003; Morrison et al., 2004; Jackson et al., 2005; Avenanti et al., 2006; Decety 
and Lamm, 2006; Gazzola et al., 2006; Jabbi et al., 2007; Jabbi and Keysers, 2008) 
or used live interactions but prevented participants from viewing the reactions 
of their partner (Singer, 2004; Singer et al., 2006). Accordingly, these experiments 
were unable, by design, to study how the observer’s response in uences the 
experience  of  the  demonstrator.  Our   nding  begs  us  to  design  experiments 
in which this feedback-loop and its neural mechanisms can be studied more 
explicitly in humans as well as in rodents. 42
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The social nature of our experiment is also evidenced by video-tracking data that 
shows the EsW opted to spend more time in the vicinity of their demontrators 
than any other witness groups, and by audio recordings that show, the EsW-
D(EsW) pairs communicated through more USVs than the NsW-D(NsW) pairs. The 
fact that the di erence in freezing between the demonstrators peaked later than 
that in the witnesses further suggests that the behaviour of the witnesses could 
have contributed to that of the demonstrators. 
USV playback alone does not trigger signi cant vicarious freezing 
In the second part of our study (Experiment 2), we examined the contribution of 
various components of the auditory channel in triggering the vicarious freezing. 
In both naïve and experienced rats, USVs only produced modest freezing rates 
(~5%) that did not exceed the freezing response to control sounds. Therefore, 
USVs alone cannot account for the bulk of the vicarious stress response in our 
experiment,  where  freezing  rates  reached  over  20%  in  EsW  in  Experiment  1. 
Although, the primary function of the rodent USVs remains poorly understood, 22 
kHz USV have often been associated with negative and 50 kHz USVs, with positive 
states (Blanchard et al., 1991; Brudzynski and Chiu, 1995; Panksepp and Burgdorf, 
2000; Burgdorf et al., 2005). However, it remains unclear whether and when 22kHz 
USV can trigger defensive behavior ( eeing or freezing) (Blanchard et al., 1991; 
Brudzynski and Chiu, 1995; Mongeau et al., 2003; Allen et al., 2007). At least in 
our experiment, and with the quality of playback achieved by our equipment, we 
concluded that USVs playback alone did not produce very robust freezing in naïve 
or experienced animals. In other situations, USVs might play a more important 
role (Kim et al., 2010). 
Additionally, in a pilot experiment, by playing back the recorded ultrasounds 
together with additional audible sounds associated with the behavior of the 
demonstrator’s  distress,  we  observed  an  experience  dependent  increase  in 
freezing (Fig. S1). This preliminary  nding suggests that audible sounds derived 
from the fear response of the demonstrator rat might convey distress signals to 
the witness. In particular the sound of the actions of the demonstrator rat (loud 
metallic sounds of running intermixed with conspicuous silence) might play an 
important role in this communication. In monkeys and humans, the sound of the 
actions of one individual triggers activity in premotor and somatosensory cortices 43
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of the listener that mirrors the activity in those of the  rst individual (Kohler et al., 
2002; Keysers et al., 2003; Gazzola et al., 2006; Etzel et al., 2008). Whether similar 
mirror mechanisms are at work in the rat remains to be explored.  
Given that previous studies have shown that visual (Kohn and Dennis, 1972; 
Langford et al., 2006) and olfactory cues (Brechbühl et al., 2008) can also play 
a role in social communication in rodents, our pilot data suggests that social 
modulation  and  empathy  seem  to  be  a  multimodal  phenomenon,  with  the 
dominant modality likely to vary from paradigm to paradigm. 
CONCLUSIONS
In conclusion, placing two rats in adjacent compartments and exposing one of 
the two to footshocks is a simple and viable paradigm to study the way in which 
distress reactions of a rat in uences the behavior of the other rat. Additionally, prior 
experience of footshocks increases the propensity of a rat to freeze in response to 
the distress of another. Our paradigm also evidences that the vicarious freezing 
of the witnessing rat can in turn in uence the behavior of the demonstrating rat, 
closing the social loop.
As mentioned in the introduction, emotional contagion refers to cases in which 
an emotion in one individual triggers a similar emotion in another, while empathy 
proper requires that the other is aware of the fact that the triggered emotion is 
not his/her, but that of another person. Because it is impossible to assess whether 
rats have any form of awareness of their own emotions (i.e. have feelings), and 
of the source that triggered the emotion, it is di cult to equate our results with 
emotional contagion or empathy (Singer et al., 2006). Even the degree to which 
the witnesses in our experiment only showed similar behaviour to that of the 
demonstrator or felt the same emotion remains veiled. All we can state is that the 
witnesses reacted with a typical distress behavior to the distress of another rat, 
and that this represents a potential model for human empathy. 44
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Figure S1. % Freezing behavior of Naïve (N) and Experienced (E) groups before and during the 
playback of the un ltered recording (22 kHz USVs and the audible sounds < 20 kHz) from the EsW-
D(EsW) pairs in Empathy Test. All data is presented as mean ± S.E.M (n = 9-10 per group). *p<0.05, 
Experienced group compared to Naive. Figure S1. % Freezing behavior of Naïve (N) and Experienced 
(E) groups before and during the playback of the un ltered recording (22 kHz USVs and the audible 
sounds < 20 kHz) from the EsW-D(EsW) pairs in Empathy Test. All data is presented as mean ± S.E.M 
(n = 9-10 per group). *p<0.05, Experienced group compared to Naive. Figure S1. % Freezing behavior 
of Naïve (N) and Experienced (E) groups before and during the playback of the un ltered recording 
(22 kHz USVs and the audible sounds < 20 kHz) from the EsW-D(EsW) pairs in Empathy Test. All data 
is presented as mean ± S.E.M (n = 9-10 per group). *p<0.05, Experienced group compared to Naive.45
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General Introduction
1. Stress and Stress Mediators
1.1. Stress 
Stress is typically de ned as any stimulus that represents a perceived or actual 
threat  to  the  psychological  and  physiological  equilibrium  or  homeostatic 
functioning of an organism (Selye, 1976). As a response to stress, the organism 
strives to reinstate the disturbed homeostasis by activating neuromodulatory 
systems. Released hormones promote the organism’s ability to cope with stress 
by acting on target systems in the periphery but also inducing a myriad of e ects 
on the brain. In addition to preparing an individual for the acute consequences of 
dangerous or threatening situations and the return to homeostasis, an important 
function of the stress response is to induce long-term adaptive changes (McEwen, 
1998; McEwen, 2001). An inability to appropriately adapt to repeated stress can 
produce a vulnerable phenotype that is associated with a high risk for a wide array 
of mental disease states, including depression and post-traumatic stress disorder 
(Sapolsky, 2000; McEwen, 2001; Kim and Diamond, 2002).
1.2. The neuroendocrine stress response
Stress leads to an activation of the autonomic nervous system and hypothalamus–
pituitary–adrenal (HPA) axis (Box 1). Activation of the autonomic nervous system 
results in the release of the catecholamines epinephrine and norepinephrine from 
the adrenal medulla and presynaptic nerve terminals (Miller and O’Callaghan, 
2002; Smith and Vale, 2006; Ulrich-Lai and Herman, 2009). These catecholamines 
trigger an elevation in heart rate and respiration, increase blood pressure and 
promote energy mobilization to contribute directly to the  ght- ight response 
with an acute preservative impact on survival systems. In the central nervous 
system, exposure to a stressful event rapidly activates the locus coeruleus (LC), 
which  is  the  main  source  of  norepinephrine  in  the  brain. These  LC  neurons 
project to other brain areas, such as the prefrontal cortex, cerebellum, amygdala, 
and  hippocampus  and  innervate  these  areas  with  noradrenergic  signals  via 
_-  and  `-adrenoceptors.  Peripherally  released  adrenaline  can  also  stimulate 
ascending vagal a erents that innervate the nucleus of solitary tract, from which 
noradrenergic neurons project to the basolateral complex of the amygdala (BLA) 
and LC. Therefore the brain is a major target for catecholamines that are released 
upon exposure to stressful events and arousing experiences. On the other hand, 56
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activation of the HPA-axis triggers a cascade of events that eventually culminates 
in the release of glucocorticoids (cortisol in human, corticosterone in rats) from 
the adrenal glands (Miller and O’Callaghan, 2002). First, corticotropin-releasing 
factor (CRF) is secreted in response to a stressor by the medial parvocellular 
region of the paraventricular nucleus of the hypothalamus (PVN). This leads to the 
release of adrenocorticotropin hormone (ACTH) from the adrenal pituitary gland 
into circulation, which subsequently stimulates the release of glucocorticoids 
from the adrenal cortex. Blood concentrations of glucocorticoids then rise to 
peak 15-30 minutes after stress, and decline slowly to pre-stress levels. In the 
periphery, glucocorticoids exert immunosuppressive actions and increase blood 
glucose  levels  by  a ecting  diverse  metabolic  processes.  Glucocorticoids  are 
highly lipophylic and, thus, directly enter the brain and bind to mineralocorticoid 
receptors (MRs) and glucocorticoid receptors (GRs) (McEwen et al., 1968). MRs 
have  a  high  a nity  for  the  natural  steroids  corticosterone  and  aldosterone 
and  are  almost  saturated  during  basal  corticosterone  levels  whereas  GRs 
become occupied by higher levels of corticosterone (de Kloet et al., 2005). The 
catecholamine component of the stress response can be thought as representing 57
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the  rst wave, and the glucocorticoid component as being the second wave. 
Catecholamines  are  secreted  and  trigger  second  messenger  cascades  in 
postsynaptic target tissues within seconds, whereas glucocorticoids are secreted 
following a latency of minutes to hours. The hormone can exert nongenomic 
actions (actions not involving transcriptional events) in a rapid fashion or slow 
genomic actions resulting from transcriptional events that take hours to emerge. 
Despite the di erential time course of actions of these hormones, there appears 
to be an overlapping presence of noradrenaline and corticosteroids in time and 
space that allows the stage for interactions, provided that signals transduced by 
receptors of these ligands act in the same time frame (Joels et al., 2011).
2. Endocannabinoid System
The endocannabinoid system is a relatively unique system, exerting modulatory 
actions  in  both  central  tissue  and  in  the  periphery.  Cannabinoid  receptors 
type 1 (CB1) and type 2 (CB2) are activated by three major classes of ligands: 
Endocannabinoids  (endogenously  produced),  plant  cannabinoids  (such  as 
tetrahydrocannabinol  (THC),  produced  by  the  cannabis  plant)  and  synthetic 
cannabinoids  (such  as  WIN55,212-2).  The  most  well-de ned  endogenous 
cannabinoid  ligands  N-arachidonylethanolamine  (anandamide;  AEA)  and 
2-arachidonoylglycerol (2-AG) are neuroactive lipids that are produced within the 
brain by neurons and glia cells and function primarily as interneuronal signaling 
molecules (Freund et al., 2003; Kano et al., 2009) (Box 2). Endocannabinoids are 
released on demand in response to altered neuronal activity. The synthesis of AEA 
and 2-AG occurs via separate enzymatic cascades and are evoked by neuronal 
depolarization,  elevations  in  intracellular  calcium,  and  activation  of  several 
metabotropic and excitatory ionotropic neurotransmitter receptors (Freund et 
al., 2003; Di Marzo et al., 2005; Kano et al., 2009). Both CB1 and CB2 receptors 
are G protein-coupled and the CB1 receptor is expressed almost ubiquitously 
throughout the brain, including the olfactory bulb, neocortex, pyriform cortex, 
hippocampus,  amygdala,  basal  ganglia,  thalamic  and  hypothalamic  nuclei, 
cerebellar cortex, and brainstem nuclei (Katona et al., 1999; Katona et al., 2001; 
Freund et al., 2003) whereas CB2 receptors are generally present peripherally in 
immunological tissues, but they have also been found within the central nervous 
system on neurons and glia cells with their expression mainly related to conditions 
of in ammation, in brain regions like the hippocampus and cerebellum (Begg 58
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et al., 2005). The termination of endocannabinoid signaling is determined by 
metabolic enzymes: Fatty acid amide hydrolase (FAAH) is the primary catabolic 
enzyme for AEA, and hydrolyzes it into ethanolamine and arachidonic acid and 
2-AG is primarily metabolized by monoacylglyceride lipase (MAG lipase) to form 
glycerol and arachidonic acid (Freund et al., 2003; Di Marzo, 2008). Recent studies 
indicated an involvement of the endocannabinoid system in many di erent brain 
functions,  including  synaptic  plasticity,  stress  response,  locomotion,  appetite, 
anxiety, reward, pain and learning and memory(Kano et al., 2009).
2.1. Role as a retrograde messenger in synaptic plasticity
It  is  now  widely  accepted  that  postsynaptic  depolarization  induces  an 
elevation  of  intracellular  Ca2+  concentrations  which  trigger  the  biosynthesis 
of endocannabinoids. Endocannabinoids are then released from postsynaptic 59
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neurons into the synapse, act as a retrograde messenger at various synapses in 
the brain and contribute to several forms of short-term and long-term synaptic 
plasticity. The released endocannabinoids activate presynaptic CB1 receptors and 
suppress transmitter release either transiently or persistently. Endocannabinoids 
are  known  to  mediate  the  transient  suppression  of  inhibition  or  excitation 
by  inhibiting  the  release  of  glutamate  (short-term:  depolarization  induced 
suppression of excitation - DSE or long-term depression at excitatory synapses 
– LTDe) or GABA (short-term: depolarization induced inhibition - DSI, long-term 
depression at inhibitory synapses - LTDi), respectively (Hashimotodani et al., 2007; 
Kano et al., 2009). The molecular identity of the retrograde endocannabinoid 
ligand that mediates DSI/ DSE or LTD has not been proven conclusively. The 
available evidence suggests that 2-AG is a more likely candidate than AEA to 
mediate DSI/DSE whereas the contribution of AEA and 2-AG to LTD seems to 
depend on the brain region investigated. For instance, AEA is reported to mediate 
LTDi in the amygdala (Azad et al., 2004) whereas 2-AG is assumed to contribute 
to hippocampal LTDi (Chevaleyre and Castillo, 2003). In addition to this, there 
are  number  of  studies  demonstrating  that  CB1  receptor  activation  inhibits 
neurotransmitter release. The neurotransmitters that are reported to be a ected 
by the CB1 receptor include glycine acetylcholine, norepinephrine, dopamine, 
serotonin, and cholecystokinin (Kano et al., 2009). 
2.2. Role of endocannabinoids in mediating the e ects of stress and glucocorticoids
Besides these functions, endocannabinoids also play important role in the stress 
response, in particular in the return to homeostasis after stress. Since an excessive 
and prolonged stress or glucocorticoid response can result in deleterious e ects 
on  cardiovascular,  immune,  metabolic,  and  neural  systems  (Chrousos,  2009), 
an appropriate inhibition of the stress response is essential once the perceived 
stressor has subsided. This inhibition is triggered by slow as well as rapid feedback 
mechanisms. Classically, slow feedback inhibition represents a mechanism by 
which glucocorticoids shut down the HPA-axis via transcriptional regulation of 
gene expression. In addition to this slow feedback, glucocorticoids also mediate 
a rapid negative feedback regulation of the HPA axis (Dallman, 2005). Recent 
 ndings revealed that the mechanism of rapid glucocorticoid feedback inhibition 
of hypothalamic hormone secretion involves endocannabinoid release in the PVN. 
This provided a link between the actions of glucocorticoids and cannabinoids 60
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in the hypothalamus (Di et al., 2003). In addition to an inhibition of the stress 
response by negative feedback mechanisms, behavioral and hormonal responses 
to repeated and predictable exposure to the same type of stressor exhibit stress 
habituation. Stress habituation is a progressive decrease in the expression of 
glucocorticoid secretion after repeated applications of the same stressor and 
represents a protective mechanism to avoid needless hormone secretion while 
maintaining the ability to mount a hormonal response. Much of the  ndings 
regarding the mechanisms of stress habituation have focused on the role of 
glucocorticoids (Jaferi et al., 2003; Jaferi and Bhatnagar, 2006). However, recent 
studies have also implicated endocannabinoid signaling system in this process 
(Patel et al., 2005; Patel and Hillard, 2008).
2.3. Role of endocannabinoid system in learning and memory
It has long been recognized that THC intake causes memory impairment in humans. 
In laboratory animals, e ects of exogenously applied cannabinoid agonists on 
learning and memory have been investigated intensively using various behavioral 
paradigms (Kano et al., 2009; Akirav, 2011; Zanettini et al., 2011). These studies 
have revealed that in cannabinoid-treated animals, certain aspects of memory 
are largely a ected, while other aspects remain intact. Since memory is assessed 
through behavior in animals and endocannabinoid signaling can a ect many 
behavioral and physiological processes, it is essential to control for side e ects of 
the cannabinoid modulation on the behavior in order to con dently attribute the 
e ects to learning and memory processes per se. 
Although  there  is  no  consensus  regarding  the  direction  of  endocannbainoid 
e ects on memory, disruptive e ects of cannabinoid agonists and antagonists 
have been reported in many di erent behavioral paradigms and on di erent 
memory processes. Systemic administration of CB1 receptor agonists such as THC 
or WIN55212-2 shortly before a learning experience has been shown to impair 
the acquisition of water maze, contextual fear memory and object recognition 
training  in  rodents,  whereas  the  CB1  receptor  antagonist/inverse  agonist 
SR141716 (rimonabant) blocks these impairing e ects and even enhances the 
acquisition per se (Lichtman et al., 1995; Da and Takahashi, 2002; Pamplona et 
al., 2006). Extensive evidence also indicates that systemic CB1 receptor agonists 
exert impairing e ects on working memory whereas the e ect on retrieval is 61
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more controversial (Lichtman et al., 1995; Nava et al., 2001; Egashira et al., 2002; 
Wise et al., 2009). Pharmacological enhancement of endocannabinoid tone or 
the activation of CB1 receptors facilitates extinction learning whereas genetic 
and  pharmacological  blockade  of  CB1  receptors  impairs  extinction  learning 
(Suzuki et al., 2004; Chhatwal et al., 2005; Kamprath et al., 2006; Pamplona et 
al., 2008). Consistently, training on a fear conditioning extinction task increases 
endocannabinoid  levels  within  the  BLA,  suggesting  that  this  brain  region 
mediates the e ects of endocannabinoids on fear extinction learning (Marsicano 
et al., 2002). Accordingly, recent  ndings indicate that microinjections of the CB1 
receptor antagonist AM251 into the BLA or hippocampus block the extinction 
of  inhibitory  avoidance  training  (Ganon-Elazar  and  Akirav,  2009;  Abush  and 
Akirav, 2010), whereas CB1 receptor antagonism in the insular cortex impairs the 
extinction of conditioned taste aversion (Kobilo et al., 2007). Pharmacological 
manipulation of the endocannabinoid system by local infusions into the brain 
also a ects other memory processes such as memory consolidation, recall and 
working memory. For instance, infusions of the CB receptor agonist WIN55,212-
2 into the BLA immediately after inhibitory avoidance training enhance 48-h 
retention performance, suggesting an enhancing e ect of endocannabinoids on 
memory consolidation (Campolongo et al., 2009). Moreover, a blockade of CB1 
receptors in the hippocampus by AM251 is known to impair the consolidation of 
inhibitory avoidance training (de Oliveira Alvares et al., 2006; de Oliveira Alvares et 
al., 2008). Studies using intrahippocampal infusions of the agonists CP55940, THC 
or WIN 55,212-2 in rats also showed a disrupted performance on radial-arm maze, 
T-maze delayed alternation, inhibitory avoidance, spatial learning as well as place 
recognition tasks and were thus interpreted as suggesting that the impairing 
e ects of endocannabinoids on learning and recall are mediated through the 
activation of CB1 receptors in the hippocampus (Akirav et al., 2011).  Infusions 
of  a  CB1  receptor  agonist  into  prefrontal  cortex  is  known  to  impair  working 
memory (Lichtman et al., 1995; Egashira et al., 2002; Wegener et al., 2008; Abush 
and Akirav, 2010; Akirav, 2011). Collectively, although most reported e ects of 
endocannabinoids are controversial and there is no consensus in the direction of 
the e ects on memory, endocannabinoids appear to be involved in the modulation 
of di erent memory processes by in uencing multiple brain regions (Kano et al., 
2009; Zanettini et al., 2011). The opposite behavioral e ects of cannabinoid drugs 
seem to derive from di erences in drug dose, route of administration and timing of 62
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exposure; however, variations in the stressfulness of the experimental conditions 
employed in the di erent studies are implicated as well. In particular, the neural 
processes underlying emotional memory formation and non-emotional memories 
(more neutral memory) seem to be di erentially sensitive to cannabinoid receptor 
activation (Chhatwal and Ressler, 2007). It is suggested that endocannabinoids 
exert e ects on mood and cognition via in uences on noradrenergic activity and 
thus the origin of the altered sensitivity to endocannabinoids might result from 
di erent level of arousal that will cause a di erent activation of the noradrenergic 
system (Carvalho and Van Bockstaele, 2011). The  nding that cannabinoid drugs 
such as WIN55,212-2 can induce opposite e ects on short- and long-term object 
recognition memory depending on the level of emotional arousal at encoding 
and thus the level of noradrenergic activity supports this view (Campolongo et 
al., unpublished observation). Moreover, the administration of cannabinoid-like 
agents has been shown to increase Fos expression in LC noradrenergic neurons 
(Patel and Hillard, 2003; Oropeza et al., 2005) and dose-dependently increases 
norepinephrine levels in limbic and cortical regions (Oropeza et al., 2005; Page et 
al., 2007).
3. Stress & Memory
New information needs to be encoded and stored in order to enable the organism to 
retrieve the accurate information and express the appropriate behavior or modify 
it accordingly. Memory is not a single entity but composed of several separate 
systems and accordingly di erent brain systems orchestrate various tasks to form 
new memories. Long–term memory can be broadly divided in at least two types: 
Declarative (explicit) and non-declarative (implicit) memory. Declarative memory 
refers to conscious knowledge of facts and events, while non-declarative memory 
refers to a collection of non-conscious knowledge systems that provide for the 
capacity of learning skills, habit formation, priming. Declarative memory is further 
divided in subcategories as episodic (remembering speci c events from the past) 
and  semantic  memory  (general  knowledge).  Declarative  memory  processes 
rely upon the hippocampus and related structures in the medial temporal lobe 
including the perirhinal, entorhinal and parahippocampal cortices. 
Memories  are  not  all  created  equally  strong:  Some  experiences  are  well 
remembered, while others are remembered poorly, if at all. Why is there a di erence 63
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in the strength of our memories? Extensive evidence indicates that emotions can 
have lasting e ects on memory. Accordingly, enhanced memory for stressful or 
emotionally arousing events has given the  rst evidence regarding an in uence 
of stress on memory. Evolutionarily this is a highly adaptive phenomenon that 
helps us to remember important information. Findings from experimental studies 
indicate that people have good recollection of where they were and what they 
were  doing  when  they  experienced  an  earthquake  or  witnessed  an  accident 
(Bohannon, 1988; Neisser et al., 1996). Similarly, rats remember the place in the 
apparatus where they received a mild footshock or the location of an escape 
platform in a tank  lled with water (Morris et al., 1986; Vazdarjanova and McGaugh, 
1998). Extensive evidence from both animal and human studies demonstrates 
that stress strengthens the consolidation of memory for emotionally arousing 
experiences (Roozendaal and McGaugh, 2011). In contrast, acute stress can cause 
a temporary impairment of the recall of memory such as the blockade of memory 
during  a  job  interview  or  an  important  exam.  Experiments  that  investigated 
this  phenomenon  employed  paradigms  in  which  human  subjects  or  rats  are 
given a session of stress shortly before assessing their ability to recall previously 
learned information. The  ndings of these experiments indicate that in both rats 
and humans, stress-induced impairment was linked to high levels of circulating 
glucocorticoids (de Quervain et al., 1998; de Quervain et al., 2000). Similar to 
the e ects of stress on memory consolidation, stress induces memory retrieval 
impairment  selectively  under  arousing  conditions  via  interactions  with  the 
noradrenergic system (de Quervain et al., 1998; Kuhlmann et al., 2005). 
3.1. Stress hormones as mediators of stress e ects on memory
Decades of research show that hormones of the adrenal medulla (epinephrine) 
and  adrenal  cortex  (glucocorticoids),  released  during  and  immediately  after 
emotionally arousing experience, mediate the multifaceted e ects of stress on 
memory (McGaugh and Roozendaal, 2002; Joels and Baram, 2009; Roozendaal 
et al., 2009; Joels et al., 2011). In adrenally intact rats, systemic injections of the 
adrenomedullary  hormone  epinephrine  enhance  memory  consolidation  of 
inhibitory  avoidance  when  administered  shortly  after  training  (Gold  and Van 
Buskirk, 1975; Gold et al., 1977). Comparable e ects were obtained in subsequent 
experiments  using  many  di erent  types  of  training  tasks  commonly  used  in 
experiments with rats and mice (Introini-Collison et al., 1991; Costa-Miserachs 64
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et al., 1994). Since epinephrine does not readily cross the blood-brain barrier, 
its e ects on memory seem to be initiated by an activation of  `-adrenoceptors 
located on vagal a erents that project to the nucleus of the solitary tract that 
sends  direct  or  indirect  noradrenergic  projections  to  the  forebrain,  including 
the BLA (Roozendaal and McGaugh, 2011). Unlike epinephrine, glucocorticoids 
are highly lipophylic and, thus, readily enter the brain and exert their e ects by 
modi cation of gene transcription through binding to intracellular or intranuclear 
receptors and as a result, binding of receptor homodimers to DNA (de Kloet, 2000). 
Glucocorticoids may also act rapidly by interacting with membrane receptors and 
potentiating the e cacy of other signaling cascades (Dallman, 2005; de Kloet et 
al., 2005; Tasker et al., 2006).    
Eventually, stress e ects on cognitive functions have been attributed to extensive 
release  of  glucocorticoids  that  occurs  as  a  result  of  chronic  stress  or  some 
pathological conditions such as a ective disorders (Sapolsky, 2000; McEwen, 2001; 
de Quervain et al., 2009; Lupien et al., 2009). Early reports found both enhancing 
and impairing properties of glucocorticoids on memory (Bohus and Lissak, 1968; 
Flood et al., 1978; Beckwith et al., 1986; Luine et al., 1993; Arbel et al., 1994). 
However, most of these studies only used repeated or chronic treatments that 
do not allow disassociating the e ects of glucocorticoids on memory from the 
e ects on other cognitive functions or directly on behavior. More recent studies 
investigating glucocorticoid e ects on memory by focused drug manipulations 
targeting a time frame of a particular memory phase revealed di erential e ects of 
these hormones on di erent memory processes. There is now extensive evidence 
from  animal  studies  that  glucocorticoids  are  critically  involved  in  regulating 
the  consolidation  of  memory  processes  (Flood  et  al.,  1978;  de  Kloet,  2000; 
Roozendaal, 2000; McGaugh and Roozendaal, 2002; Roozendaal, 2002). Acute 
systemic  administration  of  corticosterone  or  synthetic  glucocorticoid  ligands 
typically enhances long-term memory consolidation when given either before or 
immediately after a training experience in rats (Flood et al., 1978; Sandi and Rose, 
1994; Roozendaal and McGaugh, 1996; Roozendaal et al., 1996; Pugh et al., 1997; 
Roozendaal et al., 1999; Cordero et al., 2002) and human subjects (Buchanan and 
Lovallo, 2001; Abercrombie et al., 2003; Kuhlmann and Wolf, 2006; de Quervain 
et al., 2009). Glucocorticoid e ects on memory consolidation follow an inverted 
U-shape dose–response relationship: Moderate doses enhance memory, while 65
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higher doses are typically less e ective or may even impair memory consolidation 
(Roozendaal et al., 1999). A series of studies in animals showed that glucocorticoids 
do not enhance memory consolidation for all kind of training experience but 
particularly for emotionally arousing events (Okuda et al., 2004; Roozendaal et al., 
2006a; Roozendaal et al., 2006b). For example, Okuda et al. (2004) investigated the 
importance of emotional arousal in mediating glucocorticoid e ects on memory 
consolidation by manipulating the level of training-induced arousal in rats. They 
reported that systemic corticosterone does not enhance memory consolidation 
for training experience if the rat’s arousal level is decreased by extensive prior 
habituation to the training context. These  ndings indicate that glucocorticoids 
enhance memory consolidation for emotionally arousing training experiences 
but  do  not  a ect  memory  consolidation  of  emotionally  neutral  information. 
Consistent with these  ndings in rats, human studies reported similar results with 
respect to learning-associated arousal as a prerequisite for the enhancing e ects 
of glucocorticoids and stress on memory consolidation (Buchanan and Lovallo, 
2001; Abercrombie et al., 2003; Kuhlmann and Wolf, 2006; Van Stegeren et al., 
2007; Wolf, 2008; de Quervain et al., 2009; Marin et al., 2010). 
Besides  the  e ects  of  glucocorticoids  on  memory  consolidation,  many 
studies demonstrated di erential e ects of glucocorticoids on other memory 
processes  such  as  memory  retrieval  and  working  memory  (Kirschbaum  et 
al., 1996; de Quervain et al., 1998; Roozendaal et al., 2004a; Roozendaal et al., 
2004b; Roozendaal et al., 2004c; Cai et al., 2006; Barsegyan et al., 2010). The 
elevation of glucocorticoids either naturally (i.e. by stress exposure) or induced 
by  pharmacological  manipulations  shortly  before  retention  testing  induces 
impairing  e ects  on  the  retrieval  of  spatial/contextual  memory  in  rats  (de 
Quervain et al., 1998). Interestingly, this is a temporary e ect that only occurs 
during high circulating glucocorticoid levels and fades away once the hormone 
levels return to baseline (de Quervain et al., 1998). Human studies consistently 
reported similar  ndings with respect to glucocorticoid e ects on memory recall 
impairment (Kirschbaum et al., 1996; de Quervain et al., 2000; de Quervain et al., 
2003; Buss et al., 2004; Het et al., 2005; Wolf, 2008). Moreover, pharmacological 
activation of hippocampal GRs by a speci c GR agonist resulted in comparable 
memory retrieval impairment, indicating that these e ects involve GRs and not 
MRs (Roozendaal et al., 2004b). 66
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Extensive evidence from cognitive and neurobiological research indicates that 
the hippocampus is an important brain region involved in memory retrieval of 
contextual, spatial or declarative information and is also a primary target for 
stress hormones. Studies investigating glucocorticoid e ects on memory retrieval 
mostly employed hippocampus-dependent learning tasks like spatial water-maze 
or inhibitory avoidance training in rats and declarative memory tasks in humans.   
Therefore,  the  impairing  e ects  of  glucocorticoids  on  memory  retrieval  are 
largely based on the e ects found in these tasks. The few studies that investigated 
whether  glucocorticoids  also  impair  retrieval  of  hippocampus-independent 
memory (e.g. auditory fear memory) in rats reported only small or absent e ects 
(Schutsky et al., 2011). 
4. Outline of part II
Although not many can properly de ne stress, everybody knows what it means 
to have stress. The brain is the organ that interprets and determines whether 
an experience is stressful or not, and accordingly produces the behavioral and 
physiological responses thereof. A hallmark of stress response is the activation 
of the autonomic nervous system, resulting in the release of catecholamines 
from the adrenal medulla, and of the HPA-axis that culminates in the release of 
glucocorticoid hormones from the adrenal cortex. These stress response systems 
enable the organism to cope with the situation and survive acute challenges. The 
stress response also induces acute changes in behavior and cognition as well as 
long-term adaptive responses. 
Glucocorticoids,  released  from  the  adrenal  cortex,  have  potent  modulatory 
e ects  on  emotional  memory.  Speci cally,  glucocorticoids  have  been  shown 
to enhance memory consolidation of emotionally arousing experiences, but to 
impair memory retrieval and working memory during emotionally arousing test 
situations. Glucocorticoids are known to interact with arousal-induced activation 
of the noradrenergic system to selectively a ect memory of emotionally arousing 
experiences.  Glucocorticoids  modulate  cellular  function,  including  learning 
and memory, through both genomic (slow) and nongenomic (rapid) pathways 
(de Kloet, 2000; Dallman, 2005). Genomic glucocorticoid actions are mediated 
by classical steroid mechanisms involving transcriptional regulation. Although 67
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many glucocorticoid actions  t the time frame for a genomic mechanism, some 
behavioral  and  physiological  e ects  of  glucocorticoids  have  a  rapid  onset, 
occurring in seconds to minutes, that is not readily compatible with transcriptional 
regulation. The emerging view suggests that glucocorticoids, by in uences on 
fast inducible signaling systems such as endocannabinoids, exert their rapid and 
nongenomic e ects on adaptive responses to stress, behavior and memory. The 
endocannabinoid system is a rapidly activated retrograde messenger system in 
the brain that exerts diverse e ects on synaptic transmission, neuronal  ring, 
mood and memory. Chapter 3 provides an overview of the existing literature 
regarding  the  fast  actions  of  glucocorticoid  on  the  noradrenergic  system  in 
in uencing memory functions. This chapter  nalizes with a model that suggests 
endocannabinoids as a well-suited candidate system to mediate at least some 
of the rapid actions of glucocorticoids. The other chapters of this part deal with 
experiments aimed at validating this model. 
Prior studies indicated that glucocorticoids only enhance memory consolidation 
of emotionally arousing, and not neutral, experiences. It is now well established 
that  this  selectivity  originates  from  glucocorticoid-mediated  facilitation  of 
arousal-induced noradrenergic activation within the BLA. However, the neural 
mechanism of how glucocorticoids can rapidly in uence noradrenergic function 
in the context of memory consolidation remains elusive. Chapter 4 investigates 
whether  the  endocannabinoid  system  is  essentially  involved  in  regulating 
glucocorticoid e ects, via a GR on the cell surface, on the noradrenergic arousal 
system within the BLA in enhancing memory consolidation. 
As mentioned before, extensive evidence indicates that glucocorticoid hormones 
not only enhance the consolidation of memory but also impair the retrieval of 
memory  of  emotionally  arousing  experiences.  Such  glucocorticoid  e ects  on 
memory retrieval impairment are known to depend also on rapid interactions 
with arousal-induced noradrenergic activity. Chapter 5 investigates whether the 
endocannabinoid system is involved in mediating glucocorticoid e ects on the 
noradrenergic system in impairing the retrieval of contextual fear memory. 
Considerable evidence indicates that glucocorticoids do not impair the retrieval of 
all kinds of memory. Most studies investigating glucocorticoid e ects on memory 68
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retrieval examined their e ects on retrieval of spatial/contextual memory in rats 
or of declarative memory in humans. The few studies that also investigated the 
e ects of glucocorticoids on retrieval of recognition memory reported small and 
mostly nonsigni cant e ects. As animal studies have not explicitly examined 
glucocorticoid e ects on retrieval of recognition memory, Chapter 6 investigates 
whether glucocorticoids impair the retrieval of two components of information 
acquired during a single object recognition training session, i.e., memory of the 
training object per se and memory of the location of the object during the training 
session. Further, the role of the endocannabinoid system in mediating the e ects 
of glucocorticoids on retrieval of these di erent aspects of recognition memory 
is determined. 
Chapter 7 summarizes and discusses the  ndings of the second part of this thesis 
and provides conclusions and future perspectives.69
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ABSTRACT
Glucocorticoids  -  stress  hormones  released  from  the  adrenal  cortex  -  have 
potent modulatory e ects on emotional memory. Whereas early studies focused 
mostly on the detrimental e ects of chronic stress and glucocorticoid exposure 
on  cognitive  performance  and  the  classical  genomic  pathways  that  mediate 
these e ects, recent  ndings indicate that glucocorticoids exert complex and 
often rapid in uences on distinct memory phases. Speci cally, glucocorticoids 
have been shown to enhance memory consolidation of emotionally arousing 
experiences,  but  to  impair  memory  retrieval  and  working  memory  during 
emotionally arousing test situations. Furthermore, growing evidence indicates 
that  these  di erent  glucocorticoid  e ects  all  depend  on  a  nongenomically 
mediated interaction with emotional arousal-induced noradrenergic activation 
within the basolateral complex of the amygdala. In this paper, we present a model 
suggesting that the endocannabinoid system, a lipid-based retrograde signaling 
system, might play an important role in mediating such rapid glucocorticoid 
in uences on the noradrenergic system in modulating memory of emotionally 
arousing experiences. 81
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INTRODUCTION
Stress  activates  the  hypothalamus–pituitary–adrenal  (HPA)-axis,  which  results 
in the release of glucocorticoid hormones (cortisol in human, corticosterone in 
rodents) from the adrenal cortex. These hormones are known to in uence the 
organism’s ability to cope with stress, in uencing target systems in the periphery, 
but also inducing a myriad of e ects on the brain. In addition to preparing an 
individual for the acute consequences of threatening situations and the return 
to homeostasis, an important function of stress is to induce long-term adaptive 
responses  (McEwen  1998;  McEwen  2001).  It  has  long  been  recognized  that 
glucocorticoids readily enter the brain and a ect cognition. Early reports on both 
enhancing and impairing properties of glucocorticoids on memory (Bohus and 
Lissak 1968; Flood et al., 1978; Beckwith et al., 1986; Luine et al., 1993; Arbel et al., 
1994) have indicated that these hormones have complex e ects on cognition. 
More  recent  studies  investigating  glucocorticoid  e ects  on  distinct  memory 
phases and studies examining their interaction with emotional arousal helped 
to disentangle the multifaceted actions of these stress hormones. For example, 
there is now extensive evidence that glucocorticoids enhance the consolidation 
of long-term memory of emotionally arousing experiences (Roozendaal et al., 
2006a). In contrast, elevated glucocorticoid levels are known to impair memory 
retrieval  and  working  memory  during  emotionally  arousing  situations  (de 
Quervain et al., 2009). Yet, these hormones have little e ect on memory of more 
mundane experiences. Findings of experiments in both animals and humans 
investigating the neurobiological basis underlying this selectivity indicate that 
glucocorticoid modulation of these di erent memory phases all require arousal-
induced noradrenergic activation within the basolateral complex of the amygdala 
(BLA) (Roozendaal et al., 2006a). Importantly, as many of these glucocorticoid 
in uences on the noradrenergic system have an onset that appears too rapid 
to be mediated by their classic genomic actions, such  ndings, as well as other 
recent reports of rapid glucocorticoid e ects, have rekindled the interest in this 
fascinating  eld and led to the discovery of novel nongenomically mediated 
mechanisms of glucocorticoid action on cellular function, neural plasticity and 
memory (de Kloet et al., 2008).
The  endocannabinoid  system  is  one  emerging  candidate  system  thought  to 82
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mediate nongenomic glucocorticoid actions in the brain (Hill and McEwen 2009). 
Endocannabinoids,  i.e.,  anandamide  and  2-arachidonoylglycerol  (2-AG),  are 
synthesized on demand through cleavage of membrane precursors and serve 
as retrograde messengers at central synapses (Hashimotodani et al., 2007). They 
regulate ion channel activity and neurotransmitter release (Freund et al., 2003). 
CB1 and CB2 cannabinoid receptors are G-protein-coupled receptors (Matsuda et 
al., 1990; Gerard et al., 1991). Whereas the CB1 receptor is mainly expressed in the 
brain, but also in the lungs, liver and kidneys, the CB2 receptor is predominantly 
found in glia and peripheral tissues (Morgan et al., 2009; Pacher and Mechoulam 
2011). Cannabinoid receptors are activated by three major classes of ligands: 
Endocannabinoids (produced by the mammalian body), plant cannabinoids (such 
as tetrahydrocannabinol (THC), produced by the cannabis plant) and synthetic 
cannabinoids (such as WIN55,212-2). In the last decade, it became clear that the 
endocannabinoid  system  modulates  a  wide  range  of  physiological  processes 
and is also essential for an adaptive regulation of the stress response (Patel and 
Hillard 2008; Kano et al., 2009; Marsicano and Lafenetre 2009; Hill et al., 2010b). 
Bidirectional  and  functional  relationships  between  glucocorticoids  and  the 
endocannabinoid system have been demonstrated. For example, stress is known 
to  produce  rapid  changes  in  endocannabinoid  signaling  in  stress-responsive 
brain regions. In turn, the endocannabinoid system plays an important role in 
the down-regulation and habituation of HPA-axis activity in response to repeated 
stress (Patel and Hillard 2008; Hill et al., 2010a; Hill et al., 2010c). Glucocorticoids 
also recruit the endocannabinoid system to exert rapid negative feedback control 
of the HPA-axis during stress (Di et al., 2003; Patel et al., 2005; Tasker et al., 2006; 
Evanson et al., 2010). It became increasingly clear, however, that CB1 receptors 
are also abundantly expressed in the BLA and other limbic regions where they 
modulate emotional arousal e ects on synaptic transmission (Katona et al., 2001; 
Tan et al., 2011), neuronal  ring (Pistis et al., 2004) and memory (Campolongo et 
al., 2009b; Ganon-Elazar and Akirav 2009; Marsicano and Lafenetre 2009; Tan et 
al., 2011).
  In  the  present  paper,  we  will   rst  summarize  the  opposing  e ects  of 
glucocorticoids  on  memory  consolidation,  memory  retrieval  and  working 
memory.  Then,  we  will  describe  how  glucocorticoids  a ect  noradrenergic 
activity of the BLA (and other brain regions) to selectively modulate memory of 83
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emotionally arousing experiences. Finally, we will present a model suggesting that 
endocannabinoid signaling might play an essential role in mediating such rapid 
e ects of glucocorticoids on the noradrenergic system in regulating memory of 
emotionally arousing experiences. 
Glucocorticoid e ects on di erent memory phases: dependence on arousal 
status
In this section, we describe the e ects of glucocorticoids on di erent memory 
phases and their interaction with emotional arousal. There is compelling evidence 
from studies in both animals and humans that glucocorticoids are involved in 
regulating the consolidation of memory processes (Flood et al., 1978; de Kloet 
2000; Roozendaal 2000; McGaugh and Roozendaal 2002; Roozendaal 2002; Het 
et al., 2005; Sandi and Pinelo-Nava 2007; de Quervain et al., 2009; Roozendaal et 
al., 2009). Memory consolidation is the process by which a fragile memory trace 
is  transferred  into  stable  long-term  memory.  However,  not  all  information  is 
equally well transferred into long-term memory. In fact, it is well recognized that 
especially emotionally arousing experiences are well retained (McGaugh 2004). 
There is extensive evidence that glucocorticoids, along with other components 
of the stress response, are critically involved in regulating memory consolidation 
of  emotionally  arousing  experiences  (McGaugh  and  Roozendaal  2002).  A 
blockade of glucocorticoid production with the synthesis inhibitor metyrapone 
impairs memory consolidation (Roozendaal et al., 1996a; Maheu et al., 2004) and 
prevents epinephrine- and stress-induced memory enhancement (Roozendaal 
et  al.,  1996b;  Liu  et  al.,  1999).  In  contrast,  acute  systemic  administration  of 
corticosterone or synthetic glucocorticoid ligands typically enhances long-term 
memory consolidation when given either before or immediately after a training 
experience (Flood et al., 1978; Sandi and Rose 1994; Pugh et al., 1997; Roozendaal 
2000; Cordero et al., 2002). Such glucocorticoid e ects on memory consolidation 
follow an inverted U-shaped dose–response relationship: Moderate doses enhance 
memory,  whereas  lower  or  higher  doses  are  typically  less  e ective  and  may 
even impair memory consolidation (Roozendaal 2000). Optimal glucocorticoid-
induced memory enhancement depends on a variety of experimental factors, 
including the intrinsic aversive properties of the training procedure, but is usually 
achieved with a dose of corticosterone ranging between 1 and 3 mg/kg (see Fig. 
1A).84
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Glucocorticoids  are  highly  lipophilic  and,  thus,  readily  enter  the  brain  and 
bind  to  mineralocorticoid  receptors  (MRs)  and  glucocorticoid  receptors  (GRs) 
(McEwen et al., 1968; de Kloet 2000). MRs have a high a nity for the natural 
steroids corticosterone and aldosterone. GRs have an approximately 10-times 
lower  a nity  for  corticosterone,  but  show  a  high  a nity  for  the  synthetic 
ligands dexamethasone and RU 28362 (Reul et al., 1987; Sutanto and de Kloet 
1987). The memory-enhancing e ects of glucocorticoids appear to involve the 
selective activation of the low-a nity GR (Oitzl and de Kloet 1992; Roozendaal 
and McGaugh 1997). Such enhancing e ects of glucocorticoids or GR agonists 
on memory consolidation have been observed in many di erent brain regions 
and with many di erent kinds of learning tasks, including inhibitory avoidance, 
contextual and cued fear conditioning, water-maze spatial and cued training, 
object recognition and conditioned taste aversion (Roozendaal et al., 2006a). 
These   ndings  indicate  that,  in  rodents,  glucocorticoids  not  only  enhance 
Figure 1. Glucocorticoid e ects on memory consolidation for object recognition training require 
arousal-induced noradrenergic activation. Rats were either habituated to the training context for 
7 days (prior habituation) or not habituated (no prior habituation). On day 8, they were given a 3 
min training trial during which they could freely explore 2 identical objects, training was followed 
by systemic drug administration. Retention was tested 24 h later by placing the rats back into the 
apparatus for 3 min; in this trial, one object was similar to the training objects whereas the other was 
novel. Data represent discrimination index (%) on a 24-h retention trial, expressed as mean ± SEM. 
The discrimination index was calculated as the di erence in the time spent exploring the novel and 
the familiar object, expressed as the ratio of the total time spent exploring both objects. (A) E ects 
of immediate posttraining administration of the `-adrenoceptor antagonist propranolol (3.0 mg/kg, 
s.c.) on corticosterone-induced enhancement of object recognition memory in naïve (emotionally 
aroused) rats. (B) E ect of coadministration of the _2-adrenoceptor antagonist yohimbine (0.3 mg/
kg, s.c.) with corticosterone on object recognition memory in habituated (emotionally non-aroused) 
rats. **, P < 0.0001 vs. vehicle. Adapted from Roozendaal et al., Proc. Natl Acad Sci USA, 2006.85
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memory of training on hippocampus-dependent tasks that have a strong spatial/
contextual component, but also memory of recognition- and procedural training 
that depends on other brain regions (Miranda et al., 2008; Quirarte et al., 2009). 
In humans, glucocorticoid e ects on memory consolidation have mostly been 
investigated with respect to declarative memory (Het et al., 2005).  
However, glucocorticoids do not enhance memory of all experiences. Recent 
 ndings  indicate  that  glucocorticoids  enhance  memory  consolidation  of 
emotionally arousing training experiences, but do not a ect memory consolidation 
of emotionally neutral information (de Quervain et al., 2009). We investigated the 
importance of emotional arousal in mediating glucocorticoid e ects on memory 
consolidation  by  manipulating  the  level  of  arousal  during  object  recognition 
training in rats. Although no rewarding or aversive stimulation is used during 
object recognition training, such training induces modest novelty-induced stress 
or arousal (de Boer et al., 1990). However, extensive habituation of rats to the 
experimental context (in the absence of any objects) reduces the arousal level 
during the training. We found that systemic corticosterone administration does 
not  enhance  memory  consolidation  when  the  arousal  level  is  decreased  by 
extensive prior habituation to the training context (Okuda et al., 2004). Human 
studies  support  the   ndings  of  animal  experiments  that  learning-associated 
arousal is a prerequisite for enabling the e ects of glucocorticoids on memory 
consolidation (Abercrombie et al., 2006; Wolf 2008; de Quervain et al., 2009). 
Many studies  indicate  that  stress and glucocorticoids not only modulate the 
strength  of  newly  formed  memories,  but  also  in uence  the  remembrance 
of  previously  acquired  information.  In  contrast  to  the  enhancing  e ects  of 
glucocorticoids  on  memory  consolidation,  these  hormones  typically  impair 
memory  retrieval.  In  the   rst  study  investigating  the  e ects  of  stress  and 
glucocorticoids on retrieval processes (de Quervain et al., 1998), we reported 
that 30 min after exposure to footshock stress, rats had impaired retrieval of 
spatial memory of a water-maze task they had acquired 24 h earlier. Interestingly, 
memory performance was not impaired when rats were tested either 2 min or 4 
h after the stress exposure. These time-dependent e ects on retrieval processes 
corresponded to the circulating glucocorticoid levels at the time of testing, which 
suggested that the retrieval impairment was directly related to stress-induced 
increases in adrenocortical function. In a next step, we have translated these 86
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 ndings to healthy humans and found that a single administration of cortisone 
shortly before retention testing impaired the free recall of words learned 24 h 
earlier (de Quervain et al., 2000). Several further studies from di erent laboratories 
have indicated that stress exposure, glucocorticoids or the selective GR agonists 
dexamethasone and RU 28362 impair the retrieval of spatial or contextual memory 
in rats and declarative (mostly episodic) memory in humans (Wolf et al., 2001; 
Roozendaal et al., 2003; Buss et al., 2004; Rashidy-Pour et al., 2004; Roozendaal et 
al., 2004b; Het et al., 2005; Kuhlmann et al., 2005a; Kuhlmann et al., 2005b; Sajadi 
et al., 2007; Coluccia et al., 2008; Wolf 2008). Highly comparable to the above-
described e ects of glucocorticoids on memory consolidation, glucocorticoids 
only  impair  memory  retrieval  of  emotionally  arousing  information  or  during 
emotionally arousing test situations (Kuhlmann et al., 2005a; Kuhlmann et al., 
2005b; de Quervain et al., 2007; Smeets et al., 2008).
Glucocorticoids  also  impair  working  memory. Working  memory  is  a  dynamic 
process in which information is updated continuously, providing a temporary 
storage of information (Baddeley 1992). Evidence from lesion, pharmacological, 
imaging and clinical studies indicates that working memory depends on the 
integrity of the prefrontal cortex (Brito et al., 1982; Fuster 1991). Stress exposure 
is known to impair performance of rats on a delayed alternation task, a task 
commonly used to assess working memory in rodents (Arnsten 1998). Although 
basal levels of endogenous glucocorticoids are required to maintain prefrontal 
cortical  function  (Mizoguchi  et  al.,  2004),  systemic  administration  of  stress 
doses of corticosterone (1-3 mg/kg) impairs delayed alternation performance 
in rats (Roozendaal et al., 2004c). Stress or stress-level cortisol administration is 
also known to impair working memory performance in human subjects during 
demanding tasks that require a high level of arousal (Baddeley 1992; Lupien et al., 
1999; Young et al., 1999; Wolf et al., 2001; Schoofs et al., 2008). 
Glucocorticoid interactions with arousal-induced noradrenergic activation 
in the basolateral amygdala 
Why  do  glucocorticoids  only  modulate  memory  of  emotionally  arousing 
experiences? Our  ndings suggest that interactions between stress hormones 
and noradrenergic activity within the amygdala may be key in determining this 
selectivity. It is well established that emotional experiences that induce the release 87
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of adrenal stress hormones also increase amygdala neuronal activity (Pelletier et 
al., 2005). Extensive evidence from our as well as other laboratories indicates that 
the enhancing e ects of stress hormone administration on the consolidation 
of memory of emotionally arousing experiences involve noradrenergic activity 
within the amygdala. A  -adrenoceptor antagonist infused into the BLA, but not 
the neighboring central amygdala, blocks memory enhancement induced by a 
glucocorticoid administered either systemically or directly into the BLA (Quirarte 
et al., 1997; Roozendaal et al., 2002). It is well known that norepinephrine is 
released into the amygdala during emotionally arousing conditions (McIntyre et 
al., 2002) and considerable evidence indicates that glucocorticoids interact with 
training-associated  noradrenergic  activation  within  the  amygdala  to  enhance 
the consolidation of memory of emotionally arousing training experiences. For 
example, an in vivo microdialysis study reported that the administration of a 
memory-enhancing dose of corticosterone after inhibitory avoidance training 
rapidly increases norepinephrine levels within the amygdala (McReynolds et al., 
2010). In contrast, administration of the same dose of corticosterone to non-trained 
control rats does not increase norepinephrine levels in the amygdala, indicating an 
important role for emotional arousal in mediating such a glucocorticoid-induced 
facilitation of norepinephrine levels. Importantly, norepinephrine levels shortly 
after training were positively correlated with retention performance assessed 24 h 
later. Moreover, as the corticosterone-induced release of norepinephrine occurred 
in a rather rapid fashion (~15 min), it is likely that this e ect is mediated by a 
nongenomic mechanism. Human studies have also provided evidence that stress 
hormone e ects on memory enhancement for emotionally arousing experiences 
require concurrent amygdala and noradrenergic activity (Cahill et al., 1995; Cahill 
et al., 1996; Adolphs et al., 1997; Hamann et al., 1999; Canli et al., 2000). Such 
interactions between glucocorticoids and the amygdala noradrenergic arousal 
system  are  known  to  guide  neural  plasticity  and  memory  in  its  many  target 
regions such as the hippocampus, caudate nucleus and di erent cortical regions 
(McGaugh 2000; Roozendaal 2000; Vouimba et al., 2007; McReynolds et al., 2010). 
Based on the evidence summarized above, it may be hypothesized that emotional 
arousal-induced increases in noradrenergic activity within the BLA are essential 
in enabling glucocorticoid e ects on memory consolidation. Such a mechanism 
may  then  provide  a  direct  explanation  of  the   nding  that  glucocorticoids 88
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selectively enhance memory consolidation of emotionally arousing experiences. 
We  investigated  this  issue  in  rats  trained  on  an  object  recognition  task.  As 
is  discussed  above,  corticosterone  enhances  memory  of  object  recognition 
training  when  administered  to  naïve  rats,  but  is  ine ective  in  rats  that  have 
reduced training-associated emotional arousal because of prior habituation to 
the experimental context (Okuda et al., 2004). As is shown in Fig. 1A, we found 
that,  in  non-habituated  (i.e.,  emotionally  aroused)  rats,  the   -adrenoceptor 
antagonist  propranolol  administered  systemically  blocks  the  corticosterone-
induced memory enhancement (Roozendaal et al., 2006b). Propranolol infused 
directly  into  the  BLA  also  blocks  the  enhancing  e ects  of  corticosterone  on 
object recognition memory. To determine whether the failure of corticosterone 
to  enhance  memory  consolidation  under  low-arousing  conditions  is  due  to 
insu cient  training-induced  noradrenergic  activation,  low  doses  of  the   2-
adrenoceptor antagonist yohimbine, which increases norepinephrine levels in 
the brain, were co-administered with the corticosterone to well-habituated rats 
immediately after object recognition training (Fig. 1B) (Roozendaal et al., 2006b). 
The critical  nding of this study was that such an augmented noradrenergic tone 
was su cient to mimic the e ects of emotional arousal in that simultaneously 
administered  corticosterone  enhanced  memory  consolidation  (Roozendaal  et 
al., 2006b). Further, in habituated rats, corticosterone activated BLA neurons, as 
assessed by phosphorylated cAMP response-element binding (pCREB) protein 
immunoreactivity levels, only in animals also given yohimbine (Roozendaal et al., 
2006b). Such observations strongly suggest that because glucocorticoid e ects 
on memory consolidation require noradrenergic activation within the BLA, they 
only modulate memory under emotionally arousing conditions that induce the 
release of norepinephrine. 
Findings  of  studies  investigating  the  neurobiological  mechanism  of 
glucocorticoid  interactions  with  the  noradrenergic  system  suggest  that,  in 
addition to glucocorticoid-induced release of norepinephrine from presynaptic 
sites, an activation of postsynaptic GRs in pyramidal neurons of the BLA may 
facilitate memory consolidation by potentiating the norepinephrine signaling 
cascade  through  an  interaction  with  G-protein-mediated  events  (Roozendaal 
et  al.,  2002).  Posttraining  intra-BLA  infusions  of  the   -adrenoceptor  agonist 
clenbuterol or the cAMP analog 8-bromo-cAMP enhance memory consolidation 89
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in a dose-dependent fashion (Introini-Collison et al., 1991; Liang et al., 1995; 
Ferry and McGaugh 1999). The GR antagonist RU 38486 infused into the BLA 
shortly before training shifts the dose–response e ects of clenbuterol such that 
a much higher dose of clenbuterol is required to induce comparable memory 
enhancement  (Roozendaal  et  al.,  2002).  In  contrast,  the  GR  antagonist  does 
not modify the dose–response e ects of 8-bromo-cAMP, indicating that cAMP 
acts  in  the  BLA  downstream  from  the  locus  of  interaction  of  glucocorticoids 
with the  -adrenoceptor-AMP/protein kinase A (PKA) pathway. These  ndings 
strongly  suggest  that  glucocorticoids  enhance  memory  consolidation,  in  a 
permissive fashion, by potentiating  -adrenoceptor-cAMP/PKA e cacy in the 
BLA (Roozendaal et al., 2002). Findings of electrophysiological experiments in 
brain slices also indicate that glucocorticoids interact with the noradrenergic 
system in in uencing neural plasticity in BLA neurons. It should be noted that 
these  studies  indicate  that  glucocorticoids  a ect  noradrenergic  function  in  a 
time-dependent manner (Joels et al., 2011). For example, when corticosterone 
was  applied  simultaneously  with  a  `-adrenoceptor  agonist,  AMPA  receptor-
mediated responses in BLA neurons were rapidly facilitated, consistent with the 
idea that corticosterone requires concurrent noradrenergic activity to enhance 
memory  consolidation  of  emotionally  arousing  information.  However,  when 
the corticosterone was applied several hours in advance to the `-adrenoceptor 
agonist, possibly genomic GR actions kick in, resulting in a potent suppression 
of  the  `-adrenoceptor  agonist  e ect  on  AMPA  receptor-mediated  responses 
(Liebmann et al., 2009).
Recent  ndings indicate that the BLA is not the only brain region mediating 
glucocorticoid  e ects  on  the  noradrenergic  system  in  regulating  memory 
consolidation. Highly comparable to the e ects found in the BLA, infusions of a 
 -adrenoceptor antagonist or PKA inhibitor into the medial prefrontal cortex after 
inhibitory avoidance training prevent the memory enhancement of a GR agonist 
administered  concurrently  (Barsegyan  et  al.,  2010).  Moreover,  corticosterone 
administered  systemically  immediately  after  inhibitory  avoidance  training 
increases  PKA  activity  in  the  medial  prefrontal  cortex  within  30  min,  further 
supporting  the  view  that  glucocorticoid  e ects  on  facilitating  noradrenergic 
signaling  are  mediated  via  rapid,  nongenomic  actions.  Glucocorticoids  also 
interact with the noradrenergic system in the insular cortex in regulating memory 90
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consolidation. In one study (Roozendaal et al., 2010), corticosterone conjugated 
to a bovine serum albumin molecule (i.e., cort:BSA) was infused into the insular 
cortex  immediately  after  object  recognition  training  in  non-habituated  rats. 
This conjugate does not cross the cell membrane and thus selectively activates 
adrenal steroid receptors on the cell surface (Chiyo et al., 2003). This corticosterone 
conjugate enhanced memory consolidation of the training, and the e ect was 
blocked by co-administration of a GR, but not MR, antagonist, thus, providing 
support for the view that GRs on or near the cell surface are implicated in mediating 
glucocorticoid e ects on memory consolidation. Moreover, consistent with the 
view that glucocorticoids interact with the norepinephrine signaling pathway, a 
selective PKA inhibitor also blocked the cort:BSA-induced memory enhancement 
(Roozendaal et al., 2010). Immunocytochemistry revealed that cort:BSA infused 
after object recognition training increases pCREB levels in insular cortex neurons 
(Roozendaal et al., 2010).
There is now compelling evidence that the impairing e ects of glucocorticoids 
on  memory  retrieval  and  working  memory  under  emotionally  arousing  test 
conditions also depend on concurrent noradrenergic activity within the BLA (and 
other brain regions). For example, systemic administration of the  -adrenoceptor 
Figure 2. E ects of stress and glucocorticoids on memory functions. Glucocorticoids enhance 
memory  consolidation,  whereas  they  impair  memory  retrieval  and  working  memory.  All  of 
these  glucocorticoid  e ects  depend  on  emotional  arousal-induced  noradrenergic  activity.  NE, 
Norepinephrine. Adapted from de Quervain et al. Front Neuroendocrinol, 2009, with permission.91
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antagonist  propranolol,  30  min  before  retention  testing,  blocks  the  memory 
retrieval impairment of spatial/contextual information induced by a concurrent 
injection  of  corticosterone  (Roozendaal  et  al.,  2004a).  A   -adrenoceptor 
antagonist  infused  into  the  BLA  or  hippocampus  also  prevents  the  retrieval-
impairing e ect of a GR agonist administered concurrently (Roozendaal et al., 
2004b). Moreover, stimulation of  1-adrenoceptors with systemic injections of the 
selective agonist xamoterol induces memory retrieval impairment comparable 
to  that  seen  after  corticosterone  administration  (Roozendaal  et  al.,  2004b). 
Collectively, these  ndings suggest that the impairing e ects of glucocorticoids 
on memory retrieval involve a facilitation of noradrenergic mechanisms. Given 
that norepinephrine is activated by emotional arousal, this could explain why 
emotionally arousing information or an emotionally arousing test situation is a 
prerequisite for enabling glucocorticoid e ects on memory retrieval. In line with 
this view, we recently reported that the  -adrenoceptor antagonist propranolol 
blocks the impairing e ect of cortisone on the retrieval of emotionally arousing 
verbal  material  in  healthy  humans  (de  Quervain  et  al.,  2007).  Glucocorticoid 
e ects  on  working  memory  also  depend  on  interactions  with  noradrenergic 
mechanisms.  A   -adrenoceptor  antagonist  administered  systemically  blocks 
the impairing e ect of corticosterone on working memory in rats (Roozendaal 
et al., 2004c). Furthermore, a  -adrenoceptor antagonist or PKA inhibitor infused 
into the mPFC blocks working memory impairment induced by a GR agonist 
administered concurrently (Barsegyan et al., 2010). 
Thus,  the   ndings  summarized  above  indicate  that  glucocorticoids,  via 
a  nongenomically  mediated  mechanism,  interact  with  arousal-induced 
noradrenergic activation to selectively in uence memory consolidation, retrieval 
and  working  memory  during  emotionally  arousing  test  situations  (Fig.  2). 
However, they do not provide an explanation of how glucocorticoids might be 
able to rapidly in uence noradrenergic transmission. In the next section, we will 
provide a brief overview of nongenomic glucocorticoid mechanisms. 
Rapid  nongenomic  glucocorticoid  e ects:  involvement  of  the 
endocannabinoid system
Glucocorticoids are known to modulate cellular function, including learning and 
memory, through both genomic (slow) and nongenomic (rapid) pathways (de Kloet 92
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2000; Dallman 2005). Genomic glucocorticoid e ects are mediated by classical 
steroid  mechanisms  involving  transcriptional  regulation.  Glucocorticoids  can 
in uence transcription through both DNA binding-dependent and DNA binding–
independent mechanisms (de Kloet 2000). Although many glucocorticoid actions 
suit the timeframe for a genomic mechanism, some behavioral and physiological 
e ects  of  glucocorticoids,  for  example  the  above-described  e ects  on  the 
noradrenergic system, have a rapid onset, occurring in seconds to minutes, that 
is not readily compatible with transcriptional regulation. Rapid glucocorticoid 
actions have been reported in di erent limbic and brainstem structures, where 
they control functions ranging from learning and memory to neuroendocrine 
functions (Dallman 2005; Tasker et al., 2006; Haller et al., 2008; Riedemann et al., 
2010). It is important to note that glucocorticoid e ects on the consolidation 
of  long-term  memory  might  depend  on  an  interplay  between  genomic  and 
nongenomic actions (Falkenstein et al., 2000), whereas glucocorticoids’ ability 
to  temporarily  impair  memory  retrieval  and  working  memory  might  depend 
solely on nongenomic glucocorticoid actions. In support of this view, it has been 
reported that protein synthesis inhibitors fail to prevent glucocorticoid e ects on 
memory retrieval (Sajadi et al., 2006).
Nongenomic glucocorticoid actions likely involve the activation of a membrane-
associated variant(s) of the steroid receptor (Losel et al., 2003; Dallman 2005; 
Tasker et al., 2006; Riedemann et al., 2010). Orchinik and colleagues (Orchinik et 
al., 1991; Rose et al., 1993) were the  rst to provide evidence that glucocorticoids 
exert behavioral e ects through the activation of a corticosteroid receptor on 
the neuronal membrane. In this series of experiments, glucocorticoids rapidly 
suppressed  mating  behavior  in  the  amphibian  Taricha  granulosa  (rough-
skinned newt) by binding to a receptor on neuronal membranes. As mentioned, 
recent  ndings indicate that the administration of a membrane-impermeable 
glucocorticoid  ligand,  cort:BSA,  into  a  variety  of  brain  regions  of  the  rat  is 
su cient  to  enhance  the  consolidation  of  long-term  memory  of  emotionally 
arousing training experiences (Roozendaal et al., 2010; Lee et al., 2011) or to impair 
working memory (Barsegyan et al., 2010). As these cort:BSA e ects are blocked 
by co-administration of a GR, but not MR, antagonist (Barsegyan et al., 2010; 
Roozendaal et al., 2010), these  ndings suggest a role for a membrane-associated 
GR in mediating rapid glucocorticoid e ects on memory. Studies employing GR 93
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immunoreactivity,  at  both  the  light-  and  electronmicroscopic  level,  provided 
anatomical evidence for the existence of membrane-associated GRs in neurons of 
the hippocampus and hypothalamus (Liposits and Bohn 1993) and postsynaptic 
membranes of lateral amygdala neurons (Johnson et al., 2005). 
Current evidence indicates a variety of nongenomic glucocorticoid actions on 
neuroplasticity and memory, ranging from a rapid increase in glutamate-release 
probability from presynaptic sites (Karst et al., 2005) to a rapid insertion of AMPA 
receptor subunits in postsynaptic membranes (Groc et al., 2008). Recent evidence 
indicates  that  the  endocannabinoid  system  also  mediates  some  of  the  rapid 
e ects of glucocorticoids. The  rst evidence originated from an elegant series of 
in vitro studies that examined glucocorticoid e ects in hypothalamic nuclei on 
HPA-axis activity. In these experiments, Tasker and colleagues demonstrated that 
endocannabinoids  mediate  glucocorticoid-induced  suppression  of  glutamate 
release in hypothalamic neurons of the paraventricular nucleus, which, in turn, 
results in a rapid inhibition of hormone secretion (Di et al., 2003; Di et al., 2005a). 
Biochemical analysis of hypothalamic slices treated with dexamethasone revealed 
a rapid increase in the endocannabinoids anandamide and 2-AG (Di et al., 2005a; Di 
et al., 2005b). According to their model, corticosterone  rst binds to a membrane-
bound steroid receptor and this leads to an activation of divergent G-protein-
mediated signaling pathways that culminates in the release of endocannabinoids 
(Di et al., 2003; Di et al., 2005a; Malcher-Lopes et al., 2006; Tasker et al., 2006; Di 
et al., 2009). Endocannabinoid release from the postsynaptic membrane then 
suppresses the release of glutamate and this may represent a mechanism by 
which endocannabinoids regulate HPA-axis activity. A more recent in vivo study 
by Hill et al. (2010a), examining the e ect of corticosterone on tissue content of 
endocannabinoids in limbic brain regions, indicated surprisingly similar results. 
A single injection of corticosterone rapidly (within 10 min) elevated anandamide 
levels in both the amygdala and hippocampus. 
As reviewed above, glucocorticoids are able to rapidly in uence noradrenergic 
function to a ect di erent memory functions. Given the now well-described role 
of endocannabinoids in regulating glucocorticoid e ects on HPA-axis activity and 
the ability of glucocorticoids to rapidly recruit endocannabinoids in limbic brain 
regions, it is plausible that the endocannabinoid system is involved in mediating 94
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the rapid e ects of glucocorticoids on learning and memory functions. In the 
next section, we will  rst review  ndings indicating that endocannabinoids are 
involved in regulating learning and memory processes, and then we will present 
a model that implicates endocannabinoid signaling in regulating glucocorticoid 
e ects on memory of emotionally arousing experiences.
Role of endocannabinoids in regulating glucocorticoid e ects on memory: 
the model
Endocannabinoid signaling is crucial for certain forms of short- and long-term 
synaptic plasticity at excitatory and inhibitory synapses, and thereby contributes 
to various aspects of brain function, including learning and memory (Kano et al., 
2009). It has long been recognized, in animals and humans, that endocannabinoids 
in uence di erent memory phases. Behavioral studies in humans indicate that 
cannabis consumption as well as synthetic CB1 receptor agonists impair cognitive 
processes  that  subserve  executive  function.  Executive  function  comprises 
cognitive  processes  such  as  attention,  behavioral   exibility,  decision-making, 
inhibitory control, planning, time estimation and working memory, and is crucially 
involved in top-down control of behavior (Egerton et al., 2006; Solowij and Michie 
2007).  Although  the  neurobiological  mechanisms  underlying  the  deleterious 
e ects  of  cannabinoids  on  executive  function  are,  as  yet,  largely  unknown, 
accumulating  preclinical   ndings  emphasize  the  importance  of  modulatory 
actions  on  prefrontal  cortical  and  striatal  noradrenergic,  dopaminergic  and 
glutamatergic transmission (Pattij et al., 2008). Neuroimaging studies support this 
hypothesis and showed that changes in the activity of prefrontal, orbitofrontal and 
anterior cingulate cortices (among other regions) correlate with altered inhibitory 
processing in cannabis users (Solowij and Michie 2007). However, CB1 receptors 
are also highly expressed in the human limbic system, including the amygdala 
(Killgore and Yurgelun-Todd 2004). Animal studies con rmed the presence of CB1 
receptors on GABAergic interneurons in the BLA, where they modulate synaptic 
transmission (Katona et al., 2001) and neuronal  ring (Pistis et al., 2004). Preclinical 
research demonstrated a functional interaction between cannabinoids and stress 
in the activation of the amygdala, which may provide a context for understanding 
the interplay between these two systems in the regulation of memory formation 
for emotionally arousing events (Patel et al., 2005).
We  recently  investigated  whether  the  endocannabinoid  system  in  the  BLA 95
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in uences  memory  consolidation  of  an  emotionally  arousing  inhibitory 
avoidance training experience (Campolongo et al., 2009b). As is shown in Fig. 3A 
and 3B, intra-BLA infusion of the CB1 receptor agonist WIN55,212-2 administered 
immediately  after  the  inhibitory  avoidance  training  trial  dose-dependently 
enhances memory consolidation, whereas that of the CB1 receptor antagonist 
AM251 impairs memory consolidation. These  ndings indicate that a manipulation 
of  cannabinoid  transmission  in  the  BLA  in uences  memory  consolidation 
for  emotionally  arousing  experiences;  however,  whether  they  also  modulate 
memory  of  low-arousing  training  experiences  has  never  been  investigated. 
Consistent with these  ndings, others have reported that infusion of the CB1 
receptor antagonist AM251 into the amygdala (Bucherelli 2006) or hippocampus 
(de Oliveira Alvares et al., 2005) disrupts the consolidation of long-term memory, 
possibly by inhibiting long-term potentiation (de Oliveira Alvares et al., 2006). 
Several other studies indicated an involvement of the endocannabinoid system 
in the extinction of fear memories (Marsicano et al., 2002; Suzuki et al., 2004; 
Chhatwal et al., 2005). We recently found that, similar to glucocorticoid e ects 
on memory consolidation, endocannabinoid e ects on memory for inhibitory 
Figure 3. Endocannabinoids mediate glucocorticoid e ects on memory consolidation for inhibitory 
avoidance training. Data represent step-through latencies (mean + SEM) on a 48-h retention test. 
(A) Immediate posttraining intra-BLA infusions of the CB1 receptor agonist WIN55,212-2 (WIN; 5, 10, 
50 ng per 0.2 +l) enhanced memory consolidation. *, P < 0.05 vs. vehicle. (B) Immediate posttraining 
intra-BLA infusions of the CB1 receptor antagonist AM251 (0.07, 0.14, 0.28 ng per 0.2 +l) impaired 
memory consolidation. *, P < 0.05 vs. vehicle. (C) Immediate posttraining infusions of AM251 (0.14 
ng per 0.2 +l) into the BLA blocked the memory enhancement induced by a subcutaneous injection 
of corticosterone (CORT; 3.0 mg/kg; *, P < 0.05 compared with the corresponding vehicle group; #, 
P < 0.05 compared with the corresponding CORT group. Adapted from Campolongo et al., Proc Natl 
Acad Sci USA, 2009.96
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avoidance  training  follow  an  inverted-U  shaped  dose-response  relationship 
(D. Hauer, P. Atsak, E. Eggens-Meijer, P. Campolongo, G. Schelling, R. Fornari, B. 
Roozendaal,  unpublished  observation).  Accordingly,  impairing  e ects  with 
endocannabinoids have been described as well. For example,  ndings indicate 
that systemic administration of a much higher dose of the CB1 receptor agonist 
WIN55,212-2 impairs the acquisition of contextual fear conditioning (Pamplona 
and Takahashi 2006) and that pretraining intrahippocampal administration of 
Figure 4. Model on the role of the endocannabinoid system in the BLA in mediating glucocorticoid 
e ects  on  norepinephrine  release  in  regulating  memory  consolidation.  Corticosterone  (CORT) 
is  released  during  training  in  emotionally  arousing  tasks  and  binds  to  a  membrane-bound 
glucocorticoid receptor (GR) (1), that activates a pathway to induce endocannabinoid (eCB) synthesis 
(2). Endocannabinoids are then released into the synapse where they bind to CB1 receptors on 
GABAergic terminals (3), and thereby inhibit the release of GABA (4). This suppression of GABA 
release subsequently disinhibits norepinephrine (NE) release (5), and this results in an activation 
of the postsynaptic  -adrenoceptor and the downstream cAMP/PKA/pCREB intracellular signaling 
pathway (6). These stress hormone e ects on noradrenergic activation in the BLA are required for 
enhancing memory consolidation. Adapted from Hill and McEwen, Proc. Natl Acad Sci USA, 2009.97
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anandamide  impairs  memory  consolidation  of  inhibitory  avoidance  training 
(Barros et al., 2004). Moreover, it has been reported that infusion of a CB1 receptor 
antagonist into the hippocampus during water-maze spatial training enhances 
the acquisition of this task (Robinson et al., 2008). In addition to di erences in 
drug dosage, administration route and regimen, these opposite  ndings might 
be  attributed  to  binding  of  endocannabinoids  to  di erent  receptor  systems, 
e.g., anandamide-induced activation of the transient receptor potential vanilloid 
type 1 receptor (TRPV1) has been reported to produce opposite e ects to that of 
binding to the CB1 receptor (Rubino et al., 2008). Collectively, the  ndings appear 
comparable  to  those  described  for  glucocorticoids  in  that  endocannabinoids 
consistently impair working memory and memory retrieval, while having dose-
dependent favorable e ects on memory consolidation.  
Given the close interaction between the endocannabinoid and glucocorticoid 
systems,  we  investigated  whether  endocannabinoid  transmission  might  play 
a  role  in  mediating  glucocorticoid  e ects  on  memory  consolidation.  For  this 
experiment,  rats  were  trained  on  an  inhibitory  avoidance  task  and  received 
immediate posttraining infusions of the CB1 receptor antagonist AM251 into 
the BLA together with a systemic administration of corticosterone. As is shown 
in Fig. 3C, intra-BLA administration of the CB1 receptor antagonist blocked the 
ability  of  corticosterone  to  facilitate  memory  consolidation  of  the  inhibitory 
avoidance training (Campolongo et al., 2009b). Similarly, other researchers found 
that a CB1 receptor antagonist infused into the hippocampus blocked memory 
enhancement  induced  by  the  synthetic  glucocorticoid  dexamethasone  (de 
Oliveira Alvares et al., 2010) To investigate whether this glucocorticoid e ect on the 
endocannabinoid system is mediated by a GR on the cell surface, we performed 
an additional experiment. The  ndings of this experiment indicate that the CB1 
receptor antagonist AM251 infused into the BLA blocked the memory-enhancing 
e ects induced by concurrent infusions of either a speci c GR agonist or the 
membrane-impermeable ligand cort:BSA (D. Hauer, P. Atsak, E. Eggens-Meijer, P. 
Campolongo, G. Schelling, R. Fornari, B. Roozendaal, unpublished observation). 
Therefore, these  ndings indicate that endocannabinoid transmission is required 
for  mediating  glucocorticoid  e ects  on  memory  consolidation,  presumably 
involving the activation of a GR on the cell surface.98
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Does the endocannabinoid system mediate the rapid e ects of glucocorticoids 
on the noradrenergic system in selectively regulating memory of emotionally 
arousing experiences? Although direct evidence is lacking, it is well established 
that  endocannabinoid  e ects  on  memory  as  well  as  on  other  behaviors  are 
highly dependent on the emotional state of the animal (Patel et al., 2005; Hill 
et  al.,  2010c). We  investigated  whether  endocannabinoid  e ects  on  memory 
consolidation might depend on concurrent noradrenergic activity within the BLA. 
Highly comparable to the above-described e ects of glucocorticoids on memory 
consolidation, the `-adrenoceptor antagonist propranolol administered into the 
BLA prevented the memory enhancement induced by concurrent administration 
of the CB1 receptor agonist WIN55,212-2 (D. Hauer, P. Atsak, E. Eggens-Meijer, P. 
Campolongo, G. Schelling, R. Fornari, B. Roozendaal, unpublished observation). 
In  an  earlier  paper,  we  already  reported  that  systemic  administration  of  the 
endocannabinoid  oleoylethanolamide  enhances  memory  consolidation  of 
inhibitory  avoidance  training.  As  the  `-adrenoceptor  antagonist  propranolol 
infused  into  the  BLA  blocks  this  memory  enhancement  (Campolongo  et  al., 
2009a), these  ndings indicate that also oleoylethanolamide enhances memory 
consolidation via a norepinephrine-dependent mechanism in the BLA. Moreover, 
there is evidence that systemic or local administration of a CB1 receptor agonist 
increases norepinephrine levels in cortical and limbic brain regions (Oropeza et 
al., 2005; Page et al., 2007). 
Endocannabinoids  might  in uence  noradrenergic  function  via  a  modulation 
of GABAergic activity. In the BLA, CB1 receptors are abundantly expressed in 
GABAergic interneurons (Katona et al., 2001) and activation of CB1 receptors 
has consistently been shown to suppress the release of GABA (Katona et al., 
1999; Katona et al., 2001; Ohno-Shosaku et al., 2001) via a rapid inhibition of 
calcium entry into the terminals (Ho man and Lupica 2000; Wilson et al., 2001). 
It is well established that the amygdala GABAergic system is involved in memory 
modulation. Posttraining infusions of GABA receptor antagonists into the BLA 
are known to enhance memory consolidation, whereas posttraining infusions of 
GABA receptor agonists impair memory consolidation (McGaugh and Roozendaal 
2002).  Importantly,  the  modulatory  e ects  of  GABAergic  transmission  on 
memory crucially depend on an interaction with the noradrenergic system. A 
 -adrenoceptor antagonist administered systemically or directly into the BLA 99
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prevents the modulatory e ects of GABAergic drugs on memory consolidation 
(McGaugh,  2004).  Moreover,  an  in vivo  microdialysis  study  indicated  that  the 
administration of a GABA receptor antagonist increases norepinephrine levels in 
the amygdala, whereas that of a GABA receptor agonist decreases norepinephrine 
levels (Hat eld et al., 1999). Thus, endocannabinoids might increase BLA neuronal 
activity  by  decreasing  GABAergic  neurotransmission,  leading  to  increased 
noradrenergic activity within the BLA. Interestingly, a recent study indicated that 
glucocorticoids also increase the excitability of BLA neurons by decreasing the 
impact of GABAergic in uences (Duvarci and Paré 2007).
In  summary,  we  propose  the  following  model  of  how  glucocorticoids  might 
recruit the endocannabinoid system to in uence the release of norepinephrine 
in the BLA in regulating memory consolidation (Fig. 4): Glucocorticoids  rst bind 
to  a  membrane-bound  receptor  that  activates  a  G-protein-coupled  signaling 
cascade to induce endocannabinoid release. The endocannabinoids then bind 
to presynaptic CB1 receptors on GABAergic terminals which rapidly suppress the 
release of GABA. This suppression of GABAergic transmission leads to elevated 
norepinephrine levels, which increase noradrenergic signaling in BLA pyramidal 
neurons  and  result  in  a  facilitation  of  memory  consolidation  of  emotionally 
arousing experiences. 
CONCLUSIONS AND FUTURE DIRECTIONS
The  ndings summarized above indicate that glucocorticoids enhance memory 
consolidation  for  emotionally  arousing  experiences  and  impair  memory 
retrieval  and  working  memory  during  emotionally  arousing  test  situations 
via  rapid  interactions  with  arousal-induced  noradrenergic  mechanisms.  The 
endocannabinoid  system  might  play  a  crucial  role  in  mediating  such  rapid 
glucocorticoid e ects on the noradrenergic system. However, there are many 
fascinating, unanswered questions. First, our model suggests that glucocorticoids 
interact  with  the  noradrenergic  system  via  endocannabinoid  signaling. 
Although several  ndings have demonstrated that endocannabinoids modulate 
noradrenergic  transmission,  it  is  unclear  whether  this  is  actually  achieved  by 
a  suppression  of  GABAergic  transmission,  thereby  increasing  noradrenergic 100
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transmission, or by a direct in uence on the noradrenergic system. 
Second, glucocorticoids are known to in uence noradrenergic function both at 
presynaptic sites, enhancing the release of norepinephrine, and postsynaptically, 
facilitating norepinephrine e ects on the cAMP/PKA signaling pathway. It is not 
known whether endocannabinoids mediate glucocorticoid e ects on both of 
these mechanisms. 
Third, another important unanswered question is the role of emotional arousal in 
regulating glucocorticoid-endocannabinoid e ects on the noradrenergic system. 
We presented evidence that glucocorticoid administration can increase the release 
of norepinephrine in the BLA, but only so under emotionally arousing conditions. 
Where does this switch come from? Is it possible that the endocannabinoid system 
might represent such a switch mechanism for glucocorticoids? To explore this 
possibility, it would be necessary to investigate whether glucocorticoids recruit 
the endocannabinoid system under low-arousing experimental conditions. 
Fourth, a role for the endocannabinoid system in regulating glucocorticoid e ects 
on memory has only been investigated with respect to memory consolidation. 
It would be important to investigate whether the endocannabinoid system is 
also involved in mediating glucocorticoid e ects on the impairment of memory 
retrieval and working memory.
Finally, glucocorticoids have been reported to increase levels of both anandamide 
and  2-AG  (Hill  et  al.,  2010a). The  exact  role  of  these  endogenous  ligands  in 
regulating glucocorticoid e ects on the formation and retrieval of emotionally 
in uenced memory requires more extensive analysis. Further, endocannabinoid 
e ects on memory have only been studied with respect to CB1 receptor-mediated 
events. But, recent evidence indicates that the CB2 receptor is also present in the 
brain.
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ABSTRACT 
Glucocorticoid hormones are known to enhance the consolidation of long-term 
memory of emotionally arousing experiences but not that of low-arousing or 
neutral information. Prior studies indicated that nongenomically mediated actions 
of glucocorticoids on endogenous noradrenergic activation of the basolateral 
complex  of  the  amygdala  (BLA)  induced  by  emotional  arousal  underlie  this 
selectivity. However, the neural mechanism of how glucocorticoids might rapidly 
in uence noradrenergic function in the context of memory consolidation remains 
elusive. Here, we show that the endocannabinoid system, a rapidly activated 
retrograde messenger system, is essentially involved in regulating glucocorticoid 
e ects,  via  a  glucocorticoid  receptor  on  the  cell  surface,  on  the  amygdala 
noradrenergic  arousal  system  in  enhancing  memory  consolidation.  Further, 
glucocorticoids require endocannabinoid signaling in facilitating norepinephrine 
e ects on neural plasticity within the BLA, as assessed by phosphorylated cAMP 
response element-binding immunoreactivity levels. The  ndings have important 
implications  for  understanding  local  network  functions  within  the  BLA  in 
regulating stress hormone e ects on neural plasticity and memory consolidation. 115
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INTRODUCTION
Emotional  enhancement  of  memory  is  a  highly  adaptive  phenomenon 
(Christianson, 1992), but it also contributes to the development of stress-related 
pathologies such as anxiety and post-traumatic stress disorder (de Quervain et al., 
2009). Extensive evidence indicates that glucocorticoid hormones (corticosterone 
in rodents, cortisol in humans) that are released from the adrenal cortex during 
stressful events enhance the consolidation of long-term memory of emotionally 
arousing experiences in animals (de Kloet et al., 1999; McGaugh and Roozendaal, 
2002; Okuda et al., 2004; Sandi and Pinelo-Nava, 2007; Roozendaal et al., 2008a; 
Roozendaal  and  McGaugh,  2011)  and  humans  (Buchanan  and  Lovallo,  2001; 
Abercrombie  et  al.,  2006;  Kuhlmann  and  Wolf,  2006).  Yet,  these  hormones 
have little e ect on memory of more mundane experiences (de Quervain et 
al., 2000; Buchanan and Lovallo, 2001; Okuda et al., 2004; Kuhlmann and Wolf, 
2006). Findings of experiments investigating the basis underlying this selectivity 
indicate that glucocorticoid e ects on memory consolidation depend crucially 
on  nongenomically  mediated  actions,  via  a  putative  membrane-associated 
glucocorticoid  receptor  (GR),  on  endogenous  noradrenergic  activation  within 
the basolateral complex of the amygdala (BLA) induced by emotional arousal 
(Quirarte et al., 1997; Roozendaal, 2000; Roozendaal, 2002; Roozendaal et al., 
2006a; Hurlemann et al., 2007; Van Stegeren et al., 2007). In earlier studies, we 
described that glucocorticoids administered after an emotionally arousing, but 
not low-arousing, training experience rapidly elevate norepinephrine levels in 
the BLA (McReynolds et al., 2010) and facilitate norepinephrine e ects on the 
cAMP-dependent protein kinase pathway to induce the phosphorylation of cAMP 
response element-binding (pCREB) protein (Roozendaal, 2002; Roozendaal et al., 
2006b), whereas a blockade of `-adrenoceptors or cAMP signaling in the BLA 
prevents glucocorticoid-induced memory enhancement (Quirarte et al., 1997; 
Roozendaal et al., 2002b). However, the neural mechanism of how glucocorticoids 
might rapidly alter noradrenergic signaling in promoting memory consolidation 
received little attention so far.  
The  endocannabinoid  system  is  one  emerging  candidate  system  thought  to 
mediate  some  of  the  rapid  actions  of  glucocorticoids  in  the  brain  (Hill  and 
McEwen, 2009). Endocannabinoids, i.e., anandamide and 2-arachidonoylglycerol 116
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(2-AG), are short-lived retrograde messengers that are synthesized on demand 
through cleavage of membrane precursors (Hashimotodani et al., 2007). They 
bind to the cannabinoid receptor subtype 1 (CB1 receptor) on presynaptic sites 
to regulate ion channel activity and neurotransmitter release (Freund et al., 2003). 
Although  glucocorticoid  e ects  on  the  endocannabinoid  system  have  been 
studied almost exclusively with respect to nongenomically mediated actions of 
glucocorticoids on hypothalamic-pituitary-adrenal axis activity (Weidenfeld et al., 
1994; Di et al., 2003; Barna et al., 2004; Patel, 2004; Tasker et al., 2006; Hill et al., 
2010b; Tasker and Herman, 2011), it became increasingly clear that CB1 receptors 
are also abundantly expressed in the BLA (and other brain regions) where they 
modulate emotional arousal e ects on synaptic transmission, neuronal  ring and 
memory (Katona et al., 2001; Pistis et al., 2004; Ganon-Elazar and Akirav, 2009; 
Karst et al., 2010; Tan et al., 2011). The recent  ndings that systemic administration 
of corticosterone rapidly elevates endocannabinoid levels in the amygdala (Hill 
et al., 2010a), whereas a blockade of CB1 receptor activity in the BLA prevents 
corticosterone-induced  memory  enhancement  (Campolongo  et  al.,  2009) 
provided the  rst in vivo evidence in mammalian species in support of a functional 
interaction between these two stress systems in regulating memory processes. The 
current study was aimed at investigating whether such glucocorticoid-induced 
recruitment of the endocannabinoid system is an essential step in mediating the 
rapid e ects of glucocorticoids on the noradrenergic arousal system in enhancing 
the consolidation of memory of emotionally arousing training experiences. 
METHODS
Subjects.  Male adult Sprague-Dawley rats (280-320 g at time of surgery) from 
Charles River Breeding Laboratories (Kisslegg, Germany) were kept individually in 
a temperature-controlled (22oC) colony room and maintained on a standard 12-h 
light: 12-h dark cycle (07:00-19:00 h lights on) with ad libitum access to food and 
water. Training and testing were performed during the light phase of the cycle 
between 10:00 and 15:00 h. All procedures were performed in compliance with 
the European Communities Council Directive of 24 November 1986 (86/609/EEC) 
and were approved by the Institutional Animal Care and Use Committee of the 
University of Groningen, The Netherlands.117
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Surgery.  Animals, adapted to the vivarium for at least 1 week, were anesthetized 
with a subcutaneous injection of ketamine (37.5 mg/kg of body weight; Alfasan) 
and  dexmedetomidine  (0.25  mg/kg;  Orion),  and  received  the  non-steroidal 
analgesic carprofen (4 mg/kg, sc; P zer). Oxygen (30-35%) mixed with ambient air 
was administered during surgery such that blood oxygenation levels would not 
drop below 90%. Surgery was performed according to a standardized protocol 
(Fornari et al., 2012). Brie y, the skull was positioned in a stereotaxic frame (Kopf 
Instruments), and two stainless-steel guide cannulae (15 mm; 23 gauge; Small 
Parts, Inc) were implanted bilaterally with the cannula tips 2.0 mm above the 
BLA. The coordinates were based on the atlas of Paxinos and Watson (Paxinos and 
Watson, 2005): anteroposterior, -2.8 mm from Bregma; mediolateral, +5.0 mm 
from the midline; dorsoventral, -6.5 mm from skull surface; incisor bar –3.3 mm 
from interaural. The cannulae were a xed to the skull with two anchoring screws 
and dental cement. Stylets (15-mm long 00-insect dissection pins), inserted into 
each cannula to maintain patency, were removed only for the infusion of drugs. 
After surgery, the rats were administered atipamezole hydrochloride (0.25 mg/kg 
sc; Orion) to reverse anesthesia and were subsequently injected with 3 ml of saline 
to facilitate clearance of drugs and prevent dehydration. They were returned to 
their home cages for further recovery from anesthesia. The rats were allowed to 
recover for a minimum of 7 days before initiation of training and were handled 3 
times for 1 min each during this recovery period to accustom them to the infusion 
procedure. 
Inhibitory avoidance apparatus and procedure. Rats were trained and tested in an 
inhibitory avoidance apparatus consisting of a trough-shaped alley (91 cm long, 
15 cm deep, 20 cm wide at the top, and 6.4 cm wide at the bottom) divided into 
two compartments, separated by a sliding door that opened by retracting into 
the  oor (McGaugh et al., 1988). The starting compartment (30 cm) was made of 
opaque white plastic and well lit; the shock compartment (60 cm) was made of 
two electri able metal plates and was not illuminated. Training and testing were 
conducted in a sound- and light-attenuated room.
For training, the rats were placed in the starting compartment of the apparatus, 
facing away from the door, and were allowed to enter the dark (shock) compartment. 
After the rat stepped completely into the dark compartment, the sliding door 
was closed and a single inescapable footshock (0.60 mA, 1 s) was delivered. For 118
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the experiment with systemic drug administration a lower footshock intensity of 
0.35 mA was used. The rats were removed from the shock compartment 15 s after 
termination of the footshock and, after drug treatment, returned to their home 
cages. On the 48-h retention test, as on the training session, the latency to re-
enter the shock compartment with all four paws (maximum latency of 600 s) was 
recorded and used as a measure of retention. Longer latencies were interpreted 
as indicating better retention. Shock was not administered on the retention test 
trial.
Drug  and  infusion  procedures.    The  speci c  GR  agonist  RU  28362  (11b,17b-
dihydroxy-6,21-dimethyl-17a-pregna-4,6-trien-20yn-3-one;  1,  3  or  10  ng; 
kindly provided by Aventis, Frankfurt, Germany), the membrane-impermeable 
glucocorticoid Cort:BSA (1, 3 or 10 ng; Sigma-Aldrich), the CRF-BP ligand inhibitor 
human/rat CRF6-33 (0.01, 0.1 or 1 mg; Bachem, La Jolla, CA) and the `-adrenoceptor 
agonist clenbuterol (1, 10 or 100 ng; Sigma-Aldrich) were infused into the BLA 
immediately after inhibitory avoidance training either alone or together with 
the  selective  CB1  receptor  antagonist  AM251  (N-1-(2,4-dichlorophenyl)-5-(4-
iodophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide;  0.14  ng; 
Sigma-Aldrich). The GR agonist-AM251 and clenbuterol-AM251 mixtures were 
 rst dissolved in 100% DMSO and subsequently diluted in phosphate bu er to 
reach a  nal DMSO concentration of 5%. The Cort:BSA-AM251 drug solutions 
were made in a vehicle containing 5% DMSO and 0.1% BSA in phosphate bu er, 
whereas the CRF-BP ligand inhibitor-AM251 solutions were prepared in a vehicle 
containing 5% DMSO in saline.  
The  CB  receptor  agonist  WIN55,212-2  (R-(+)-(2,3-dihydro-5-methyl-3-
[(morpholinyl)methyl]  pyrol[1,2,3-de]-1,4-benzoxazin-6-yl)(1-naphthalenyl) 
methanone  monomethanesulfonate;  10,  30  or  100  ng;  Sigma-Aldrich)  was 
dissolved in a vehicle containing 2% DMSO and 0.2% Triton X-100 in phosphate 
bu er and infused into the BLA either alone or together with the speci c GR 
antagonist  RU  38486  (17b-hydroxy-11b-(4-dimethylaminophenyl)-17a-(1-
propynyl)-oestra-4,9-dien-3-one;  1  ng;  kindly  provided  by  Aventis,  Frankfurt, 
Germany),  the  nonselective  CRF  receptor  antagonist_ -helical  CRF9-41  (1  mg; 
Bachem) or the`-adrenoceptor antagonist propranolol (0.5 mg; Sigma-Aldrich). 
Drug doses were selected on the basis of previous experiments (Roozendaal et 119
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al., 2002a; Roozendaal et al., 2002b; Roozendaal et al., 2008b; Campolongo et al., 
2009; Roozendaal et al., 2010).
Bilateral  infusions  of  drug,  or  an  equivalent  volume  of  vehicle,  into  the  BLA 
were given immediately after inhibitory avoidance training by using 30-gauge 
injection needles connected to 10-+l Hamilton microsyringes by polyethylene 
(PE-20) tubing. The injection needles protruded 2.0 mm beyond the cannula tips 
and a 0.2-+l injection volume per hemisphere was infused over a period of 30 
s by an automated syringe pump (Stoelting Co., Dublin, Ireland). The injection 
needles were retained within the cannulae for an additional 20 s following drug 
infusion to maximize di usion and to prevent back ow of drug into the cannulae.   
The infusion volume was based on  ndings that drug infusions of this volume 
into the BLA, but not into the adjacent central nucleus of the amygdala, modulate 
memory consolidation (Roozendaal and McGaugh, 1997; Roozendaal et al., 2007; 
Campolongo et al., 2009).
Systemic  drug  administration:  Corticosterone  (3  mg/kg;  Sigma-Aldrich)  either 
alone or together with the inverse CB1 receptor agonist SR141716 (rimonabant, 
5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-
pyrazole-3-carboxamide;  1  mg/kg;  Kemprotec  Ltd,  Middlesbrough,  UK)  was 
given subcutaneously, in a volume of 2 ml/kg, immediately after the training 
trial. Corticosterone and SR141716 were dissolved in a vehicle containing 5% 
polyethylene glycol, 5% tween-80 and 5% ethanol in saline.
Histology. Rats were anesthetized with an overdose of sodium pentobarbital and 
perfused transcardially with a 0.9% saline solution followed by 4% formaldehyde 
dissolved  in  water.  Following  decapitation,  the  brains  were  removed  and 
immersed in fresh 4% formaldehyde. At least 24 h before sectioning, the brains 
were submerged in a 25% sucrose (wt/vol) solution in water for cryoprotection. 
Coronal sections of 50 mm were cut on a cryostat, mounted on gelatin-coated 
slides, and stained with cresylviolet. The sections were examined under a light 
microscope and determination of the location of injection needle tips in the 
BLA was made according to the standardized atlas plates of Paxinos and Watson 
(Paxinos and Watson, 2005) by an observer blind to drug treatment condition. 
Only rats with needle tips within the boundaries of the BLA were included in the 120
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data analysis. Rats with extensive tissue damage at the injection needle tip were 
also excluded from analysis.
Immunohistochemitry: Sixty minutes after training and systemic drug treatment, 
rats were perfused transcardially with ice-cold 0.01 M phosphate-bu ered saline 
(PBS), pH 7.4, followed by ice-cold 4% paraformaldehyde in 0.1 M phosphate 
bu er (PB), pH 7.4. The brains were removed, post xed overnight at 4°C, and then 
transferred to a 25% sucrose solution in 0.1 M PB for 3-6 days at 4°C. Frozen coronal 
sections at the level of the BLA were cut at a thickness of 20  m on a cryostat and 
collected in Tris-bu ered saline (TBS) with 0.1% sodium azide and phosphatase 
inhibitors  (20  mM  sodium   uoride  and  2  mM  sodium  orthovanadate).  Every 
eighth section was used for quanti cation. Free- oating sections were pretreated 
with 1% H2O2 for 1 h to block endogenous peroxidase and with 5% normal donkey 
serum (nds, Jackson ImmunoResearch) to block nonspeci c binding and 0.3% 
Triton X-100 to increase antibody penetration. These substances were diluted in 
TBS with phosphatase inhibitors. Subsequently, sections were incubated with 
a monoclonal rabbit anti-pCREB (Ser133) antibody (Cell Signaling Technology, 
#9198, 1:30) in TBS containing phosphatase inhibitors, 0.3% Triton X-100 and 1% 
nds at 4°C for 48 h. After rinsing thorough, sections were subsequently incubated 
with biotinylated donkey anti-rabbit IgG secondary antibody (2 µg/ml, Jackson 
ImmunoResearch) for 1 h followed by incubation with avidin-biotin complex-
peroxidase  (1:500,  ABC  kit, Vector  laboratories)  for  1  h  at  room  temperature. 
Finally,  sections  were  stained  with  0.025%  diaminobenzidine,  0.2%  nickel 
ammonium  sulphate  adding  0.3%  H2O2.  Sections  were  mounted,  dehydrated 
and coverslipped. Omission of the primary antibody resulted in complete loss of 
pCREB immunoreactivity. pCREB-positive cells were blindly quanti ed in the BLA 
(2.3-3.1 mm posterior to Bregma) using an automated imaging analysis system. 
The selected areas were digitized by using a Sony charge-coupled device digital 
camera mounted on a LEICA Leitz DMRB microscope (Leica, Wetzlar, Germany) at 
100x magni cation. Regions of interest were outlined and pCREB-positive nuclei 
were counted using a computer-based image analysis system (Leica Imaging 
System Ltd., Cambridge, UK). Data are reported as number of positive cells/0.1 
mm. The number of positive cells for the experimental groups is shown relative 
to vehicle. As no left–right asymmetry in pCREB immunoreactivity was found, the 
mean of both sides was calculated.121
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Figure 1. Glucocorticoid interactions with the endocannabinoid system of the BLA in enhancing 
memory consolidation of inhibitory avoidance training. (A) Step-through latencies (mean + SEM) 
in seconds on the 48-h inhibitory avoidance retention test of rats given immediate posttraining 
infusions into the BLA of the CB1 receptor antagonist AM251 (0.14 ng in 0.2 +l) together with the 
GR agonist RU 28362 (1, 3 or 10 ng). , P < 0.01 compared with the corresponding vehicle group; 
, P < 0.01 compared with the corresponding RU 28362 alone group (n = 9-12 per group). (B) 
Representative photomicrograph illustrating placement of a cannula and needle tip in the BLA. 
Arrow points to needle tip. L, lateral nucleus; B, basal nucleus; AB accessory basal nucleus; CEA, 
central nucleus of the amygdala. (C) Step-through latencies (mean + SEM) in seconds on the 48-h 
inhibitory avoidance retention test of rats given immediate posttraining infusions into the BLA of 
the CB1 receptor antagonist AM251 (0.14 ng in 0.2 +l) together with the membrane-impermeable 
glucocorticoid Cort:BSA (1, 3 or 10 ng). , P < 0.05; , P < 0.01 compared with the corresponding 
vehicle group; , P < 0.05 compared with the corresponding Cort:BSA alone group (n = 11-14 
per group). (D) Step-through latencies (mean + SEM) in seconds on the 48-h inhibitory avoidance 
retention test of rats given immediate posttraining infusions into the basolateral amygdala of the 
CB receptor agonist WIN55,212-2 (10, 30 or 100 ng in 0.2+l) either alone or together with the GR 
antagonist RU 38486 (1 ng) , P < 0.01 compared with the corresponding vehicle group; (n = 
10-14 per group).122
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Statistics. Data are presented as mean + SEM. Training and retention test latencies 
were analyzed using two-way ANOVAs with immediate posttraining infusions of 
di erent doses of the agonist and antagonist as between-subject variables. Further 
analysis used Fisher’s post-hoc tests to determine the source of the detected 
signi cances, when appropriate. To determine whether learning had occurred, 
paired t-tests were used to compare the training and retention latencies. For all 
comparisons, a probability level of < 0.05 was accepted as statistical signi cance. 
The number of rats per group is indicated in the  gure legends. 
RESULTS
Involvement  of  the  endocannabinoid  system  of  the  BLA  in  mediating 
glucocorticoid receptor agonist e ects on memory consolidation. 
In view of the evidence that the low-a nity GR, and not the mineralocorticoid 
receptor,  mediates  the  e ects  of  glucocorticoids  on  both  noradrenergic 
activity and memory consolidation (Oitzl and de Kloet, 1992; Roozendaal, 2002; 
Barsegyan et al., 2010), the  rst experiment was aimed at delineating whether the 
GR is also implicated in mediating the crosstalk between glucocorticoids and the 
endocannabinoid system of the BLA. Therefore, rats were trained on a one-trial 
inhibitory avoidance task and immediately afterwards administered the speci c 
GR agonist RU 28362 (1, 3 or 10 ng) into the BLA either alone or together with the 
CB1 receptor antagonist AM251 (0.14 ng). Retention of the training was tested 48 
h later.
Average step-through latencies for all groups during training, i.e., before footshock 
or drug treatment, were 13.4 + 0.7 s (mean + SEM). Two-way ANOVA for training 
latencies showed no signi cant di erences between groups (for all comparisons: 
P  >  0.14;  data  not  shown).  Forty-eight-hour  retention  test  latencies  of  rats 
administered vehicle into the BLA immediately after training were signi cantly 
longer than their response latencies on the training trial (52.7 + 13.5 s; paired 
t-test: P = 0.01), indicating that the rats retained signi cant memory of the shock 
experience. As is shown in Fig. 1A, AM251 blocked the retention enhancement 
induced by the GR agonist RU 28362. Two-way ANOVA for 48-h retention latencies 
revealed a signi cant RU 28362 e ect (F3,80 = 2.98; P = 0.04), a signi cant AM251 
e ect (F1,80 = 4.26; P = 0.04), as well as a signi cant interaction between both 
factors (F3,80 = 4.07; P = 0.04). RU 28362 infused alone into the BLA induced dose-123
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dependent enhancement of retention performance (1 ng: P < 0.01). The low dose 
of the CB1 receptor antagonist AM251 alone did not impair retention latencies, 
but blocked the retention enhancement induced by concurrently administered 
RU  28362.  Retention  latencies  of  rats  treated  with  AM251  together  with  the 
1 ng dose of RU 28362 were signi cantly shorter than those of rats given the 
corresponding dose of RU 28362 alone (P < 0.01). Thus, these  ndings indicate 
that the low-a nity GR mediates glucocorticoid e ects on the endocannabinoid 
system in enhancing the consolidation of inhibitory avoidance memory.
Histological analysis revealed the majority of needle placements to be localized 
within the boundaries of the BLA as de ned by Paxinos and Watson (Paxinos and 
Watson, 2005). Rats found to have needle tip placements outside the boundaries 
of the BLA were excluded from data analysis. A representative photomicrograph 
of a needle track terminating within the BLA is shown in Fig. 1B. 
 
Involvement of the endocannabinoid system of the BLA in regulating memory 
enhancement induced by a membrane-impermeable glucocorticoid. 
Next, we investigated whether glucocorticoid e ects on the endocannabinoid 
system  of  the  BLA  in  regulating  the  consolidation  of  inhibitory  avoidance 
memory involve the activation of a corticosteroid receptor on the cell surface. 
Emerging  evidence  indicates  that  rapid  actions  of  glucocorticoids,  including 
those on the noradrenergic system, are mediated via an activation of putative 
G-protein-coupled receptors or membrane-associated cytosolic steroid receptors 
(Orchinik et al., 1991; Johnson et al., 2005; Karst et al., 2005; Hill and McEwen, 
2009; Barsegyan et al., 2010).
As is shown in Fig. 1C, the CB1 receptor antagonist AM251 (0.14 ng) administered 
into the BLA after inhibitory avoidance training blocked retention enhancement 
induced by concurrent infusions of the membrane-impermeable conjugate of 
corticosterone and bovine serum albumin (Cort:BSA; 1, 3 or 10 ng). Two-way 
ANOVA for step-through latencies on the training trial showed no signi cant 
di erences between groups (for all comparisons: P > 0.09; data not shown). In 
contrast,  two-way  ANOVA  for  48-h  retention  latencies  revealed  a  signi cant 
Cort:BSA e ect (F3,92 = 2.85; P = 0.04), a signi cant AM251 e ect (F1,92 = 7.33; P = 
0.008), as well as a signi cant interaction between both factors (F3,92 = 2.76; P = 
0.046).  Cort:BSA infused alone into the BLA immediately after the training induced 124
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a dose-dependent enhancement of retention performance (1 ng: P < 0.05; 3 ng: P 
< 0.01). The CB1 receptor antagonist AM251 blocked the retention enhancement 
produced  by  concurrently  administered  Cort:BSA.  Retention  latencies  of  rats 
treated with AM251 together with the intermediate dose of Cort:BSA (3 ng) were 
signi cantly shorter than those of rats given that dose of Cort:BSA alone (P < 0.05). 
Blockade of glucocorticoid receptors in the BLA does not prevent memory 
enhancement induced by a CB receptor agonist. 
These  ndings indicating that CB1 receptor activity within the BLA is essentially 
involved  in  mediating  glucocorticoid  e ects  on  memory  enhancement,  lend 
support for the view that glucocorticoids, via a membrane-associated GR, in uence 
downstream endocannabinoid activity (Hill and McEwen, 2010). However, they 
do not reveal whether the endocannabinoid pathway is the principle route by 
which glucocorticoids enhance the consolidation of memory. Glucocorticoids 
might in uence memory consolidation by concurrently activating GRs at several 
functional levels within the cell or local network, some that are independent of 
Figure 2. Interactions between CRF and the endocannabinoid system of the BLA in enhancing 
memory consolidation of inhibitory avoidance training. (A) Step-through latencies (mean + SEM) 
in seconds on the 48-h inhibitory avoidance retention test of rats given immediate posttraining 
infusions into the BLA of the CB1 receptor antagonist AM251 (0.14 ng in 0.2 +l) together with the 
CRF-BP inhibitor CRF6-33 (0.01, 0.1 or 1 mg). , P < 0.01 compared with the vehicle group; , 
P < 0.01 compared with the corresponding CRF6-33 alone group (n = 10-13 per group). (B) Step-
through latencies (mean + SEM) in seconds on the 48-h inhibitory avoidance retention test of rats 
given immediate posttraining infusions into the basolateral amygdala of the CB receptor agonist 
WIN55,212-2 (10, 30 or 100 ng in 0.2 +l) either alone or together with the CRF receptor antagonist 
_-helical CRF9-41 (1 +g). , P < 0.01 compared with the vehicle group; , P < 0.05; , P < 0.01 
compared with the corresponding WIN55,212-2 alone group (n = 10-14 per group).125
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endocannabinoid activity (e.g. via a translocation of the ligand-receptor complex 
to in uence gene transcription in the nucleus) (Oitzl et al., 2001). To investigate 
the signi cance of the endocannabinoid pathway in contributing to the memory-
modulatory  e ects  of  glucocorticoids,  we  examined  whether  an  activation 
of  endocannabinoid  signaling  with  the  full  CB  receptor  agonist WIN55,212-2 
enhances the consolidation of inhibitory avoidance memory under a condition 
when other GR-mediated actions are pharmacologically blocked. 
As is shown in Fig. 1D, the GR antagonist RU 38486 (1 ng) infused into the BLA 
immediately after inhibitory avoidance training did not preclude the retention 
enhancement induced by concurrently administered WIN55,212-2 (10, 30 or 100 
ng). Two-way  ANOVA  for  training  latencies  showed  no  signi cant  di erences 
between groups (for all comparisons: P > 0.56; data not shown). In contrast, two-
way ANOVA for 48-h retention latencies revealed a signi cant WIN55,212-2 e ect 
(F3,91 = 13.65; P < 0.0001), but no signi cant GR antagonist e ect (F1,91 = 0.33; P 
= 0.57) or interaction between both factors (F3,91 = 0.04; P = 0.99).  WIN55,212-2 
infused alone induced dose-dependent enhancement of retention performance. 
The  10  ng  dose  of  WIN55,212-2  signi cantly  enhanced  retention  (P  <  0.01), 
whereas retention latencies of animals given the higher (30 or 100 ng) doses 
failed to reach signi cance.  As with WIN55,212-2 administered alone, the 10 ng 
dose of WIN55,212-2 infused together with the GR antagonist induced signi cant 
enhancement of retention latencies (P < 0.01). Thus, these  ndings indicate that 
a GR-mediated activation of downstream endocannabinoid signaling appears to 
be a major route of how glucocorticoids a ect memory consolidation.
Is the endocannabinoid system uniquely involved in mediating glucocorticoid 
e ects on memory consolidation? 
Glucocorticoids are certainly not the only hormones known to enhance memory 
consolidation  of  emotionally  arousing  experiences.  Other  stress-activated 
response systems such as peripheral catecholamines and central corticotropin-
releasing  factor  (CRF)  are  also  potent  modulators  of  memory  consolidation 
(Roozendaal  and  McGaugh,  2011).  Moreover,  it  is  known  that  the  memory-
enhancing e ects of both catecholamines and CRF depend on noradrenergic 
activity within the BLA (Roozendaal and McGaugh, 2011). To investigate whether 
the  stress-activated  CRF  system  enhances  memory  consolidation  also  via  an 126
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interaction with the endocannabinoid system, the next experiment examined 
whether the CB1 receptor antagonist AM251 (0.14 ng) administered into the 
BLA after inhibitory avoidance training blocks the memory-enhancing e ect of 
concurrently administered CRF6-33 (0.01, 0.1 or 1 mg). We previously reported that 
CRF6-33, which has a high a nity for the CRF-binding protein (CRF-BP) and is devoid 
of any intrinsic activity at the CRF receptor (Sutton et al., 1995), enhances memory 
consolidation by displacing CRF from the CRF-BP complex and increasing the ‘free’ 
concentration of endogenous CRF (Behan et al., 1995; Roozendaal et al., 2008b). 
As is shown in Fig. 2A, intra-BLA infusions of AM251 blocked CRF6-33-induced 
retention  enhancement.  Two-way  ANOVA  for  training  latencies  showed  no 
signi cant di erences between groups (for all comparisons: P > 0.32; data not 
shown).  In  contrast,  two-way  ANOVA  for  48-h  retention  latencies  revealed  a 
signi cant CRF6-33 e ect (F3,86 = 3.42; P = 0.02), a signi cant AM251 e ect (F1,86 = 
4.50; P = 0.04), as well as a signi cant interaction between both factors (F3,86 = 
3.69; P = 0.02). CRF6-33 infusions alone induced a dose-dependent enhancement 
Figure 3. Interactions between the endocannabinoid and noradrenergic systems of the BLA in 
enhancing  memory  consolidation  of  inhibitory  avoidance  training. (A)  Step-through  latencies 
(mean + SEM) in seconds on the 48-h inhibitory avoidance retention test of rats given immediate 
posttraining infusions into the BLA of the `-adrenoceptor antagonist propranolol (0.5 mg in 0.2 
+l) together with the CB1 agonist WIN55,212-2 (10, 30 or 100 ng). , P < 0.01 compared with 
the corresponding vehicle group; , P < 0.01 compared with the corresponding WIN55,212-2 
alone group (n = 9-12 per group). (B) Step-through latencies (mean + SEM) in seconds on the 48-h 
inhibitory avoidance retention test of rats given immediate posttraining infusions into the BLA of 
the CB1 receptor antagonist AM251 (0.14 ng in 0.2 +l) together with the `-adrenoceptor agonist 
clenbuterol (1, 10 or 100 ng)., P < 0.05; , P < 0.01 compared with the corresponding vehicle 
group; , P < 0.05 compared with the corresponding clenbuterol alone group (n = 9-12 per group).127
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of retention performance (0.1 mg: P < 0.01). The CB1 receptor antagonist AM251 
infused alone into the BLA immediately after the training trial did not impair 
retention,  but  blocked  the  retention  enhancement  induced  by  concurrently 
administered CRF6-33. Retention latencies of rats treated with AM251 together with 
the intermediate dose of CRF6-33 (0.1 mg) were signi cantly shorter than those of 
rats given the corresponding dose of CRF6-33 alone (P < 0.01).
To determine whether the endocannabinoid system is located downstream from 
the CRF receptor, in the second part of the experiment, we investigated whether 
the nonselective CRF receptor antagonist _-helical CRF9-41 (1 +g) administered into 
the BLA after inhibitory avoidance training altered the memory-enhancing e ect 
of concurrently administered WIN55,212-2 (10, 30 or 100 ng) (Fig. 2B).  Two-way 
ANOVA for training latencies showed no signi cant di erences between groups 
(for all comparisons: P > 0.08; data not shown). In contrast, two-way ANOVA for 
48-h retention latencies showed a non-signi cant _-helical CRF9-41 e ect (F1,87 = 
0.37; P = 0.54), but a signi cant WIN55,212-2 e ect (F3,87 = 4.31; P = 0.007) and 
interaction between conditions (F3,87 = 8.13; P < 0.0001). WIN55,212-2 infused 
alone  induced  dose-dependent  enhancement  of  retention  performance. The 
Figure 4. Endocannabinoids enable the glucocorticoid-induced enhancement of BLA neuronal 
activity and IA memory. (A) Number of pCREB immunopositive cells in BLA of rats given vehicle (5 
% ethanol) or CORT (3mg/kg) alone or together with SR141716 (1 mg/kg). , P < 0.01 compared 
with the corresponding vehicle group; , P < 0.01 compared with the corresponding CORT 
alone group (n = 5 - 6 per group). (B) Step-through latencies (mean + SEM) in seconds on the 
48-h inhibitory avoidance retention test of rats given immediate posttraining systemic treatment 
of either vehicle (5% ethanol) or CORT (3 mg/kg) alone or together with SR141716 (1 mg/kg). 
, P < 0.01 compared with the corresponding vehicle group; , P < 0.01 compared with the 
corresponding CORT alone group (n = 10 per group).128
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10 ng dose of WIN55,212-2 signi cantly enhanced retention (P < 0.01), whereas 
retention latencies of animals given the higher (30 or 100 ng) doses failed to reach 
signi cance.  In rats also given _-helical CRF9-41, the lowest dose of WIN55,212-2 
(10 ng) failed to enhance retention, and a 10-times higher dose of WIN55,212-2 
(100 ng) was necessary to induce signi cant retention enhancement (P < 0.01). 
Thus, these  ndings indicating that CRF receptor blockade, unlike GR blockade, 
shifted  the  dose-response  e ects  of WIN55,212-2  on  retention  enhancement 
demonstrate that the endocannabinoid system is not just located downstream 
from the CRF receptor. These  ndings provide further evidence for a selective 
and  speci c  role  of  endocannabinoid  transmission  as  a  rapid  mediator  of 
glucocorticoid actions.
Interactions between the endocannabinoid and noradrenergic systems of 
the BLA on memory enhancement of inhibitory avoidance. 
The  ndings described so far clearly show that endocannabinoid signaling is 
critically involved in regulating the memory-modulatory e ects of glucocorticoids. 
However, we have not yet explored whether such endocannabinoid activity is 
an intermediary step in mediating glucocorticoid e ects on the noradrenergic 
arousal  system.  To  address  this  issue,  we   rst  investigated  whether  the 
endocannabinoid and noradrenergic systems of the BLA interact in regulating 
memory consolidation. 
The   rst  experiment  examined  whether  the  `-adrenoceptor  antagonist 
propranolol (0.5 mg) infused into the BLA immediately after inhibitory avoidance 
training blocked the memory enhancement induced by concurrent infusions of 
the CB receptor agonist WIN55,212-2 (10, 30 or 100 ng). As is shown in Fig. 3A, 
two-way ANOVA for 48-h retention latencies revealed signi cant WIN55,212-2 
(F3,75 = 4.33; P = 0.007) and propranolol e ects (F1,75 = 4.64; P = 0.03) as well as a 
signi cant interaction between conditions (F3,75 = 3.15; P = 0.03). In agreement 
with the above-mentioned  ndings, WIN55,212-2 administered posttraining into 
the BLA induced dose-dependent enhancement of retention performance (10 ng: 
P < 0.01). Propranolol infused alone into the BLA immediately after the training trial 
did not impair retention performance, but blocked the retention enhancement 
induced by concurrently administered WIN55,212-2. Retention latencies of rats 
treated with propranolol together with the 10 ng dose of WIN55,212-2 were 129
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signi cantly shorter than those of rats given the corresponding dose of WIN55,212-
2 alone (P < 0.01). Thus, these  ndings indicate that, as with glucocorticoids, 
endocannabinoid e ects on memory consolidation enhancement depend on 
concurrent noradrenergic activity within the BLA.
Previously, we reported that a blockade of GRs in the BLA with its antagonist 
RU  38486  shifted  the  dose-response  e ects  of  the  `-adrenoceptor  agonist 
clenbuterol such that a much higher dose of clenbuterol was required to induce 
comparable memory enhancement (Roozendaal et al., 2002). The second part of 
the experiment investigated whether blockade of CB1 receptors in the BLA with 
posttraining infusions of AM251 (0.14 ng in 0.2 +l) induced a similar shift in the 
dose-response e ects of clenbuterol (1, 10 or 100 ng). As is shown in Fig. 3B, relative 
to vehicle controls, immediate posttraining infusions of clenbuterol into the BLA 
induced dose-dependent enhancement of retention performance. The lowest 
dose (1 ng) enhanced retention (P < 0.05), whereas higher doses of clenbuterol 
(10 or 100 ng) were ine ective. Two-way ANOVA for retention latencies showed 
non-signi cant clenbuterol (F3,75 = 1.55; P = 0.21) or AM251 e ects (F1,75 = 0.32; P 
= 0.57), but a signi cant interaction between conditions (F3,75 = 6.13; P = 0.0009). 
AM251 administered alone did not a ect retention latencies, but shifted the dose-
response e ects of clenbuterol. When AM251 was co-infused with clenbuterol, 
the lowest dose of clenbuterol (1 ng) failed to enhance retention performance, 
and a 100-times higher dose of clenbuterol was necessary to induce signi cant 
retention enhancement (P < 0.01). These  ndings indicating that a blockade of 
endocannabinoid activity decreases the sensitivity of the BLA to the memory-
enhancing e ects of noradrenergic stimulation are thus highly comparable to the 
e ects of GR blockade within the BLA (Roozendaal et al., 2002b).
Endocannabinoid  activity  is  necessary  for  enabling  glucocorticoid-
norepinehrine interactions on BLA neuronal activity. 
Our     ndings    indicating    that  a  blockade  of  either  glucocorticoid  or 
endocannabinoid signaling reduces the sensitivity of the BLA to the memory-
enhancing e ect of noradrenergic stimulation suggest that corticosterone, via 
an endocannabinoid mechanism, interacts with training-induced noradrenergic 
activation at a postsynaptic level in increasing BLA neuronal activity (Roozendaal 
et al., 2006b). To assess postsynaptic BLA neuronal activity, in the next experiment 130
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we determined immunoreactivity for the phosphorylated form of the transcription 
factor CREB (pCREB) protein. Noradrenergic stimulation induces pCREB activation 
(Roseboom  and  Klein,  1995;  Davies  et  al.,  2004)  and  several   ndings  have 
implicated CREB phosphorylation in the amygdala in the modulation of memory 
consolidation (Silva et al., 1998; Kida et al., 2002; Bozon et al., 2003; Josselyn et 
al., 2004; Han et al., 2007). In a previous study we reported that corticosterone 
administration  increased  the  number  of  pCREB-positive  neurons  within  the 
BLA,  but  only  when  there  was  su cient  noradrenergic  activity  (Roozendaal 
et al., 2006b). To determine whether endocannabinoid activity is required for 
mediating the facilitating e ect of corticosterone on norepinephrine-induced 
pCREB immunoreactivity, in the present study the inverse CB1 receptor agonist 
SR141716 (rimonabant; 1 mg/kg) was administered subcutaneously together with 
corticosterone (3 mg/kg) immediately after inhibitory avoidance training, and the 
number of neurons expressing immunoreactivity for pCREB within the BLA was 
assessed 1 h later. Other rats were administered SR141716 and corticosterone 
after inhibitory avoidance training and their retention latencies were tested 48 h 
later. 
As is shown in Fig. 4A, two-way ANOVA for the number of pCREB-positive cells 
in  the  BLA  1  h  after  inhibitory  avoidance  training  and  drug  administration 
revealed a signi cant corticosterone e ect (F1,18 = 6.21, P = 0.02), a signi cant 
SR141716 e ect (F1,18 = 8.50, P = 0.001) and as well as a signi cant interaction 
e ect between these two factors (F1,18 = 6.53, P = 0.02). Post-hoc comparison tests 
indicated that corticosterone induced a signi cant increase in the number of 
pCREB-positive cells in the BLA (P < 0.01, relative to vehicle), whereas SR141716 
completely blocked this corticosterone-induced increase in pCREB expression. 
SR141716 administration alone did not induce any changes in pCREB expression 
within the BLA. As is shown in Fig. 4B SR141716 also blocked the enhancing 
e ect  of  corticosterone  on  48-h  inhibitory  avoidance  retention  performance. 
Two-way ANOVA for retention latencies indicated a signi cant corticosterone 
(F1,36 = 9.09, P = 0.004) and SR141716 e ects (F1,36 = 27.16, P = 0.0001) as well as a 
signi cant interaction between these two parameters (F1,36 = 10.97, P = 0.0021). 
Collectively, these  ndings indicate that endocannabinoids mediate the e ects 
of corticosterone on pCREB expression within the BLA and memory enhancement 
via a modulatory in uence on postsynaptic noradrenergic signaling mechanisms. 131
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DISCUSSION
The present study was undertaken to investigate whether the endocannabinoid 
system of the BLA mediates the rapid e ects of glucocorticoid hormones onto the 
noradrenergic system in regulating the consolidation of memory of emotionally 
arousing  experiences.  The  interest  of  this  question  stems  from  previous 
work,  in  animals  and  humans,  indicating  that  glucocorticoid  administration 
selectively enhances the consolidation of memory of emotionally salient training 
experiences (Buchanan and Lovallo, 2001; Okuda et al., 2004; Abercrombie et al., 
2006; Kuhlmann and Wolf, 2006) because of a critical interaction with arousal-
induced noradrenergic activation within the BLA (Roozendaal et al., 2006a; Van 
Stegeren et al., 2007). However, as these e ects are too rapid to be mediated via 
genomic glucocorticoid actions, the neurobiological processes underlying the 
glucocorticoid in uence on noradrenergic activity remained to be determined.
Although it has long been recognized that steroid hormones primarily exert their 
e ects on neuronal function through their ability to modulate gene transcription 
in the nucleus (de Kloet et al., 1999), an array of physiological and behavioral 
e ects of glucocorticoids have been documented to occur in a fashion that cannot 
be explained by genomic regulation (Dallman, 2005; Atsak et al., 2012). These 
 ndings have prompted the hypothesis that glucocorticoids possess membrane-
associated  receptors  through  which  nongenomic  signaling  may  evoke  rapid 
e ects on physiology and behavior. The present  nding that the CB1 receptor 
antagonist AM251 administered into the BLA after inhibitory avoidance training 
blocked the memory–enhancing e ect of the GR agonist RU 28362 or of the 
membrane-impermeable ligand Cort:BSA indicates that endocannabinoid activity 
within the BLA is essentially involved in regulating the memory-enhancing e ects 
of glucocorticoids. This glucocorticoid action most likely involves the activation 
of a GR on the cell surface, launching a G-protein-dependent signaling cascade 
that induces the synthesis of endocannabinoid ligands (Di et al., 2003; Johnson 
et al., 2005; Barsegyan et al., 2010; Hill and McEwen, 2010). Multiple lines of 
research indicate that the endocannabinoid system of the BLA, with anandamide 
possibly as its central component (Busquets-Garcia et al., 2011), is importantly 
involved in neural plasticity mechanisms related to emotionally salient learning 
and memory (Marsicano et al., 2002; Ganon-Elazar and Akirav, 2009; Karst et al., 132
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2010). Previously, we reported that pharmacological activation of CB1 receptors 
in the BLA with WIN55,212-2 induces dose-dependent enhancement of inhibitory 
avoidance  memory  (Campolongo  et  al.,  2009).  The  present   nding  that  a 
pharmacological blockade of GRs in the BLA with its antagonist RU 38486 did 
not inhibit this WIN55,212-2 e ect indicates that the endocannabinoid system, 
at least from a functional perspective, is located downstream from the GR site 
of  action.  Prior  evidence  indicating  that  systemic  injection  of  corticosterone 
induces a rapid, i.e., within 10 min, elevation in endocannabinoid levels in the 
amygdala (Hill et al., 2010) supports this conclusion and further reinforces the 
nongenomic nature of this e ect. On a broader level, these  ndings reiterate the 
growing notion of the endocannabinoid system as a rapid mediator of responses 
to stress and stress hormones (Tasker et al., 2006; Ganon-Elazar and Akirav, 2009) 
and are also consistent with  ndings of in vitro electrophysiological recording 
studies demonstrating that glucocorticoids rapidly suppress glutamate release 
onto parvocellular neurons in hypothalamic regions, in controlling hypothalamic-
pituitary-adrenal-axis activity, through a mechanism that involves postsynaptic 
activation  of  a  membrane-bound  GR  and  the  synthesis  of  endocannabinoid 
ligands (Di et al., 2003). 
To  investigate  whether  endocannabinoid  signaling  is  uniquely  involved  in 
regulating glucocorticoid e ects on memory consolidation, we also examined 
possible  interactions  between  CRF  and  the  endocannabinoid  system.  Our 
 ndings indicate that a blockade of endocannabinoid signaling within the BLA 
also prevented the enhancing e ects of the CRF-BP ligand inhibitor CRF6-33 on 
inhibitory avoidance memory. Although it is possible that an activation of CRF 
receptors, as with GRs, directly evokes endocannabinoid signaling in the BLA, 
evidence for this view is lacking. Moreover, as CRF receptor blockade altered the 
memory-enhancing e ect of WIN55,212-2 administration, these  ndings indicate 
that, unlike with GRs, the endocannabinoid system is not located downstream 
from the CRF receptor. More likely, glucocorticoids interact with the memory-
enhancing e ects of CRF via an endocannabinoid mechanism. Consistent with 
other evidence that the glucocorticoid and CRF systems are intimately linked 
(Sawchenko,  1987;  Pavcovich  and  Valentino,  1997;  Ma  and  Aguilera,  1999; 
Helmreich et al., 2001), we previously reported that the GR antagonist RU 38486 
infused into the BLA blocked the enhancing e ect of CRF6-33 administration on 133
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the consolidation of inhibitory avoidance memory (Roozendaal et al., 2008b). Also 
the present  nding that the CRF receptor antagonist _-helical CRF9-41 infused into 
the BLA shifted the dose-response e ects of the CB receptor agonist WIN55,212-
2  such  that  a  10-times  higher  dose  of  WIN55,212-2  was  required  to  induce 
memory enhancement is highly comparable to our prior  nding indicating that 
the CRF receptor antagonist induces a near identical shift in the dose-response 
relationship of the GR agonist RU 28362 (Roozendaal et al., 2008b). Such  ndings 
that manipulation of either GR or CB1 receptor has a common impact on the 
memory-enhancing e ects of CRF provide further evidence for a close functional 
relationship between glucocorticoids and the endocannabinoid system in the 
BLA in regulating memory enhancement. 
Our   nding  that  immediate  posttraining  infusions  of  the  `-adrenoceptor 
antagonist propranolol blocked the enhancing e ect of the CB receptor agonist 
WIN55,212-2 on inhibitory avoidance memory indicates that endocannabinoids 
enhance the consolidation of memory via an interaction with the noradrenergic 
system. These  ndings, together with the evidence that synthetic cannabinoids, as 
with corticosterone (McReynolds et al., 2010), alter the release of norepinephrine 
in the BLA and other brain regions (Oropeza et al., 2005; Page et al., 2007), indicate 
that the endocannabinoid system is a likely candidate for mediating the rapid 
e ects of glucocorticoids onto stimulating the release of norepinephrine from 
presynaptic sites. However, our  nding that the CB1 receptor antagonist AM251 
infused into the BLA shifted the dose-response e ects of the `-adrenoceptor 
agonist clenbuterol such that a 100-times higher dose of clenbuterol was required 
to  induce  memory  enhancement  suggests  that  these  two  neuromodulatory 
systems  also  interact  at  the  postsynaptic  level.  This   nding,  which  is  highly 
comparable to prior evidence that GR antagonism in the BLA induces a near 
identical  shift  in  the  dose-response  e ects  of  clenbuterol  (Roozendaal  et  al., 
2002b), suggests that glucocorticoids, through an endocannabinoid mechanism, 
might increase the excitability of BLA pyramidal neurons (Duvarci and Paré, 2007), 
rendering them more sensitive to the memory-enhancing e ects of postsynaptic 
noradrenergic stimulation (Roozendaal et al., 2002b; Roozendaal et al., 2006b). 
To  address  this  issue,  we  investigated  whether  the  enhancing  e ects  of 
glucocorticoids on neural plasticity mechanisms within the BLA, as assessed by 134
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the number of pCREB-positive neurons, after inhibitory avoidance training require 
concurrent  endocannabinoid  signaling.  It  is  now  well  established  that  CREB 
phosphorylation in the BLA depends on arousal-induced noradrenergic activity 
(Roseboom and Klein, 1995; Davies et al., 2004) and is critically involved in the 
modulation of memory consolidation (Silva et al., 1998; Kida et al., 2002; Bozon et 
al., 2003; Josselyn et al., 2004). In a previous study we reported that corticosterone 
administered  systemically  immediately  after  an  emotionally  arousing  training 
experience increased the number of pCREB-positive neurons within the BLA, but 
that corticosterone did not alter the number of pCREB-positive neurons when 
administered after a low-arousing training experience (Roozendaal et al., 2006b). 
However, the combined administration of corticosterone and the noradrenergic 
stimulant  yohimbine  signi cantly  increased  pCREB  immunoreactivity  in  BLA 
pyramidal  neurons  under  low-arousing  conditions  (Roozendaal  et  al.,  2006b), 
indicating  that  corticosterone  interacts  with  the  noradrenergic  system  in 
increasing pCREB activity. Our current  nding that blocking CB1 receptors with 
its  inverse  agonist  SR141716  prevented  the  corticosterone-induced  pCREB 
activation in the BLA after inhibitory avoidance training, as well as blocked the 
memory-enhancing  e ects  of  corticosterone,  provides  further  evidence  for 
the view that the endocannabinoid system is essentially involved in mediating 
rapid glucocorticoid e ects on the facilitation of norepinephrine-induced neural 
plasticity  mechanisms  within  the  BLA  in  regulating  memory  consolidation. 
Findings of electrophysiological experiments in brain slices are consistent with the 
view that glucocorticoids interact with the noradrenergic system in in uencing 
neural plasticity in BLA neurons. However, these studies further indicate that 
glucocorticoids  a ect  noradrenergic  function  in  a  highly  time-dependent 
fashion (Joels et al., 2011). Whereas corticosterone applied simultaneously with a 
`-adrenoceptor agonist induced a rapid facilitation of AMPA receptor-mediated 
responses, corticosterone given several hours in advance to the `-adrenoceptor 
agonist, possibly because of genomic GR actions, resulted in a potent suppression 
of the `-adrenoceptor agonist e ect (Liebmann et al., 2009). An involvement of 
the endocannabinoid system in regulating these rapid and/or slow glucocorticoid 
e ects on noradrenergic function has not been investigated. 
A possible scenario is that the ensuing release of endocannabinoids in uences 
noradrenergic function via an inhibition of GABAergic transmission (Campolongo 135
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et al., 2009; Hill and McEwen, 2009; Atsak et al., 2012). Within the BLA, CB1 receptors 
are found predominantly on local inhibitory GABAergic interneurons (Katona et al., 
2001; McDonald and Mascagni, 2001). A recent study indicated that CB1 receptors 
are  particularly  enriched  in  axon  terminals  of  cholecystokinin  (CCK)-positive 
interneurons and form invaginating perisomatic synapses with pyramidal neurons 
in the BLA (Yoshida et al., 2011). CCK-positive interneurons have been proposed to 
function as  ne-tuning devices for the cooperation of pyramidal neurons, which 
are sensitive to the emotional and motivational state of the animal (Freund et al., 
2003). Various studies have reported that activation of CB1 receptors regulates 
long-term depression at inhibitory synapses and decreases GABAergic synaptic 
transmission (Katona et al., 1999; Ohno-Shosaku et al., 2001; Hajos and Freund, 
2002). Such a suppression of GABAergic transmission can account for changes 
in noradrenergic signaling at both pre- and postsynaptic sites. On the one hand, 
extensive evidence indicates that inhibition of local GABAergic circuits in the 
BLA enhances memory consolidation (Brioni et al., 1989; Castellano et al., 1989; 
McGaugh, 2004) by increasing the release of norepinephrine from presynaptic 
sites (Hat eld et al., 1999). On the other hand, GABAergic antagonists are known 
to act postsynaptically to increase the excitability of BLA pyramidal neurons (Azad 
et al., 2004; Pistis et al., 2004; Zhu and Lovinger, 2005; Yoshida et al., 2011). These 
 ndings, together with the evidence that glucocorticoids and CRF enhance the 
excitability of BLA pyramidal neurons by decreasing the impact of inhibitory 
GABAergic in uences (Rainnie et al., 1992; Duvarci and Paré, 2007), support the 
hypothesis that the nongenomically mediated actions of glucocorticoids on the 
noradrenergic  system  require  a  rapid  increase  in  endocannabinoid  signaling 
within the BLA to e ectively shut o  local inhibitory GABAergic interneurons. Such 
a suppression of GABAergic activity might then result in increased noradrenergic 
signaling in BLA pyramidal neurons and an enhanced consolidation of long-term 
memory of emotionally arousing experiences. 136
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ABSTRACT
There is extensive evidence that glucocorticoid hormones impair the retrieval 
of  memory  of  emotionally  arousing  experiences.  Although  it  is  known  that 
glucocorticoid  e ects  on  memory  retrieval  impairment  depend  on  rapid 
interactions with arousal-induced noradrenergic activity, the exact mechanism 
underlying  this  presumably  non-genomically  mediated  glucocorticoid  action 
remains to be elucidated. Here, we show that the hippocampal endocannabinoid 
system,  a  rapidly  activated  retrograde  messenger  system,  is  involved  in 
mediating glucocorticoid e ects on retrieval of contextual fear memory. Systemic 
administration  of  corticosterone  (0.3–3  mg/kg)  to  male  Sprague-Dawley  rats 
1 h before retention testing impaired the retrieval of contextual fear memory, 
without impairing the retrieval of auditory fear memory or directly a ecting the 
expression of freezing behavior. Importantly, a blockade of hippocampal CB1 
receptors with AM251 prevented the impairing e ect of corticosterone on retrieval 
of contextual fear memory, whereas the same impairing dose of corticosterone 
increased hippocampal levels of the endocannabinoid 2-arachidonoylglycerol. 
We further found that antagonism of hippocampal ß-adrenoceptor activity with 
local infusions of propranolol blocked the memory retrieval impairment induced 
by the CB receptor agonist WIN55,212-2. Thus, these  ndings strongly suggest 
that the endocannabinoid system plays an intermediary role in regulating rapid 
glucocorticoid e ects on noradrenergic activity in impairing memory retrieval of 
emotionally arousing experiences.147
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INTRODUCTION
It is well established that glucocorticoid (GC) hormones, released from the adrenal 
cortex during stressful episodes, can modulate di erent memory processes (de 
Kloet et al., 1999; McGaugh and Roozendaal, 2002; Sandi and Pinelo-Nava, 2007; 
Roozendaal et al., 2009). Although most studies focused on GC e ects on the 
acquisition and consolidation of memory, extensive evidence also indicates that 
acutely elevated GC levels at the time of retention testing impair the retrieval of 
memory of spatial and contextual training (de Quervain et al., 1998; de Quervain 
et al., 2000; Het et al., 2005; Kuhlmann et al., 2005a; Schwabe et al., 2011). As a 
glucocorticoid  receptor  (GR)  agonist  infused  into  the  hippocampus  prior  to 
retention induces comparable memory retrieval impairment (Roozendaal et al., 
2003; Roozendaal et al., 2004b), such  ndings suggest that GC e ects on memory 
retrieval depend, at least in part, on activation of GRs in the hippocampus. Findings 
of studies of human subjects are consistent with those of animal studies and 
indicate that exogenous GC administration or exposure to a psychosocial stressor 
shortly before retention testing impairs retrieval of declarative (mostly episodic) 
information (Kirschbaum et al., 1996; de Quervain et al., 2000; Kuhlmann et al., 
2005b) and reduces hippocampal activity (de Quervain et al., 2003). Moreover, 
previous  ndings indicate that emotionally arousing information is especially 
sensitive to the retrieval-impairing e ects of GCs (Kuhlmann et al., 2005a) and 
that emotional arousal during the test situation enables GC e ects on memory 
retrieval (Kuhlmann and Wolf, 2006). Findings of recent clinical studies suggest 
that the administration of stress doses of GCs may have therapeutic value by 
attenuating the re-experiencing of highly traumatic memories in patients who 
have post-traumatic stress disorder (PTSD) and other anxiety disorders (Aerni et 
al., 2004; Schelling et al., 2004; Schelling et al., 2006; de Quervain et al., 2009).
Our previous  nding that GCs interact with arousal-induced noradrenergic activity 
in impairing the retrieval of hippocampus-dependent memory (Roozendaal et al., 
2003; Roozendaal et al., 2004a; Roozendaal et al., 2004b; Roozendaal et al., 2006) 
might explain why GCs selectively impair memory retrieval of emotionally arousing 
or traumatic experiences (Kuhlmann et al., 2005a). However, it is not understood 
how GCs interact with the noradrenergic system in in uencing memory retrieval, 
as these e ects appear to be too rapid to act via the classical genomic mode of 148
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action of GCs (de Quervain et al., 1998; Roozendaal et al., 2003; Roozendaal et 
al., 2004a; Roozendaal et al., 2004b; Roozendaal et al., 2006; McReynolds et al., 
2010; Schutsky et al., 2011). Findings of recent studies investigating the cellular 
mechanism underlying the rapid e ects of GCs suggest a possible involvement of 
the endocannabinoid system (Tasker et al., 2006; Hill and McEwen, 2009; Evanson 
et al., 2010; Hill et al., 2010b). Endogenous ligands for cannabinoid CB1 receptors, 
i.e.,  anandamide  (AEA)  and  2-arachidonoylglycerol  (2-AG),  are  synthesized  on 
demand  through  cleavage  of  membrane  precursors  and  serve  as  retrograde 
messengers  at  central  synapses  (Kano  et  al.,  2009).  They  bind  to  G-protein-
coupled CB1 receptors at presynaptic sites to regulate ion channel activity and 
neurotransmitter release (Freund et al., 2003). It is now well established that 
stress and GCs can induce rapid changes in endocannabinoid signaling in stress-
responsive brain regions (Patel and Hillard, 2008; Hill and McEwen, 2010). Although 
these e ects have been mostly studied with respect to non-genomically mediated 
e ects of GCs on hypothalamic-pituitary-adrenocortical (HPA) axis activity (Tasker 
et al., 2006; Evanson et al., 2010; Hill and McEwen, 2010), CB1 receptors are also 
abundantly expressed in the hippocampus, basolateral amygdala and other brain 
regions where they modulate synaptic transmission, neuronal  ring and memory 
(Freund et al., 2003; Campolongo et al., 2009; Marsicano and Lafenetre, 2009; 
Akirav, 2011). 
We previously reported evidence that GCs interact with the endocannabinoid 
system  within  the  basolateral  amygdala  in  enhancing  the  consolidation  of 
memory  of  emotionally  arousing  training  experiences  (Campolongo  et  al., 
2009;  Atsak  et  al.,  2012).    In  the  present  study,  we  investigated  whether  the 
endocannabinoid system is involved in mediating GC-induced memory retrieval 
impairment. We focus here on retrieval of contextual fear memory, as we  rst 
found that a systemic injection of corticosterone (CORT) administered shortly 
before retention testing impairs the retrieval of contextual, but not auditory, fear 
memory. Further, in view of the extensive evidence indicating that GC e ects 
on memory retrieval depend on arousal-induced noradrenergic activity, we also 
examined whether endocannabinoids interact with the noradrenergic system 
within the hippocampus in impairing retrieval of contextual fear memory. 149
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METHODS
Subjects.  Male adult Sprague-Dawley rats (280-330 g at time of surgery) from 
Charles River Breeding Laboratories (Kisslegg, Germany) were kept individually 
in a temperature-controlled (22 oC) colony room and maintained on a standard 
12-h light: 12-h dark cycle (07:00-19:00 h lights on) with ad libitum access to food 
and water.  All behavioral procedures were performed during the light cycle 
between 10:00 and 15:00 h.  All procedures were in compliance with the European 
Community’s Council Directive on the use of laboratory animals of November 24, 
1986 (86/609/EEC) and were approved by the Institutional Animal Care and Use 
Committee of the University of Groningen, The Netherlands.
Surgery.  Animals, adapted to the vivarium for at least 1 week, were anesthetized with 
a mixture of ketamine (37.5 mg/kg of body weight; Alfasan) and dexmedetomidine 
(0.25 mg/kg; Orion) and surgery was performed according to a standardized 
protocol (Fornari et al., 2012). Brie y, the skull was positioned in a stereotaxic 
frame (Kopf Instruments, Tujunga, CA) and two stainless-steel guide cannulae 
(11 mm; 23 gauge; Small Parts, Inc, Miami Lakes, FL) were implanted bilaterally 
with the cannula tips 1.5 mm above the dorsal hippocampus (anteroposterior, 
-3.4 mm from Bregma; mediolateral, +1.8 mm from the midline; dorsoventral, 
2.7 mm below skull surface; incisor bar –3.3 mm from interaural) (Paxinos and 
Watson, 2005). The cannulae were a xed to the skull with two anchoring screws 
and dental cement.  Stylets (11-mm long 00-insect dissection pins), inserted into 
each cannula to maintain patency, were removed only for the infusion of drugs. 
After surgery, the rats were administered atipamezole hydrochloride (2.5 mg/kg; 
Orion) to reverse anesthesia and were subsequently injected with 3 ml of saline 
to facilitate clearance of drugs and prevent dehydration. The rats were allowed to 
recover for 10 days before initiation of training and were handled 3 times for 1 min 
each during this recovery period to accustom them to the infusion procedure. 
Fear Conditioning. After handling days were completed, all rats were habituated 
to  the  training  context  for  5  min,  without  shock  exposure.  On  the  next  day, 
animals were trained on either the contextual or auditory fear conditioning task. 
For contextual fear conditioning, each rat was placed in the fear conditioning 
apparatus (in cm: 24 width x 25 depth x 34 height) and exposed to 5 footshocks (1.4 150
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mA, 1 s, 1 min inter-trial interval) after 2 min of baseline. Twenty-four hours later, 
rats were re-exposed to the fear conditioning context for 5 min. For auditory fear 
conditioning, animals were exposed to 5 tones (80 dB, 4 kHz, 10 s) co-terminating 
with footshock (1.4 mA, 1 s). Twenty-four hours later, animals were tested in a 
di erent context with tone trials only (5 trials, each 10 s) after 3 min of baseline. 
Control groups were habituated to the training apparatus and, 24 h later, trained 
on the contextual fear conditioning task; however, on the retention test day, they 
were tested for 5 min in a di erent but previously habituated context. Freezing 
behavior  was  analyzed  with  Behafreeze  software  (http://www.pmbogusz.net/
software/) and some of the groups were also analyzed manually blind to drug 
treatment as a quality control. 
Endocannabinoid Quanti cation. After rapid decapitation, the hippocampus was 
dissected and lipid extraction was performed according to a standardized protocol 
as  explained  in  the  SI  Methods  (Vogeser  et  al.,  2006).  For  endocannabinoid 
measurements, automated on-line solid phase extraction using column switching 
with  subsequent  direct  transfer  to  high-performance  liquid  chromatography 
and a tandem mass spectrometry system was applied. Pure solutions were used 
for  calibration. The  method  is  linear  within  the  calibration  ranges.  All  liquid 
chromatography mass spectrometry (LC-MS) analyses were carried out using an 
1100 LC system (binary pump and autosampler, Agilent, CA, USA) coupled to an 
API 4000 mass spectrometer (Applied Biosystems, CA, USA) and equipped with a 
Turbo-Ion-Spray (ESI) source. Because in biological matrices, 2-AG (including its 
deuterated analog) rapidly isomerizes to 1-AG (Vogeser and Schelling, 2007), we 
quanti ed 2-AG as the sum of both isomers. 
Drug and infusion procedures. All systemic and local drug manipulations were 
made 1 h before retention testing. For the  rst experiment, di erent doses of 
CORT (0.3, 1, 3 mg/kg; Sigma-Aldrich), dissolved in 5% ethanol, were administered 
subcutaneously. CORT doses were based on previous  ndings (de Quervain et 
al., 1998; Cai et al., 2006). For the second experiment, the selective CB1 receptor 
antagonist AM251 (0.35 ng in 0.5 µl per side; Sigma-Aldrich) was infused into the 
dorsal hippocampus together with a subcutaneous injection of either an impairing 
dose of CORT (3 mg/kg) or vehicle. AM251 was  rst dissolved in 100% DMSO and 
subsequently diluted in phosphate bu er to reach a  nal DMSO concentration of 151
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2%. For the third experiment, the CB receptor agonist WIN55,212-2 (10 or 30 ng in 
0.5 µl per side; Sigma-Aldrich) either alone or together with the ß-adrenoceptor 
antagonist  propranolol  (1.25  mg;  Sigma-Aldrich)  was  dissolved  in  a  vehicle 
containing 2% DMSO and 0.2% Triton X-100 in phosphate bu er and infused into 
the dorsal hippocampus. For the last experiment, norepinephrine (1 or 3 µg in 0.5 
µl per side: Sigma-Aldrich) either alone or together with AM251 (0.35 ng; Sigma-
Aldrich), dissolved in 2% DMSO in phosphate bu er, was infused into the dorsal 
hippocampus. 
Bilateral infusions of drug, or vehicle into the dorsal hippocampus were given by 
using 30-gauge injection needles connected to 10-µl Hamilton microsyringes by 
polyethylene (PE-20) tubing. The injection needles protruded 1.7 mm beyond 
the cannula tips and a 0.5 µl injection volume per hemisphere was infused over 
a period of 50 s by an automated syringe pump (Stoelting Co., Dublin, Ireland). 
The injection needles were retained within the cannulae for an additional 20 s to 
prevent back ow of drug into the cannulae. 
Histology. Rats were anesthetized with an overdose of sodium pentobarbital (100 
mg/kg, i.p.; Sigma-Aldrich) and perfused transcardially with a 0.9% saline (wt/
vol) solution followed by 4% formaldehyde (wt/vol) dissolved in water. Brains 
were removed and after cryoprotection in 25% sucrose, coronal sections of 50 
mm were cut on a cryostat, mounted on gelatin-coated slides, and stained with 
cresyl violet. The location of the injection needle tips in the dorsal hippocampus 
was  examined  under  a  light  microscope  according  to  the  standardized  atlas 
plates of Paxinos and Watson (Paxinos and Watson, 2005) by an observer blind 
to drug treatment condition.  Rats with injection needle placements outside the 
hippocampus or with extensive tissue damage at the injection needle tips were 
excluded from analysis.
Statistics. Data are expressed as mean ± SEM.  Overall freezing scores on the 
retention test trials of the contextual and auditory fear conditioning tasks were 
analyzed with one-way or two-way ANOVAs, when appropriate. Endocannabinoid 
levels were analyzed with one-way ANOVA. To investigate the e ect of time (for 
contextual fear conditioning) or tone trial (for auditory fear conditioning) on 
the freezing response, freezing retention scores were analyzed with repeated-152
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measures ANOVA with time bin (1 min each) or tone trial as within-subject factor. 
Freezing scores during the training session of the contextual and auditory fear 
conditioning tasks were always analyzed with repeated-measures ANOVA with 
shock trial as within-subject factor. The analyses were followed by Fisher’s LSD 
multiple-comparison tests, when appropriate. P values of less than 0.05 were 
Figure 1. E ect of systemic corticosterone administration on retrieval of fear memory. (A) Systemic 
CORT (0.3, 1, 3 mg/kg) treatment administered 1 h before retention testing dose-dependently 
impairs retrieval of contextual fear memory. Results represent mean ± SEM, **p < 0.01 vs. vehicle 
(n = 11-13/group). (B) E ect of systemic CORT (3mg/kg) treatment on freezing during retrieval of 
contextual fear memory analyzed in 1-min time bins. Results represent mean ± SEM, *p < 0.05; **p 
< 0.01 vs. vehicle (n = 11-13/group). (C) Systemic CORT (0.3, 1, 3 mg/kg) treatment given 1 h before 
retention testing does not impair retrieval of auditory fear memory. Results represent mean ± SEM 
(n = 8/group). (D) E ect of systemic CORT (0.3, 1, 3 mg/kg) administration on basal freezing levels in 
a non-training context. Results represent mean ± SEM (n = 10 - 15/group).153
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considered statistically signiﬁcant. The number of rats per group is indicated in 
the  gure legends. 
RESULTS
Systemic corticosterone administration dose-dependently impairs retrieval 
of contextual, but not auditory, fear memory
This experiment investigated whether CORT administered systemically 1 h before 
retention  testing  impaired  retrieval  of  contextual  and  auditory  fear  memory. 
During training, di erent groups of animals acquired the contextual (F7,301 = 81.62; 
p < 0.0001) and auditory (F7,196 = 61.56; p < 0.0001) fear conditioning tasks, as 
indicated by progressively increasing freezing scores during shock trials. Further, 
the groups that were assigned to receive control or drug treatments subsequently 
did not di er in acquisition performance (contextual fear conditioning: F3,43 = 1.60; 
p = 0.20; auditory fear conditioning: F3,28 = 0.82; p = 0.96; Table S1). Twenty-four 
hours later, rats received a systemic injection of either vehicle or di erent doses of 
CORT (0.3, 1, 3 mg/kg) 1 h before retention testing on the contextual and auditory 
fear conditioning tasks. As is shown in Fig. 1A, one-way ANOVA indicated that 
CORT treatment induced a dose-dependent reduction in overall percent freezing 
during retention testing on the contextual fear conditioning task (F3,43 = 2.98; p = 
0.04). Fisher’s post-hoc analysis revealed that the 3 mg/kg dose of CORT, but not 
lower doses, signi cantly decreased freezing levels (p < 0.01 compared to vehicle). 
We further analyzed whether freezing levels of rats administered the 3 mg/kg dose 
of CORT were lower throughout the retention test or whether CORT facilitated the 
extinction of fear during the retention test session. Repeated-measures ANOVA 
for freezing levels in  ve consecutive 1-min time bins (CORT 3 mg/kg and vehicle 
groups only) demonstrated a signi cant e ect of CORT treatment (F1,23 = 12.22; 
p = 0.001), but not of time  (F4,92 = 1.69; p = 0.15) or interaction between CORT 
treatment and time (F4,92 = 0.65; p = 0.62), suggesting that freezing levels did not 
change over the course of the retention test and, thus, that freezing of the CORT 
3 mg/kg group was lower than that of the vehicle group throughout the test (Fig. 
1B). In contrast to contextual fear memory, systemic CORT treatment did not alter 
freezing levels during retention on the auditory fear conditioning task (F3,28 = 0.20; 
p = 0.89; Fig. 1C). 
To further exclude the possibility that CORT treatment might directly in uence the 154
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expression of freezing, separate groups of animals were trained on the contextual 
fear conditioning task and, 24 h later, administered di erent doses of CORT (0.3, 
1, 3 mg/kg) 1 h before placing them in a context that was distinctly di erent 
from the training context. CORT treatment did not a ect basal freezing levels 
in this non-training context (F3, 47 = 1.24; p = 0.31; Fig. 1D). Thus, these  ndings 
indicate that CORT selectively impaired conditioned freezing during retention 
of contextual fear memory and did not a ect freezing during retention of the 
auditory fear conditioning task or induced any direct de cits in the expression of 
freezing behavior. 
Endocannabinoid  signaling  in  the  hippocampus  mediates  the  impairing 
e ect of corticosterone on retrieval of contextual fear memory
To investigate whether the endocannabinoid system of the hippocampus plays a 
role in mediating the impairing e ect of CORT treatment on retrieval of contextual 
fear memory, bilateral infusions of the CB1 receptor antagonist AM251 (0.35 ng in 
0.5 µl) were administered into the dorsal hippocampus 1 h before retention testing 
together with systemic injections of either vehicle or CORT (3 mg/kg). Repeated-
measures  ANOVA  for  freezing  scores  during  training  showed  that  all  groups 
acquired  the  contextual  fear  conditioning  task  as  indicated  by  progressively 
increasing freezing scores during shock trials (F7,203 = 63.66, p < 0.0001), without a 
di erence in the acquisition rate between later drug groups (F3,29 = 0.79; p = 0.50; 
Table S2). As is shown in Fig. 2A, two-way ANOVA for percent freezing during 24-h 
retention testing revealed no signi cant main e ects of CORT (F1,29 = 1.93, p = 
0.17) or AM251 (F1,29 = 1.76, p = 0.19), but a signi cant interaction e ect between 
these two treatments (F1,29 = 4.61, p = 0.04). Fisher’s post-hoc comparison tests 
demonstrated that systemic CORT administration signi cantly reduced freezing 
in control rats administered vehicle into the hippocampus (p < 0.05). However, 
this e ect of CORT on freezing behavior was blocked in animals administered 
AM251 into the hippocampus (p < 0.05 compared to CORT alone). 
Next, we investigated whether CORT administration a ected endocannabinoid 
tissue levels in the hippocampus.  For this, rats were trained on the contextual 
fear conditioning task and, 24 h later, given a systemic injection of CORT (0.3, 1 
or 3 mg/kg) 1 h before placing them in a non-training but previously habituated 
context  for  5  min.  Immediately  afterwards,  the  hippocampus  was  dissected 155
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for endocannabinoid measurements. As is shown in Fig. 2C and 2D, one-way 
ANOVA revealed that CORT treatment dose-dependently elevated hippocampal 
levels of the endocannabinoid 2-AG (F3,47 = 3.15; p = 0.03), without a ecting 
levels of AEA (F3,47 = 0.23; p = 0.87) or other measured endocannabinoids such 
as oleoylethanolamide and palmitoylethanolamide (Tabl  e S3). Fisher’s post-hoc 
analyses indicated that the highest dose of CORT (3 mg/kg), but not any of the 
lower and non-impairing doses, increased 2-AG levels compared to vehicle (p 
< 0.05). Thus, these  ndings indicating that CORT administration elevates 2-AG 
levels in the hippocampus whereas a blockade of hippocampal CB1 receptors 
prevents CORT e ects on memory retrieval impairment suggest that hippocampal 
endocannabinioid  signaling  is  critically  involved  in  mediating  the  impairing 
e ects of CORT on retrieval of contextual fear memory.
Intra-hippocampal infusion of a CB receptor agonist WIN55,212-2 impairs 
retrieval of contextual fear memory via an interaction with the noradrenergic 
system
As described above, we previously reported that GC e ects on memory retrieval 
of emotionally arousing experiences involve an essential interaction with arousal-
induced  noradrenergic  activity  (Roozendaal  et  al.,  2004b;  de  Quervain  et  al., 
2007). Hence, in this experiment we investigated whether cannabinoid e ects on 
memory retrieval also depend on interactions with the noradrenergic system. To 
address this issue, we  rst investigated whether bilateral microinfusions of the 
CB receptor agonist WIN55,212-2 (10 or 30 ng in 0.5  l) administered into the 
dorsal hippocampus 1 h before the retention test impaired retrieval of contextual 
fear  memory,  and  whether  concurrent  administration  of  the  ß-adrenoceptor 
antagonist propranolol (1.25  g) blocked the impairment. All animals acquired 
the contextual fear conditioning task as indicated by progressively increasing 
freezing scores during shock trials (F7,420 = 108.00; p < 0.0001) without a signi cant 
di erence in freezing scores between later drug groups (F2,63 = 2.18; p = 0.12; Table 
S4). As is shown in Fig. 3A, two-way ANOVA for percent freezing on the retention 
test showed a signi cant WIN55,212-2 e ect (F2,63 = 3.26; p = 0.04), a signi cant 
propranolol e ect (F1,63 = 15.65; p = 0.0001) as well as a signi cant interaction e ect 
between these two treatments (F2,63 = 3.63; p = 0.03). Post-hoc analysis showed 
that both doses of WIN55,212-2 signi cantly impaired freezing levels (10 ng; p < 
0.001, 30 ng: p < 0.05 compared to vehicle). However, WIN55,212-2 did not reduce 156
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freezing levels in rats also administered propranolol. Thus, these  ndings indicate 
that,  as  with  GCs,  endocannabinoid  e ects  on  memory  retrieval  impairment 
depend on concurrent noradrenergic activity within the hippocampus.
The  second  part  of  this  experiment  investigated  whether  blockade  of 
hippocampal CB1 receptors with AM251 (0.35 ng in 0.5 µl) would a ect memory 
retrieval impairment induced by local infusions of norepinephrine (1 or 3 µg). 
During training, animals increased their freezing as shock trials progressed (F7,490 = 
137.59, p < 0.0001) and there were no di erences in the acquisition rate between 
later drug groups (F2,72 = 0.59, p = 0.56; Table S5). As is shown in Fig. 3B, two-way 
ANOVA for percent freezing during 24-h retention testing revealed a signi cant 
norepinephrine e ect (F2,72 = 8.28; p = 0.0005), but no signi cant AM251 e ect   
(F1,72= 0.33; p = 0.86) or interaction between norepinephrine and AM251 (F2,72= 
0.37; p = 0.70). Microinjection of either dose of norepinephrine into the dorsal 
hippocampus  1  h  before  retention  testing  signi cantly  reduced  conditioned 
freezing levels (1  g; p < 0.01, 3  g: p < 0.01 compared to vehicle). As with 
norepinephrine administered alone, the 3 µg dose of norepinephrine infused 
together with the CB1 receptor antagonist induced a signi cant reduction in 
freezing (p < 0.05) whereas the 1 µg dose of norepinephrine just failed to reach 
signi cance (p = 0.08). Infusion of this low dose of AM251 alone did not alter 
freezing levels (p = 0.68).  These  ndings indicate that the e ect of noradrenergic 
activation is downstream of CB1 receptor activation.
To  exclude  the  possibility  that WIN55,212-2  or  norepinephrine  infusions  into 
the hippocampus might have decreased freezing during the retention test by 
directly a ecting the expression of freezing behavior, we investigated, in separate 
groups of animals, the e ect of intra-hippocampal infusions of the same doses 
of WIN55,212-2 (10 or 30 ng in 0.5  l) or norepinephrine (1 or 3  g in 0.5  l) on 
freezing  behavior  during  retention  of  auditory  fear  conditioning.  Repeated-
measures ANOVA comparing freezing levels in the WIN55,212-2-treated groups 
showed  a  signi cant  e ect  of  tone  trial  (F4,108  =  126.63;  p  <  0.0001),  but  no 
signi cant e ect of WIN55,212-2 (F2,27 = 0.41; p = 0.66) or interaction between 
tone trial and WIN55,212-2 treatment (F8,108 = 0.84; p = 0.56; Fig. S1A). Highly 
comparable, repeated-measures ANOVA comparing retention freezing scores of 
norepinephrine-treated groups showed a signi cant e ect of tone trial (F4,108 = 
90.82; p < 0.0001), but no signi cant e ect of norepinephrine (F2,27 = 0.25; p = 0.77) 157
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or interaction between tone trial and norepinephrine treatment (F8,108= 0.86; p = 
0.55; Fig. S1B). Thus, these  ndings indicate that WIN55,212-2 or norepinephrine 
e ects on contextual fear memory were not mediated by a general, non-speci c 
change in the expression of freezing behavior. 
DISCUSSION
The  present  study  investigated  a  putative  involvement  of  the  hippocampal 
endocannabinoid system in regulating GC e ects on the retrieval of fear memory. 
The interest of this question stems from previous work indicating, in both rats and 
healthy human participants, that GCs interact with arousal-induced noradrenergic 
mechanisms in impairing memory retrieval of emotionally arousing information 
(de Quervain et al., 1998; de Quervain et al., 2000; Het et al., 2005; Kuhlmann et 
al., 2005a). However, as these e ects are too rapid to be mediated via genomic 
GC  actions,  the  neurobiological  processes  underlying  the  GC  in uence  on 
noradrenergic activity remained to be determined (Joels et al., 2011). The present 
 ndings indicate that a blockade of hippocampal CB1 receptors prevents the 
impairing e ects of GCs on retrieval of contextual fear memory, whereas the 
administration of an impairing dose of CORT increases hippocampal levels of 
the endocannabinoid 2-AG. We further found that antagonism of hippocampal 
ß-adrenoceptor activity blocks the memory retrieval impairment induced by the 
CB receptor agonist WIN55,212-2, whereas CB1 receptor blockade fails to alter 
memory  retrieval  impairment  induced  by  concurrent  hippocampal  infusions 
of  norepinephrine. These   ndings  suggest  that  the  endocannabinoid  system 
is involved in mediating GC e ects on the noradrenergic system in impairing 
memory retrieval. 
Our  nding that CORT administration shortly before retention testing impaired 
retrieval of contextual fear memory, without a ecting retrieval of auditory fear 
memory or baseline freezing, is consistent with previous reports indicating that 
GCs impair memory retrieval of hippocampus-dependent contextual fear memory 
and that this stress hormone e ect is not directly attributable to acute fear relief 
or to de cits in the expression of freezing behavior (Cai et al., 2006; Schutsky 
et al., 2011). Moreover, our  nding that CORT did not facilitate the extinction 
of freezing within the course of the retention test is in line with other evidence 158
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indicating that CORT facilitates the consolidation, but not the acquisition, of fear 
extinction memory (Cai et al., 2006; Yang et al., 2006). Findings of several other 
studies investigating the e ects of stress, GCs or speci c GR agonists on memory 
retrieval of other training tasks in rats, requiring the expression of other behavioral 
responses, as well as those of verbal reports in healthy human subjects, support the 
view that GCs impair immediate and delayed recall of hippocampus-dependent 
memory (de Quervain et al., 1998; de Quervain et al., 2000; Roozendaal et al., 2003; 
Roozendaal et al., 2004b). There is extensive evidence that the hippocampus is 
involved in the retrieval of contextual, spatial or declarative memory and is also 
a primary target for stress hormones (de Kloet et al., 1999; Riedel et al., 1999; 
Corcoran and Maren, 2001). Moreover, prior  ndings indicate that direct infusions 
of GCs into the hippocampus impair the retrieval of spatial memory (Roozendaal 
et al., 2003; Roozendaal et al., 2004b) and that a single GC administration to 
human  subjects  decreases  hippocampal  activity  during  declarative  memory 
retrieval  (Oei  et  al.,  2007). The   ndings  of  studies  investigating  whether  GCs 
might also impair memory retrieval of hippocampus-independent learning tasks 
are consistent with our current observation that GCs appear to have little or no 
e ect on retrieval of auditory fear memory or other hippocampus-independent 
memories (Kirschbaum et al., 1996; Schutsky et al., 2011). However, we cannot 
exclude the possibility that CORT might have impaired the retrieval of memory 
of  some  speci c  features  of  the  conditioning  tone  (e.g.,  frequency,  intensity, 
duration, et cetera) used in the present study. 
Our   nding  that  pre-test  blockade  of  hippocampal  CB1  receptors  with  local 
infusions of AM251 prevented the GC-induced impairment of contextual fear 
memory retrieval indicates that endocannabinoid signaling plays an important 
role in regulating GC e ects on memory retrieval. Moreover, comparable to the 
e ect of systemic CORT administration, intrahippocampal infusions of the full 
CB agonist WIN55,212-2 impaired the retrieval of contextual, but not auditory, 
fear memory. This selective impairment of retrieval of contextual fear memory 
indicates  that  the  WIN55,212-2  administration  did  not  non-speci cally  a ect 
the expression of freezing behavior, a  nding that is in accordance with other 
reported evidence that intrahippocampal administration of WIN55,212-2 or other 
cannabinoid agonists (delta-9-tetrahydrocannabinol or CP 55,940) impairs spatial 
memory without directly a ecting the expression of behaviors that were assessed 159
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as an index of memory (Lichtman et al., 1995; Egashira et al., 2002; Wegener et 
al., 2008). Moreover, we found that CORT administration, in a dose that impairs 
memory retrieval, increased hippocampal levels of 2-AG, but not AEA or other 
measured  endocannabinoids,  in  the  same  time  course  of  the  retention  test. 
These  ndings are consistent with previous evidence that stress and GCs rapidly 
alter endocannabinoid signaling in a variety of stress-responsive brain regions, 
including the hippocampus (Hill et al., 2010a; Hill and McEwen, 2010). Although 
some controversy exists in the literature, stress has been shown to mobilize 2-AG 
Figure 2. Role of the endocannabinoid system in regulating glucocorticoid e ects on retrieval of 
contextual fear memory. (A) Hippocampal infusion of the CB1 receptor antagonist AM251 (0.35 ng in 
0.5 µl) administered 1 h before retention testing blocks the impairment of retrieval of contextual fear 
memory induced by concurrent systemic CORT (3 mg/kg) treatment. Results represent mean ± SEM, 
*p < 0.05 vs. vehicle (n = 7-11/group). (B) Representative photomicrograph illustrating placement of 
cannula and needle tip in the dorsal hippocampus with sub elds dentate gyrus (DG), CA1 and CA3. 
(C, D) Systemic CORT (0.3, 1, 3 mg/kg) treatment dose-dependently increases hippocampal 2-AG, 
but not AEA, in the same time window of the retention test. All results represent mean ± SEM, *p < 
0.05 vs. vehicle (n = 10-15/group).160
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while concurrently decreasing AEA levels in the hippocampus (Patel and Hillard, 
2008;  Hill  and  McEwen,  2010).  Interestingly,  GR  antagonists  block  this  stress-
induced increase in hippocampal 2-AG levels (Wang et al., 2012). Although it is 
currently unknown how GCs might increase 2-AG levels (i.e. changes in synthesis, 
release, uptake or degradation), the e ect appears to depend on activation of 
a G-protein-coupled receptor and intracellular cAMP-dependent protein kinase 
signaling (Di et al., 2009). 
Extensive evidence indicates that stress and GC e ects on memory retrieval of 
emotionally arousing experiences depend crucially on an interaction with arousal-
induced noradrenergic activity (Roozendaal et al., 2003; Roozendaal et al., 2004b; 
de  Quervain  et  al.,  2007;  Schutsky  et  al.,  2011).  A  ß-adrenoceptor  antagonist 
administered  systemically  or  directly  into  the  hippocampus  or  basolateral 
amygdala in rats blocks GC e ects on memory retrieval. Moreover, GCs have been 
shown to rapidly increase the release of norepinephrine in the amygdala after an 
emotionally arousing experience (McReynolds et al., 2010) in a time frame that 
appears incompatible with that of the classical genomic e ects of GCs. The present 
Figure  3.  Endocannabinoid  and  norepinephrine  interactions  in  the  dorsal  hippocampus  on 
retrieval of contextual fear memory. (A) The CB receptor agonist WIN55,212-2 (WIN: 10 or 30 ng in 
0.5 µl) infused into the hippocampus 1 h before the retention test impairs retrieval of contextual 
fear memory. Concurrent infusion of the ß-adrenoceptor antagonist propranolol (1.25 µg) blocks 
this WIN55,212-2-induced memory retrieval impairment. Results represent mean ± SEM, *p < 0.05; 
**p < 0.001 vs. vehicle (n = 10-14/group). (B) Intrahippocampal infusions of norepinephrine (1 or 3 
µg in 0.5 µl) administered 1 h before the retention test, impair retrieval of contextual fear memory.   
Concurrent infusion of the CB1 receptor antagonist AM251 (0.35 ng) does not block this impairment. 
Results represent mean ± SEM, *p < 0.05; **p < 0.01 vs. vehicle (n = 11-15/group).161
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 ndings indicate that GC-induced impairment of memory retrieval is mediated, 
at least in part, via rapid in uences on the endocannabinoid system. Moreover, 
our  nding that the ß-adrenoceptor antagonist propranolol blocks the impairing 
e ect  of  the  CB  receptor  agonist  WIN55,212-2,  whereas  a  blockade  of  CB1 
receptors with AM251 fails to prevent norepinephrine-induced memory retrieval 
impairment, indicates that norepinephrine is functionally located downstream 
from the endocannabinoid system. Collectively, these  ndings strongly suggest 
that endocannabinoids play an intermediary role in regulating GC e ects on the 
norepinephrine system in impairing memory retrieval. In support of this view, 
previous  ndings indicate that the administration of a synthetic cannabinoid 
agonist dose-dependently increased norepinephrine levels in limbic and cortical 
regions (Oropeza et al., 2005; Page et al., 2007). 
A  possible  scenario  is  that  endocannabinoids  might  in uence  noradrenergic 
function via an inhibition of GABAergic transmission (Campolongo et al., 2009; 
Hill and McEwen, 2009; Atsak et al., 2012). Although this possibility was originally 
proposed  for  GC-induced  enhancement  of  memory  consolidation  involving 
the  basolateral  amygdala  (Campolongo  et  al.,  2009),  CB1  receptors  are  also 
abundantly  expressed  on  hippocampal  GABAergic  terminals  and  to  a  minor 
extent on glutamatergic terminals (Katona et al., 1999). An activation of CB1 
receptors has consistently been shown to suppress the release of GABA in the 
hippocampus through a Ca2+-dependent depolarization-induced suppression of 
inhibition (DSI) (Kano et al., 2009). In support of our  nding that CORT might a ect 
memory retrieval via increased 2-AG endocannabinoid signaling, recent  ndings 
suggest that particularly 2-AG is involved in the modulation of DSI, and thus in the 
suppression of GABA release, in the hippocampus (Hashimotodani et al., 2008; 
Wang et al., 2009; Tanimura et al., 2010). Additionally, substantial evidence from 
pharmacological studies on memory consolidation has indicated that a blockade 
of GABAergic transmission with speci c antagonists increases norepinephrine 
release from presynaptic sites (McGaugh, 2004). Based on these  ndings, a similar 
working model for GC-induced impairment of memory retrieval can be proposed: 
GCs  rst boost the release of 2-AG in the hippocampus. This endocannabinoid 
then binds to CB1 receptors on GABAergic interneurons to suppress the release 
of GABA, resulting indirectly in elevated norepinephrine levels, which, as we have 
shown in this study, impairs memory retrieval of salient information (Fig. S2). 162
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As noted above, there is currently growing interest in GC in uences on retrieval 
of  memory  of  emotionally  arousing  experiences  because  of  clinical   ndings 
indicating  that  GC  administration  to  PTSD  patients  signi cantly  reduces  re-
experiencing of highly traumatic memories and other chronic stress symptoms 
(Aerni et al., 2004, de Quervain et al., 2009). However, in a clinical setting the 
sustained use of GCs is undesirable because of the pleiotropic nature of these 
hormones to a ect a wide array of physiological functions (e.g., immune and 
metabolic functions). The present  nding that the hippocampal endocannabinoid 
system is involved in mediating GC e ects on memory retrieval impairment could 
aid in the development of non-GC-based therapies for PTSD. Although clinical 
studies  have  not  as  yet  investigated  interactions  between  these  two  stress 
systems, recent  ndings indicate that administration of the synthetic cannabinoid 
nabilone to PTSD patients resulted in a highly comparable reduction of treatment-
resistant daytime  ashbacks and nightmares (Fraser, 2009). Moreover, PTSD is 
often associated with high levels of cannabis consumption (Calhoun et al., 2000), 
which might be related, in part, to an inadequate activation of the endogenous 
GC and endocannabinoid systems in these patients (Yehuda, 2009). Furthermore, 
based on our  nding that systemic CORT administration impaired the retrieval of 
hippocampus-dependent contextual fear memory, without a ecting the retrieval 
of hippocampus-independent auditory fear memory, it would seem important 
to also investigate whether GC or cannabinoid administration might selectively 
reduce the retrieval of hippocampus-dependent traumatic memories in PTSD 
patients.
Supporting Information
Tissue processing and lipid extraction for endocannabinoid measurement
After  rapid  decapitation,  the  hippocampus  was  dissected  and  placed  in  pre-
cooled tubes and frozen in liquid nitrogen within 3 min of decapitation. Tissue 
samples were stored at -80 °C until extraction. For detection of endocannabinoids, 
the  collected  hippocampal  tissue  was  weighed  and  homogenized  in  2  ml 
polypropylene tubes (Sarstedt, Numbrecht, Germany). For lipid extraction, internal 
standards consisting of the stable isotope labeled endocannabinoids arachidonyl 
ehanolamide-d4,  2-arachidonoyl  glycerol-d5,  palmitoyl  ethanolamide-d4, 163
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 ﾠ
Drug ﾠgroups ﾠ ﾠ
(mg/kg) ﾠ
Shock ﾠtrials ﾠ
1 ﾠ 2 ﾠ 3 ﾠ 4 ﾠ 5 ﾠ
Vehicle ﾠ 8 ﾠ± ﾠ5 ﾠ 27 ﾠ± ﾠ7 ﾠ 38 ﾠ± ﾠ5 ﾠ 51 ﾠ± ﾠ9 ﾠ 63 ﾠ± ﾠ8 ﾠ
CORT ﾠ0.3 ﾠ 7 ﾠ± ﾠ2 ﾠ 32 ﾠ± ﾠ8 ﾠ 43 ﾠ± ﾠ8 ﾠ 43 ﾠ± ﾠ8 ﾠ 51 ﾠ± ﾠ8 ﾠ
CORT ﾠ1 ﾠ 6 ﾠ± ﾠ3 ﾠ 20 ﾠ± ﾠ7 ﾠ 29 ﾠ± ﾠ7 ﾠ 54 ﾠ± ﾠ9 ﾠ 51 ﾠ± ﾠ11 ﾠ
CORT ﾠ3 ﾠ 2 ﾠ± ﾠ1 ﾠ 17 ﾠ± ﾠ7 ﾠ 37 ﾠ± ﾠ11 ﾠ 44 ﾠ± ﾠ10 ﾠ 59 ﾠ± ﾠ10 ﾠ
 ﾠ
Table S1. Percentage freezing during training of contextual fear conditioning
There was no di erence in the acquisition rate between later drug groups. Data are 
expressed as mean ± SEM (n = 10 –15/group).
 ﾠ
Drug ﾠgroups ﾠ  ﾠ Shock ﾠtrials ﾠ
1 ﾠ 2 ﾠ 3 ﾠ 4 ﾠ 5 ﾠ
Vehicle ﾠ Vehicle ﾠ 29 ﾠ± ﾠ9 ﾠ 52 ﾠ±10 ﾠ 54 ﾠ± ﾠ9 ﾠ 62 ﾠ± ﾠ8 ﾠ 66 ﾠ± ﾠ9 ﾠ
CORT ﾠ(3 ﾠmg/kg) ﾠ 27 ﾠ± ﾠ15 ﾠ 40 ﾠ± ﾠ13 ﾠ 44 ﾠ± ﾠ15 ﾠ 44 ﾠ± ﾠ13 ﾠ 60 ﾠ± ﾠ13 ﾠ
AM251 ﾠ Vehicle ﾠ 31 ﾠ± ﾠ8 ﾠ 47 ﾠ± ﾠ12 ﾠ 67 ﾠ± ﾠ9 ﾠ 58 ﾠ± ﾠ8 ﾠ 67 ﾠ± ﾠ6 ﾠ
CORT ﾠ(3 ﾠmg/kg) ﾠ 28 ﾠ± ﾠ5 ﾠ 44 ﾠ± ﾠ5 ﾠ 53 ﾠ± ﾠ5 ﾠ 67 ﾠ±11 ﾠ 81 ﾠ± ﾠ3 ﾠ
 ﾠ
Table S2. Percentage freezing during training of contextual fear conditioning.
There was no di erence in the acquisition rate between later drug groups. Values are 
expressed as mean ± SEM (n = 11–15/group).
N-arachidonoyl dopamine-d8 and arachidonoyl glycine-d8 synthesized by Roche 
Diagnostics, Mannheim, Germany and Cayman Europe, Tallinn, Estonia was added 
to the tubes. The purity of these materials was >97.2%. Then 1 ml of methyl tertiary 
butyl ether (Sigma-Aldrich, Germany) was added and the mixture was vortexed 
for 30 s and centrifuged at 12,000   g for 6 min. The clear supernatant was 
transferred into clean 2 mL polypropylene tubes (Sarstedt, Numbrecht, Germany) 
and evaporated under N2 at 37 °C. Dried organic phases were then reconstituted 
in 100  L of acetonitrile, vortexed for 30 s, centrifugated at 12,000 g for 6 min and 
then endocannabinoid levels were determined with the high-performance liquid 164
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Table S3. The e ects of corticosterone administration before the non-training context exposure on 
the hippocampal tissue content of palmitoylethanolamine and oleoylethanolamine.
 ﾠ
 ﾠ
 ﾠ PEA ﾠ(pmol/g ﾠtissue) ﾠ OEA ﾠ(pmol/g ﾠtissue) ﾠ
Vehicle ﾠ ﾠ
CORT ﾠ0.3 ﾠ
CORT ﾠ1 ﾠ
CORT ﾠ3 ﾠ
542 ﾠ± ﾠ54 ﾠ ﾠ
539 ﾠ± ﾠ33 ﾠ
521 ﾠ± ﾠ52 ﾠ
528 ﾠ± ﾠ43 ﾠ
96 ﾠ± ﾠ10 ﾠ
93 ﾠ± ﾠ10 ﾠ
94 ﾠ± ﾠ8.2 ﾠ
90 ﾠ± ﾠ7.1 ﾠ
 ﾠ  ﾠ  ﾠ
There was no e ect of CORT (0.3, 1, 3 mg/kg) administration on the hippocampal tissue 
content of either palmitoylethanolamide (PEA) or oleoylethanolamine (OEA). Values are 
expressed as mean ± SEM (n = 10–15/group).
 
Drug groups    Shock trials 
1  2  3  4  5 
Vehicle 
Vehicle  25 ± 6  48 ±7  52 ± 9  57 ± 8  52 ± 8 
WIN (10ng)  11 ± 8  21 ± 10  24 ± 12  24 ± 11  42 ± 11 
WIN (30ng)  30 ± 6  51 ± 7  59 ± 8  64 ± 7  63 ± 8 
Propranolol 
Vehicle  14 ± 7  33 ± 8  42 ± 9  44 ± 8  40 ± 9 
WIN (10ng)  17 ± 6  24 ±7  43 ± 8  53 ±7  65 ± 8 
WIN (30ng)  34 ± 6  43 ± 7  60 ± 8  54 ± 7  56 ± 7 
 
Table S4. Percentage freezing during training of contextual fear conditioning.
There was no di erence in the acquisition rate between later drug groups. Values are 
expressed as mean ± SEM (n = 10 – 14/group).
 
Drug groups    Shock trials 
1  2  3  4  5 
Vehicle 
Vehicle  26 ± 7  37 ± 8  50 ± 9  57 ± 7  66 ± 6 
NE (1 µg)  19 ± 8  32 ± 9  43 ± 12  53 ± 9  61 ± 9 
NE (3 µg)  20 ± 6  32 ± 9  44 ± 10  59 ± 7  66 ± 9 
AM251 
Vehicle  29 ± 8  45 ± 8  60 ± 9  63 ± 7  54 ± 9 
NE (1 µg)  32 ± 7  48 ±7  53 ± 6  58 ± 6  52 ± 8 
NE (3 µg)  19 ± 5  31 ± 8  38 ± 9  50 ± 10  49 ± 10 
 
Table S5. Percentage freezing during training of contextual fear conditioning
There was no di erence in the acquisition rate between later drug groups. Values are 
expressed as mean ± SEM (n = 11–15/group).165
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!
Figure S1. The e ect of intrahippocampal WIN55,212-2 (WIN) or norepinephrine (NE) on freezing 
behavior during retention of auditory fear conditioning. (A) E ect of NE (1 or 3  g in 0.5  l) infused 
into the dorsal hippocampus one hour before the auditory fear conditioning retention during 
baseline (B) and tone trials (T1-T4). Results represent mean ± SEM (n = 7 – 12) (B) E ect of WIN (10 or 
30 ng in 0.5  l) infused into the dorsal hippocampus one hour before the auditory fear conditioning 
retention during baseline and tone trials (T1-T4). Results represent mean ± SEM (n = 9–11/group).
Fig.  S2.  Model  on  the  role  of  the 
endocannabinoid  system  in 
the  hippocampus  in  mediating 
glucocorticoid  e ects  on  the 
noradrenergic system in inducing
memory  retrieval  impairment. 
Corticosterone  (CORT)  binds  to  a 
membrane-bound  glucocorticoid 
receptor  (GR)  that  activates  a 
pathway to induce endocannabinoid 
(eCB)  synthesis.  Endocannabinoids 
are  then  released  into  the  synapse, 
where they bind to CB1 receptors on 
GABAergic interneurons and thereby,
inhibit  the  release  of  GABA. 
This  suppression  of  GABA 
release  subsequently  disinhibits 
norepinephrine (NE) release, resulting 
in an activation of the postsynaptic 
 -adrenoceptor  and  downstream 
signaling pathways.166
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chromatography and a tandem mass spectrometry. 
ACKNOWLEDGMENTS
The  authors  thank  Jelle  De  Boer  for  assistance  with  data  analysis  and  Petra  Bakker, 
Angelika Jurdzinski, Hassiba Beldjoud and Fany Messanvi for technical assistance with the 
collection of tissue for endocannabinoid measurements. This research was supported by 
Jan Kornelis De Cock Stichting grant 6861063 (to PA) and National Science Foundation 
grant IOB-0618211 (to BR).   
REFERENCES 
Aerni  A,  Traber  R,  Hock  C,  Roozendaal  B,  Schelling  G,  Papassotiropoulos  A,  Nitsch 
RM,  Schnyder  U,  de  Quervain  DJ  (2004)  Low-dose  cortisol  for  symptoms  of 
posttraumatic stress disorder. Am J Psychiatry 161: 1488-1490.
Akirav I (2011) The role of cannabinoids in modulating emotional and non-emotional 
memory processes in the hippocampus. Front Behav Neurosci 5: 34.
Atsak  P,  Roozendaal  B,  Campolongo  P  (2012)  Role  of  the  endocannabinoid  system 
in  regulating  glucocorticoid  e ects  on  memory  for  emotional  experiences. 
Neuroscience 204: 104-116.
Cai WH, Blundell J, Han J, Greene RW, Powell CM (2006) Postreactivation glucocorticoids 
impair recall of established fear memory. J Neurosci 26: 9560-9566.
Calhoun PS, Sampson WS, Bosworth HB, Feldman ME, Kirby AC, Hertzberg MA, Wampler TP, 
Tate-Williams F, Moore SD, Beckham JC (2000) Drug use and validity of substance 
use  self-reports  in  veterans  seeking  help  for  posttraumatic  stress  disorder.  J 
Consult Clin Psychol 68: 923-927.
Campolongo P, Roozendaal B, Trezza V, Hauer D, Schelling G, McGaugh JL, Cuomo V 
(2009)  Endocannabinoids  in  the  rat  basolateral  amygdala  enhance  memory 
consolidation and enable glucocorticoid modulation of memory. Proc Natl Acad 
Sci USA 106: 4888-4893.
Corcoran KA, Maren S (2001) Hippocampal inactivation disrupts contextual retrieval of 
fear memory after extinction. J Neurosci 21: 1720-1726.
de Kloet ER, Oitzl MS, Joëls M (1999) Stress and cognition: are corticosteroids good or bad 
guys? Trends Neurosci 22: 422-426.
de Quervain DJ, Aerni A, Roozendaal B (2007) Preventive e ect of beta-adrenoceptor 
blockade on glucocorticoid-induced memory retrieval de cits. Am J Psychiatry 
164: 967-969.167
C
h
a
p
t
e
r
 
5
Glucocorticoids interact with the hippocampal endocannabinoid system in impairing
de  Quervain  DJ,  Aerni  A,  Schelling  G,  Roozendaal  B  (2009)  Glucocorticoids  and  the 
regulation of memory in health and disease. Front Neuroendocrinol 30: 358-370.
de Quervain DJ, Henke K, Aerni A, Treyer V, McGaugh JL, Berthold T, Nitsch RM, Buck A, 
Roozendaal B, Hock C (2003) Glucocorticoid-induced impairment of declarative 
memory retrieval is associated with reduced blood  ow in the medial temporal 
lobe. Eur J Neurosci 17: 1296-1302.
de Quervain DJ, Roozendaal B, McGaugh JL (1998) Stress and glucocorticoids impair 
retrieval of long-term spatial memory. Nature 394: 787-790.
de Quervain DJ, Roozendaal B, Nitsch RM, McGaugh JL, Hock C (2000) Acute cortisone 
administration impairs retrieval of long-term declarative memory in humans. Nat 
Neurosci 3: 313-314.
Di S, Maxson M, Franco A, Tasker J (2009) Glucocorticoids regulate glutamate and GABA 
synapse-speci c retrograde transmission via divergent nongenomic signaling 
pathways. J Neurosci 29: 393-401.
Egashira N, Mishima K, Iwasaki K, Fujiwara M (2002) Intracerebral microinjections of delta 
9-tetrahydrocannabinol:  search  for  the  impairment  of  spatial  memory  in  the 
eight-arm radial maze in rats. Brain Res 952: 239-245.
Evanson NK, Tasker JG, Hill MN, Hillard CJ, Herman JP (2010) Fast feedback inhibition 
of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. 
Endocrinology 151: 4811-4819.
Fornari RV, Wichmann, R., Atsak, P., Atucha, E., Barsegyan, A., Beldjoud, H., Messanvi, F., 
Thuring,  C.  M.,  Roozendaal,  B.  (2012)  Rodent  stereotaxic  surgery  and  animal 
welfare outcome improvements for behavioral neuroscience. J Vis Exp e3528, 
DOI: 10.3791/3528.
Fraser GA (2009) The use of a synthetic cannabinoid in the management of treatment-
resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci Ther 
15: 84-88.
Freund TF,  Katona  I,  Piomelli  D  (2003)  Role  of  endogenous  cannabinoids  in  synaptic 
signaling. Physiol Rev 83: 1017-1066.
Hashimotodani Y, Ohno-Shosaku T, Maejima T, Fukami K, Kano M (2008) Pharmacological 
evidence for the involvement of diacylglycerol lipase in depolarization-induced 
endocanabinoid release. Neuropharmacology 54: 58-67.
Het S, Ramlow G, Wolf OT (2005) A meta-analytic review of the e ects of acute cortisol 
administration on human memory. Psychoneuroendocrinol 30: 771-784.
Hill MN, Karatsoreos I, Hillard C, Mcewen B (2010a) Rapid elevations in limbic endocannabinoid 168
C
h
a
p
t
e
r
 
5
Glucocorticoids interact with the hippocampal endocannabinoid system in impairing
content by glucocorticoid hormones in vivo. Psychoneuroendocrinol 35: 1333-
1338.
Hill MN, McEwen B (2009) Endocannabinoids: the silent partner of glucocorticoids in the 
synapse. Proc Natl Acad Sci USA 106: 4579-4580.
Hill  MN,  McEwen  B  (2010)  Involvement  of  the  endocannabinoid  system  in  the 
neurobehavioural e ects of stress and glucocorticoids. Prog Neuro-Psychoph 34: 
791-797.
Hill  MN,  Patel  S,  Campolongo  P,  Tasker  JG,  Wotjak  CT,  Bains  JS  (2010b)  Functional 
interactions  between  stress  and  the  endocannabinoid  system:  from  synaptic 
signaling to behavioral output. J Neurosci 30: 14980-14986.
Joels M, Fernandez G, Roozendaal B (2011) Stress and emotional memory: a matter of 
timing. Trends Cogn Sci 15: 280-288.
Kano  M,  Ohno-Shosaku  T,  Hashimotodani  Y,  Uchigashima  M,  Watanabe  M  (2009) 
Endocannabinoid-mediated  control  of  synaptic  transmission.  Physiol  Rev  89: 
309-380.
Katona I, Sperlágh B, Sík A, Käfalvi A, Vizi ES, Mackie K, Freund TF (1999) Presynaptically 
located CB1 cannabinoid receptors regulate GABA release from axon terminals 
of speci c hippocampal interneurons. J Neurosci 19: 4544-4558.
Kirschbaum C, Wolf OT, May M, Wippich W, Hellhammer DH (1996) Stress- and treatment-
induced  elevations  of  cortisol  levels  associated  with  impaired  declarative 
memory in healthy adults. Life Sci 58: 1475-1483.
Kuhlmann S, Kirschbaum C, Wolf OT (2005a) E ects of oral cortisol treatment in healthy 
young women on memory retrieval of negative and neutral words. Neurobiol 
Learn Mem 83: 158-162.
Kuhlmann S, Piel M, Wolf OT (2005b) Impaired memory retrieval after psychosocial stress 
in healthy young men. J Neurosci 25: 2977-2982.
Kuhlmann  S,  Wolf  OT  (2006)  Arousal  and  cortisol  interact  in  modulating  memory 
consolidation in healthy young men. Behav Neurosci 120: 217-223.
Lichtman AH, Dimen KR, Martin BR (1995) Systemic or intrahippocampal cannabinoid 
administration impairs spatial memory in rats. Psychopharmacology (Berl) 119: 
282-290.
Marsicano G, Lafenetre P (2009) Roles of the endocannabinoid system in learning and 
memory. Curr Top Behav Neurosci 1: 201-230.
McGaugh JL (2004) The amygdala modulates the consolidation of memories of emotionally 
arousing experiences Annu Rev Neurosci 27: 1-28.169
C
h
a
p
t
e
r
 
5
Glucocorticoids interact with the hippocampal endocannabinoid system in impairing
McGaugh JL, Roozendaal B (2002) Role of adrenal stress hormones in forming lasting 
memories in the brain. Curr Opin Neurobiol 12: 205-210.
McReynolds  JR,  Donowho  K,  Abdi  A,  McGaugh  JL,  Roozendaal  B,  McIntyre  CK 
(2010)  Memory-enhancing  corticosterone  treatment  increases  amygdala 
norepinephrine and Arc protein expression in hippocampal synaptic fractions. 
Neurobiol Learn Mem 93: 312-321.
Oei NY, Elzinga BM, Wolf OT, de Ruiter MB, Damoiseaux JS, Kuijer JP, Veltman DJ, Scheltens 
P, Rombouts SA (2007) Glucocorticoids decrease hippocampal and prefrontal 
activation during declarative memory retrieval in young men. Brain Imaging 
Behav 1: 31-41.
Oropeza VC, Page ME, Van Bockstaele EJ (2005) Systemic administration of WIN 55,212-2 
increases norepinephrine release in the rat frontal cortex. Brain Res 1046: 45-54.
Page ME, Oropeza VC, Sparks SE, Qian Y, Menko AS, Van Bockstaele EJ (2007) Repeated 
cannabinoid administration increases indices of noradrenergic activity in rats. 
Pharmacol Biochem Behav 86: 162-168.
Patel S, Hillard C (2008) Adaptations in endocannabinoid signaling in response to repeated 
homotypic stress: a novel mechanism for stress habituation. Eur J Neurosci 27: 
2821-2829.
Paxinos G, Watson C (2005). The rat brain in stereotaxic coordinates. San Diego, Elsevier.
Riedel  G,  Micheau  J,  Lam  AG,  Rolo   EL,  Martin  SJ,  Bridge  H,  de  Hoz  L,  Poeschel  B, 
McCulloch J, Morris RG (1999) Reversible neural inactivation reveals hippocampal 
participation in several memory processes. Nat Neurosci 2: 898-905.
Roozendaal B, de Quervain DJ, Schelling G, McGaugh JL (2004a) A systemically administered 
beta-adrenoceptor  antagonist  blocks  corticosterone-induced  impairment  of 
contextual memory retrieval in rats. Neurobiol Learn Mem 81: 150-154.
Roozendaal  B,  Gri th  QK,  Buranday  J,  de  Quervain  DJ,  McGaugh  JL  (2003)  The 
hippocampus mediates glucocorticoid-induced impairment of spatial memory 
retrieval: dependence on the basolateral amygdala. Proc Natl Acad Sci USA 100: 
1328-1333.
Roozendaal B, Hahn EL, Nathan SV, de Quervain DJ, McGaugh JL (2004b) Glucocorticoid 
e ects  on  memory  retrieval  require  concurrent  noradrenergic  activity  in  the 
hippocampus and basolateral amygdala. J Neurosci 24: 8161-8169.
Roozendaal B, McEwen B, Chattarji S (2009) Stress, memory and the amygdala. Nat Rev 
Neurosci 10: 423-433.
Roozendaal B, Okuda S, de Quervain DJ, McGaugh JL (2006) Glucocorticoids interact with 170
C
h
a
p
t
e
r
 
5
Glucocorticoids interact with the hippocampal endocannabinoid system in impairing
emotion-induced  noradrenergic  activation  in  in uencing  di erent  memory 
functions. Neuroscience 138: 901-910.
Sandi C, Pinelo-Nava M (2007) Stress and Memory: Behavioral e ects and neurobiological 
mechanisms. Neural Plast 2007: 1-20.
Schelling G, Roozendaal B, de Quervain DJ (2004) Can posttraumatic stress disorder be 
prevented with glucocorticoids? Ann N Y Acad Sci 1032: 158-166.
Schelling G, Roozendaal B, Krauseneck T, Schmoelz M, DE Quervain D, Briegel J (2006) 
E cacy of hydrocortisone in preventing posttraumatic stress disorder following 
critical illness and major surgery. Ann N Y Acad Sci 1071: 46-53.
Schutsky K, Ouyang M, Castelino CB, Zhang L, Thomas SA (2011) Stress and glucocorticoids 
impair  memory  retrieval  via  {beta}2-Adrenergic,  Gi/o-coupled  suppression  of 
cAMP signaling. J Neurosci 31: 14172-14181.
Schwabe L, Joels M, Roozendaal B, Wolf OT, Oitzl MS (2011) Stress e ects on memory: An 
update and integration. Neurosci Biobehav Rev (Available online 13 July 2011, 
10.1016/j.neubiorev.2011.07.002.).
Tanimura  A,  Yamazaki  M,  Hashimotodani  Y,  Uchigashima  M,  Kawata  S,  Abe  M,  Kita 
Y,  Hashimoto  K,  Shimizu  T,  Watanabe  M,  Sakimura  K,  Kano  M  (2010)  The 
endocannabinoid  2-arachidonoylglycerol  produced  by  diacylglycerol  lipase 
alpha mediates retrograde suppression of synaptic transmission. Neuron 65: 320-
327.
Tasker JG, Di S, Malcher-Lopes R (2006) Minireview: rapid glucocorticoid signaling via 
membrane-associated receptors. Endocrinology 147: 5549-5556.
Vogeser M, Hauer D, Christina Azad S, Huber E, Storr M, Schelling G (2006) Release of 
anandamide from blood cells. Clin Chem Lab Med 44: 488-491.
Vogeser M, Schelling G (2007) Pitfalls in measuring the endocannabinoid 2-arachidonoyl 
glycerol in biological samples. Clin Chem Lab Med 45: 1023-1025.
Wang M, Hill MN, Zhang L, Gorzalka BB, Hillard CJ, Alger BE (2012) Acute restraint stress 
enhances hippocampal endocannabinoid function via glucocorticoid receptor 
activation. J Psychopharmacol 26: 56-70.
Wang  S,  Teixeira  C,  Wheeler  A,  Frankland  P  (2009)  The  precision  of  remote  context 
memories does not require the hippocampus. Nat Neurosci 12: 253-255.
Wegener N, Kuhnert S, Thuns A, Roese R, Koch M (2008) E ects of acute systemic and 
intra-cerebral  stimulation  of  cannabinoid  receptors  on  sensorimotor  gating, 
locomotion and spatial memory in rats. Psychopharmacology (Berl) 198: 375-385.
Yang  YL,  Chao  PK,  Lu  KT  (2006)  Systemic  and  intra-amygdala  administration  of 171
C
h
a
p
t
e
r
 
5
Glucocorticoids interact with the hippocampal endocannabinoid system in impairing
glucocorticoid agonist and antagonist modulate extinction of conditioned fear. 
Neuropsychopharmacology 31: 912-924.
Yehuda R (2009) Status of glucocorticoid alterations in post-traumatic stress disorder. Ann 
N Y Acad Sci 1179: 56-69.Glucocorticoids Impair 
Retrieval of Recognition 
Memory: Role of the 
Endocannabinoid System 
6





	

Piray Atsak and Benno Roozendaal
Department of Neuroscience, Section Anatomy, University Medical Center 
Groningen, University of Groningen, 9713 AV Groningen, The Netherlands174
C
h
a
p
t
e
r
 
6
Glucocorticoids impair retrieval of recognition memory: Role of the endocannabinoid system 
ABSTRACT
Considerable  evidence  indicates  that  stress  exposure  or  glucocorticoid 
administration shortly before retention testing impairs the retrieval of spatial/
contextual  memory  in  rats  and  of  declarative  memory  in  humans.  However, 
other  ndings of human studies suggest that glucocorticoids are less e ective 
in  impairing  the  retrieval  of  recognition  memory.  Here  we  investigated  in 
male  Sprague-Dawley  rats  the  e ect  of  corticosterone  (0.3  or  1  mg/kg.  sc) 
administration, 1  h before  retention  testing,  on  the  retrieval  of  two  di erent 
components of information acquired during an object recognition task. We found 
that corticosterone impaired recognition of both the training object per se and of 
the location of the objects during the training session, without in uencing total 
exploration of the objects or experimental apparatus. In view of recent  ndings 
suggesting that glucocorticoid e ects on memory retrieval impairment depend 
on  rapid,  nongenomically  mediated  interactions  with  the  endocannabinoid 
system, we also investigated the involvement of endocannabinoid signaling in 
the e ects of glucocorticoids on retrieval of these two components of object 
recognition memory. We found that the inverse CB1 agonist SR141716 (1 mg/kg) 
administered systemically before retention testing blocked the corticosterone-
induced  impairment  of  retrieval  of  both  components  of  object  recognition 
memory. Thus, these  ndings indicate that glucocorticoids impair the retrieval of 
recognition memory and that these e ects require concurrent endocannabinoid 
signaling.     
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INTRODUCTION
Glucocorticoid hormones (corticosterone in rodents, cortisol in humans), released 
from the adrenal cortex during emotionally arousing stimulation, are known to 
in uence di erent memory functions (Roozendaal, 2002; de Quervain et al., 2009; 
Roozendaal and McGaugh, 2011; Schwabe et al., 2011). Considerable evidence 
indicates that corticosterone or glucocorticoid receptor (GR) agonists administered 
to rats or mice shortly before retention testing impair the retrieval of previously 
acquired spatial and contextual memory (de Quervain et al., 1998; Rashidy-Pour 
et al., 2004; Roozendaal et al., 2004b; Cai et al., 2006; Schutsky et al., 2011; Atsak 
et al., 2012a). Likewise, human subjects treated with cortisol or cortisone before 
a  retention  test  exhibit  impaired  free  or  cued  recall  on  declarative  memory 
paradigms (de Quervain et al., 2000; de Quervain et al., 2003; Buss et al., 2004; Het 
et al., 2005; Kuhlmann et al., 2005; Tollenaar et al., 2009). Few human studies also 
investigated the e ect of glucocorticoids on retrieval of recognition memory (de 
Quervain et al., 2000; de Quervain et al., 2003; Tops et al., 2003; Domes et al., 2004; 
Buchanan et al., 2006). Findings of these studies indicate that glucocorticoids 
induce small and mostly nonsigni cant recognition impairment. As free and cued 
recall of declarative information, as retrieval of spatial and contextual memory 
in rats, depend heavily on the hippocampus (Squire, 1992; Moser and Moser, 
1998; Tulving and Markowitsch, 1998; Holt and Maren, 1999) whereas recognition 
memory might rely more on cortical regions (Baxter and Murray, 2001; Winters 
et al., 2008), the relative sparing of recognition memory could be interpreted 
as suggesting that glucocorticoids preferably impair the retrieval of memory of 
hippocampus-dependent information. The present study investigated, in rats, 
the e ects of systemic corticosterone administration, 1 h before retention testing, 
on the recognition of two di erent components of information acquired during 
a single object recognition task, namely memory of the training object per se 
(object recognition memory) and memory of the location of the object during 
the training trial (object location memory). Studies on memory consolidation 
indicate that these two components of object recognition memory are processed 
by dissociable memory systems such that the representation of the object itself 
requires information processing within cortical regions, particularly the perirhinal 
and insular cortices, whereas memory regarding the location of the object within 
its context depends primarily on the hippocampus (Murray and Richmond, 2001; 176
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Bermudez-Rattoni et al., 2005; Roozendaal et al., 2010) .   
A second aim of this study was to investigate whether glucocorticoid e ects on 
the retrieval of these two components of object recognition memory depend 
on interactions with the endocannabinoid system. As glucocorticoid e ects on 
memory retrieval are known to have a rapid onset, but also dissipate shortly 
after hormone levels return to baseline (de Quervain et al., 1998; Cai et al., 2006; 
Schutsky et al., 2011), the temporal dynamics of this glucocorticoid e ect do not 
appear to be compatible with their classical genomic mode of action. Many recent 
investigations  are  aimed  at  determining  the  neural  mechanisms  underlying 
such  presumably  nongenomically  mediated  actions  of  glucocorticoids  on 
physiology and behavior. Several studies have now indicated that stress exposure 
or  glucocorticoid  administration  can  launch  a  G-protein-dependent  signaling 
cascade that induces the synthesis of endocannabinoid ligands (Di et al., 2003; 
Di  et  al.,  2005).  Endocannabinoids  are  small  lipid-based  molecules  that  are 
rapidly produced in response to increased neuronal activity. Once released, they 
act as retrograde neurotransmitter and bind to G protein-coupled cannabinoid 
type 1 (CB1) and cannabinoid type 2 (CB2) receptors on presynaptic sites to 
in uence  di erent  brain  functions,  including  neural  plasticity,  learning  and 
memory, and mood (Kano 2009, Freud 2003; Campolongo et al., 2009; Atsak et 
al., 2012a). In a recent study, we demonstrated that the endocannabinoid system 
within the hippocampus is essentially involved in mediating the rapid e ects 
of glucocorticoids on retrieval of contextual fear memory (Atsak et al., 2012b). 
Systemic  corticosterone  administration  elevated  hippocampal  levels  of  the 
endocannabinoid 2-arachidonoylglycerol, whereas a blockade of hippocampal 
CB1 receptors prevented the impairing e ect of glucocorticoid administration 
on retrieval of contextual fear memory. The present study investigated whether 
antagonism  of  CB1  receptors  with  a  systemic  injection  of  its  inverse  agonist 
SR141716  1  h  before  retention  testing  blocks  also  the  impairing  e ects  of 
corticosterone  on  retrieval  of  these  two  components  of  object  recognition 
memory. 177
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METHODS
Animals. Male adult Sprague–Dawley rats (350–430 g at time of training) from 
Charles River Breeding Laboratories (Kisslegg, Germany) were kept individually in 
a temperature-controlled (22oC) colony room and maintained on a standard 12-h 
light: 12-h dark cycle (07:00-19:00 h lights on) with ad libitum access to food and 
water. Training and testing were conducted during the light phase of the cycle 
between 10:00 and 16:00 h. All procedures were performed in compliance with 
the European Communities Council Directive of November 24, 1986 (86/609/EEC) 
and were approved by the Institutional Animal Care and Use Committee of the 
University of Groningen, The Netherlands.
Drug treatment. The  adrenocortical  hormone  corticosterone  (0.3  or  1  mg/kg; 
Sigma-Aldrich)  was  dissolved  either  alone  or  together  with  the  inverse  CB1 
receptor agonist SR141716 (rimonabant, 5 - (4 - chlorophenyl) - 1 - (2,4 - dichloro-
phenyl) – 4 - methyl – N - (piperidin – 1 - yl) - 1H - pyrazole – 3 -carboxamide; 1 mg/
kg; Kemprotec Ltd, Middlesbrough, UK) in a vehicle containing 5% polyethylene 
glycol, 5% Tween-80 and 5% ethanol in saline and administered subcutaneously, 
in a volume of 2 ml/kg, 1 h before the retention test. Doses of corticosterone and 
SR141716 were selected on the basis of prior studies (de Quervain et al., 1998; 
Hauer et al., 2011; Atsak et al., 2012a).
Object recognition and object location retrieval tasks. The experimental apparatus 
was a gray open- eld box (40 cm   40 cm   40 cm) with a sawdust-covered  oor, 
placed in a dimly illuminated room. The objects to be discriminated were white 
glass light bulbs (6 cm diameter and 11 cm length) and transparent glass vials 
(5.5 cm diameter and 5 cm height). All rats were handled for 5 days for 1 min each 
immediately preceding the training day. On the training trial, the rat was placed in 
the experimental apparatus and allowed to explore two identical objects (A1 and 
A2) placed 5 cm away from the corners of the apparatus for 10 min. To avoid the 
presence of olfactory trails, sawdust was stirred and the objects were thoroughly 
cleaned with 70% ethanol between rats. Rat’s behavior was recorded by using 
a video camera positioned above the experimental apparatus. The time spent 
exploring the two objects was taken as a measure of object exploration. Retention 
was tested 24 h after the training trial. Independent groups of rats were tested for 178
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memory of the training object per se (i.e., object recognition memory) and for 
memory of the location of the objects during the training (i.e., object location 
memory). For object recognition memory testing, one copy of the familiar object 
(A3) and a new object (B) were placed at the same location as stimuli during the 
training trial. For object location memory testing, one copy of the familiar object 
(A3) was placed in the middle of the box and the other copy of the familiar object 
(A4  was placed in the same location as during the training trial. All combinations 
and locations of objects were used in a balanced order to reduce potential biases 
due to preference for particular locations or objects. The rat was placed in the 
experimental apparatus for 3 min and the time spent exploring each object and 
the total time spent exploring both objects were scored. Exploration of an object 
was de ned as pointing the nose to the object at a distance of <1 cm and/or 
touching it with the nose. Turning around, climbing or sitting on an object was 
not  considered  as  exploration.  A  discrimination  index  was  calculated  as  the 
di erence in time exploring the novel and familiar object (or location), expressed 
as the ratio of the total time spent exploring both objects. Rats showing a total 
exploration time < 5 s on either training or testing were excluded. To assess the 
rats’ exploratory behavior of the experimental apparatus on the retention test, 
the  oor of the apparatus was divided into four imaginary squares and the total 
number of crossings between quadrants was determined.
Plasma corticosterone levels. Corticosterone levels were determined in parallel 
groups of rats that were injected with corticosterone (0.3 or 1 mg/kg) and/or 
SR141716 (1 mg/kg) and sacri ced 1 h later under pentobarbital (100 mg/kg) 
anesthesia. Trunk blood was collected in tubes containing 0.5 M EDTA and samples 
were centrifuged at 1,900 g at 4°C for 10 min. Plasma was stored at -20°C and 
analyzed for corticosterone using a radioimmunoassay, according to a previously 
described protocol (Lin et al., 2008).
Statistics. All data are expressed as mean ± SEM. Data were analyzed by two-
way analysis of variance (ANOVA) with corticosterone (3 levels) and SR141716 (2 
levels) as between-subject variables. Further analyses used Fisher post-hoc tests 
to determine the source of the signi cance, when appropriate. One-sample t tests 
were used to determine whether the discrimination index was di erent from zero. 
A probability level of < 0.05 was accepted as statistically signi cant. The number 179
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of rats per group is indicated in the  gure legends. 
RESULTS 
Systemic  SR141716  treatment  blocks  corticosterone-induced  retrieval 
impairment of object recognition memory 
This experiment investigated whether corticosterone (0.3 or 1 mg/kg) administered 
systemically 1 h before retention testing, 24 h after training, impairs retrieval of 
object recognition memory and whether concurrent blockade of CB1 receptors 
with SR141716 (1 mg/kg) prevents the corticosterone e ect.  
Training trial: The average time spent exploring the two identical objects on the 
10-min training trial was 29.5 ±1.4 s.  Two-way ANOVA indicated no di erences 
between groups that were subsequently assigned to receive corticosterone and/
or SR141716 (corticosterone: F1,55 = 0.05, P = 0.94; SR141716: F1,55 = 0.01, P = 0.93; 
corticosterone x SR141716: F1,55 = 2.61, P = 0.08). 
Retention  trial:  As  is  shown  in  Fig.  1A,  one-sample  t  test  revealed  that  the 
discrimination  index  of  vehicle-treated  rats  was  signi cantly  di erent  from 
zero (t10 = 7.20, P < 0.0001), indicating that control rats readily discriminated 
the novel object on the 24-h retention test. Two-way ANOVA for discrimination 
index showed no main e ect of corticosterone treatment (F1,55 = 0.14, P = 0.86), 
but a signi cant e ect of SR141716 (F1,55 = 8.18, P = 0.005) as well as a signi cant 
Figure 1. Corticosterone impairs retrieval of object recognition memory and SR141716 blocks this 
e ect. (A) Discrimination index  (%) of rats that were administered either CORT (0.3 or 1 mg/kg) alone 
or together with SR141716 (1 mg/kg) 1 hr before the object recognition retention test. (B) Total 
time spent (s) exploring both objects during the object recognition retention test. (C) The quadrant 
crossings in the experimental apparatus during object recognition retention test. , p < 0.05; 
, p < 0.001 SR141716 groups compared to the corresponding vehicle, *, p <0.05 corticosterone 
compared to vehicle. All data is presented as mean ± SEM (n = 9 -12/group).180
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interaction e ect between these two treatments (F1,55 = 3.31, P = 0.04). Fisher 
post-hoc comparison tests indicated that corticosterone in a dose of 0.3 mg/
kg, but not 1 mg/kg, signi cantly impaired the discrimination index (P < 0.05 
compared to vehicle). Further, one sample t test indicated that rats administered 
this lower dose of corticosterone did not show a preference for the novel object 
(t8 = 0.75, P = 0.47). Corticosterone treatment did not impair the discrimination 
index of rats that were also administered SR141716. The discrimination index of 
rats administered SR141716 alone or together with either dose of corticosterone 
did not di er signi cantly from that of the vehicle group (P > 0.41).
As is shown in Fig. 1B, two-way ANOVA for total exploration of the two objects 
on the retention test revealed a signi cant SR141716 e ect (F1,55 = 16.71, P < 
0.0001), but no corticosterone e ect (F1,55 = 2.61, P = 0.09) or interaction between 
both factors (F1,55 = 0.24, P = 0.78). Corticosterone treatment did not a ect total 
object exploration times, but rats treated with SR141716, irrespective of whether 
they had received corticosterone or not, exhibited less total exploration of the 
objects than rats not administered SR141716 (P < 0.001). Comparably, two-way 
ANOVA for drug e ects on exploration of the experimental apparatus, assessed 
by the number of quadrant crossings on the retention test, revealed a signi cant 
SR141716 e ect (F1,55 = 6.11, P = 0.01), but no corticosterone e ect (F1,55 = 0.56, P 
Figure 2. Cortciosterone impairs retrieval of object location memory and SR141716 blocks this 
e ect. (A) Discrimination index (%) of rats that were administered either CORT (0.3 or 1 mg/kg) alone 
or together with SR141716 (1 mg/kg) 1 hr before the object location memory retrieval. (B) Total 
time spent (s) exploring both objects during the object location retention test. (C) The quadrant 
crossings in the experimental apparatus during object location retention test. All data is presented 
as mean ± SEM. , p < 0.001 SR141716 compared to the corresponding vehicle, ***, p <0.0001 
corticosterone groups compared to vehicle. All data is presented as mean  SEM (n = 9 - 14/group).181
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= 0.57) or interaction between both treatments (F1,55 = 0.01, P = 0.98), indicating 
that SR141716 treatment also reduced general exploration of the experimental 
apparatus (Fig. 1C). 
Systemic  SR141716  treatments  blocks  corticosterone-induced  retrieval 
impairment of object location memory
This experiment investigated, in di erent groups of rats, whether corticosterone 
(0.3 or 1 mg/kg) administered systemically 1 h before retention testing impairs 
retrieval of object location memory and whether concurrent blockade of CB1 
receptors with SR141716 (1 mg/kg) prevents this corticosterone e ect.  
Training trial: The average total exploration time of the two identical objects on 
the 10-min training trial was 33.7 + 1.6 s. Two-way ANOVA indicated no e ect of 
later corticosterone treatment (F2,61 = 2.47, P = 0.09), later SR141716 treatment 
(F1,61 = 0.12, P = 0.72) or interaction between these two treatments (F1,61 = 1.89, P 
= 0.16). 
Retention  trial:  As  is  shown  in  Fig.  2A,  one-sample  t  test  revealed  that  the 
discrimination index of rats administered vehicle 1 h before the retention test 
was signi cantly di erent from zero (t9 = 4.90, P < 0.001), indicating that these 
rats discriminated the object placed in the novel location on the 24-h retention 
test. Two-way ANOVA for discrimination index revealed signi cant main e ects 
of corticosterone (F2,61 = 4.20, P = 0.02) and SR141716 (F1,61 = 17.47, P < 0.0001) 
Figure 3. Plasma corticosterone levels of the rats 1 hr after the administration of CORT (0.3 or 1 mg/
kg) alone or together with SR141716 (1mg/kg). All data is presented as mean ± SEM., p < 0.05 
compared to corresponding vehicle, ***, p <0.0001 corticosterone groups compared to vehicle. All 
data is presented as mean ± SEM (n = 9 -15/group).182
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as well as a signi cant interaction between these two treatments (F1,61 = 6.18, P 
= 0.004). Fisher post-hoc tests indicated that both doses of corticosterone (0.3 
and 1 mg/kg) signi cantly impaired the discrimination index (for both doses: P 
< 0.0001 compared to vehicle). In addition, one-sample t tests indicated that the 
discrimination index of rats treated with corticosterone did not di er signi cantly 
from zero (0.3 mg/kg: t13 = - 0.70, P = 0.49, 1 mg/kg:  t12 = - 0.66, P = 0.51). Highly 
comparable to the  ndings of the  rst experiment, SR141716 treatment blocked 
the impairing e ect of corticosterone on retrieval of object location memory. The 
discrimination index of rats administered SR141716 together with either dose 
of corticosterone was signi cantly higher than those of rats administered the 
corresponding dose of corticosterone alone (for both doses: P < 0.001) and did 
not di er signi cantly from that of vehicle control rats (P > 0.62). 
As is shown in Fig. 2B, two-way ANOVA for the total time spent exploring the two 
objects on the retention test revealed a signi cant SR141716 e ect (F1,61 = 5.26, P 
= 0.02), but no corticosterone e ect (F2,61 = 2.72, P = 0.08) or interaction e ect (F2,61 
= 1.15, P = 0.32). Further, as is shown in Fig. 2C, two-way ANOVA for exploration 
of the experimental apparatus, as assessed by the number of quadrant crossings 
during the test session, indicated a signi cant SR141716 e ect (F1,61 = 4.20, P = 
0.04), but no corticosterone e ect (F2,61 = 1.07, P = 0.38) or interaction between 
these two treatments (F2,61 = 1.17, P = 0.83) (Fig. 1D). Thus, consistent with the 
 ndings of the  rst experiment, whereas corticosterone did not a ect exploration, 
SR141716  treatment  induced  a  general  reduction  in  the  exploration  of  both 
objects and experimental apparatus. 
E ects of corticosterone and SR141716 treatment on plasma corticosterone levels
Fig. 3 shows plasma corticosterone levels assessed 1 h after corticosterone (0.3 
or 1 mg/kg) and SR141716 (1 mg/kg) administration. Two-way ANOVA indicated 
signi cant  e ects  of  corticosterone  (F2,54  =  28.00,  P  <  0.0001)  and  SR141716 
treatments (F1,54 = 8.99, P = 0.004), but no interaction e ect (F2,54 = 0.20, P = 0.81). 
Post-hoc analyses revealed that corticosterone administration dose-dependently 
elevated plasma corticosterone levels. Plasma levels induced by the higher dose 
of corticosterone (1 mg/kg) were signi cantly higher than those of vehicle-treated 
rats (P < 0.0001), whereas plasma corticosterone levels induced by the 0.3 mg/
kg dose of corticosterone just failed to di er signi cantly from those of vehicle 183
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controls (P = 0.06). SR141716 per se signi cantly elevated plasma corticosterone 
levels (P < 0.05 vs. vehicle) and corticosterone treatment further increased these 
levels.  Plasma  corticosterone  levels  of  rats  administered  SR141716  together 
with the 1 mg/kg dose of corticosterone were signi cantly higher than those of 
rats treated with SR141716 only (P < 0.05) and did not di er from those of rats 
administered corticosterone (1 mg/kg) alone (P = 0.24). 
DISCUSSION
The  present  study  investigated  the  e ects  of  glucocorticoid  administration 
on the retrieval of two di erent components of object recognition memory in 
rats. We  found  that  corticosterone  administered  1  h  before  retention  testing 
impaired the retrieval of both object recognition and object location memory, 
without in uencing total exploration time of the objects or general exploration 
of the experimental apparatus. Furthermore, a blockade of CB1 receptors with co-
administration of SR141716 prevented the impairing e ects of corticosterone on 
retrieval of both components of object recognition memory. 
Prior studies investigating stress and glucocorticoid e ects on memory retrieval 
indicated that high circulating levels of glucocorticoids at the time of retention 
testing  impaired  the  recall  of  hippocampus-dependent  spatial/contextual 
information in animals and of declarative information in humans (Roozendaal, 
2002; de Quervain et al., 2009). An essential involvement of the hippocampus, 
which  expresses  high  levels  of  adrenal  steroid  receptors  (McEwen,  2001),  in 
regulating glucocorticoid e ects on memory retrieval of spatial and contextual 
information was further demonstrated by  ndings of pharmacological studies in 
rats indicating that the administration of corticosterone or selective GR agonists 
directly into the dorsal hippocampus shortly before retention testing induced 
comparable memory retrieval impairment (Roozendaal et al., 2003; Roozendaal 
et al., 2004a; Schutsky et al., 2011). Furthermore, human neuroimaging studies 
indicated that cortisone administered shortly before recall testing reduced activity 
of the parahippocampal gyrus, an e ect that was associated with impaired cued 
recall of words (de Quervain et al., 2003; Oei et al., 2007). In contrast, the few human 
studies that investigated the e ect of cortisol on recall of recognition memory 
reported  nding only modest and nonsigni cant impairment (de Quervain et al., 184
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2000; de Quervain et al., 2003; Buchanan et al., 2006). Collectively, these  ndings 
led to the suggestion that glucocorticoids might preferably impair the retrieval of 
hippocampus-dependent memories. 
Our current  ndings indicating that corticosterone administration impaired not 
only the retrieval of object location memory but also of object recognition memory 
suggest that glucocorticoids might have a more general inhibitory in uence on 
memory retrieval. As the corticosterone did not a ect either total exploration of 
the objects or of the experimental apparatus, the impaired discrimination index is 
thus not caused by any general in uence of corticosterone on exploratory behavior 
or a reduced interest of the rats in the objects. Rather, the  ndings are consistent 
with  the  view  that  corticosterone  impaired  neural  processes  underlying  the 
retrieval of recognition memory. The corticosterone-induced retrieval impairment 
of object location memory is likely mediated by the hippocampus. On the other 
hand, cortical regions, particularly the perihinal and insular cortices, are broadly 
implicated in both the consolidation and recall of object recognition memory 
(Baxter and Murray, 2001; Winters et al., 2008). Recently, we reported a double 
dissociation  between  the  e ects  of  pharmacological  activation  of  the  insular 
cortex and hippocampus and the enhanced consolidation of object recognition 
and object location memory, respectively (Roozendaal et al., 2010). Findings of 
other studies indicated that posttraining administration of corticosterone or GR 
agonists in the insular cortex also enhance the consolidation of object recognition 
memory (Roozendaal et al., 2010) as well as that of memory of other training   
(Miranda et al., 2008; Roozendaal et al., 2010). Although prior studies have not 
examined the e ects of glucocorticoid infusions into these cortical regions on 
memory retrieval, it seems likely that the systemically administered corticosterone 
might have acted directly upon the insular and/or perirhinal cortex in inducing 
retrieval impairment of object recognition memory (Winters et al., 2008). However, 
some  lesion  studies  suggested  also  an  involvement  of  the  hippocampus  in 
object recognition memory (Broadbent et al., 2004). Although very large lesions, 
destroying  75-100  %  of  the  hippocampal  volume,  were  necessary  to  induce 
impairment on an object recognition task, we cannot completely exclude the 
possibility that the hippocampus has a role in regulating glucocorticoid e ects 
on the retrieval of both components of recognition memory. Nevertheless, our 
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di er with the small and nonsigni cant recognition de cits observed in human 
studies. As recognition memory paradigms in humans are typically rather simple 
compared to free or cued recall tasks and glucocorticoids are known to induce 
impairment of recall performance only when the task is su ciently demanding 
(Diamond et al., 1999; de Quervain et al., 2000; de Quervain et al., 2003; Buchanan 
et al., 2006), the discrepancy between the relative absence of a glucocorticoid 
e ect on recognition memory in humans and our  ndings is possibly explained 
by a di erence in the demand of the tasks employed. 
Our   ndings  further  indicate  that  the  endocannabinoid  system  is  essentially 
involved in mediating the impairing e ects of glucocorticoids on retrieval of 
these two components of recognition memory. We found that the administration 
of the inverse CB1 receptor agonist SR161714 blocked the impairing e ect of 
corticosterone on retrieval of both object recognition and object location memory. 
The  nding that SR141716 also reduced total exploration of the objects and 
experimental apparatus, without directly a ecting the preference for the novel 
object or location, is in line with previous reports indicating that CB1 blockade 
in uences habituation and explorative behaviors (Kamprath et al., 2006). Our 
 ndings add to the increasing evidence indicating the existence of bidirectional 
and functional interactions between glucocorticoids and the endocannabinoid 
system (Patel, 2004; Hill and McEwen, 2009; Evanson et al., 2010; Hill and McEwen, 
2010; Hill et al., 2010b). Prior  ndings show that glucocorticoids, possibly by 
activating a GR on the cell membrane, rapidly elevate endocannabinoid levels in 
speci c brain regions (Hill et al., 2010a; Atsak et al., 2012b; Wang et al., 2012). The 
released endocannabinoids then activate CB1 receptors on presynaptic sites to 
a ect neuronal function (Freund et al., 2003; Kano et al., 2009). CB1 receptors are 
abundantly present in memory-related brain regions such as the hippocampus, 
amygdala and cortex (Katona et al., 1999; Katona et al., 2000; Katona et al., 2001). In 
a previous study (Atsak et al., 2012a), we reported that endocannabinoid signaling 
within the hippocampus is essentially involved in mediating the impairing e ects 
of glucocorticoids on retrieval of highly arousing contextual fear memory. Here, 
we  extend  these   ndings  and  show  that  endocannabinoid  signaling  is  also 
involved in mediating glucocorticoid e ects on retrieval of non-aversive object 
recognition memory. 186
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As  the  endocannabinoid  system  is  also  implicated  in  regulating  the  stress 
response; particularly, a suppression of endocannabinid signaling is known to 
alter hypothalamic-pituitary-adrenal (HPA) axis activity (Patel, 2004; Steiner et 
al., 2008; Hill and McEwen, 2010; Hill et al., 2011), we determined plasma levels 
of corticosterone in parallel groups of animals 1 h following drug treatment. 
Our   nding  that  SR141716  treatment  alone  elevated  plasma  corticosterone 
levels is consistent with previous evidence indicating that a genetic disruption 
or pharmacological blockade of CB1 receptor signaling also increases HPA-axis 
activity  (Hill  and  McEwen,  2010).  However,  as  SR141716-treated  rats,  despite 
having  higher  corticosterone  levels,  did  not  show  impairment  of  memory 
retrieval on either the object recognition or object location tasks, these  ndings 
demonstrate that SR141716 did not rescue the glucocorticoid-induced memory 
retrieval  impairment  by  altering  HPA-axis  activity  and  resultant  circulating 
corticosterone levels. Thus, consistent with our previous  ndings indicating that 
local infusion of CB1 antagonist into the hippocampus blocked corticosterone 
e ects on memory, in the present study systemic SR141716 administration likely 
prevented the glucocorticoid-induced memory retrieval impairment by directly 
blocking endocannabinoid signaling in memory-related brain regions. 
In  summary,  the  present   ndings  that  corticosterone  administration  impairs 
the retrieval of both object recognition and object location memory show that 
glucocorticoids  might  in uence  memory  retrieval  processes  more  generally 
than previously thought. Our  ndings also provide strong support for the view 
that endocannabinoid signaling is a common mediator of rapid, nongenomic 
glucocorticoids e ects on adaptive responses to stress, behavior and memory 
(Hill et al., 2010a; Tasker and Herman, 2011; Atsak et al., 2012a; Atsak et al., 2012b). 187
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1. Summary
1.1. Endocannabinoids mediate nongenomic glucocorticoid e ects on memory 
consolidation
Substantial evidence indicates that glucocorticoids, along with other components 
of the stress response, are critically involved in regulating the consolidation of 
memory of emotionally arousing experiences (Flood et al., 1978; de Kloet, 2000; 
Roozendaal, 2000; McGaugh and Roozendaal, 2002; Roozendaal, 2002; Het et 
al., 2005; Sandi and Pinelo-Nava, 2007; de Quervain et al., 2009; Roozendaal et 
al., 2009). Such glucocorticoid-induced enhancement of memory consolidation 
seems to entail the selective activation of the low-a nity glucocorticoid receptor 
(GR) (Oitzl and de Kloet, 1992; Roozendaal and McGaugh, 1997). Accordingly, 
the activation of GRs by agonists administered into many di erent brain regions 
has been reported to enhance memory consolidation of many di erent kinds of 
emotionally arousing learning experiences, including inhibitory avoidance (IA), 
contextual and cued fear conditioning, water-maze spatial and cued training, 
object recognition and conditioned taste aversion (Roozendaal et al., 2006a). 
Glucocorticoids are thought to modulate neurophysiology and behavior through 
both genomic and nongenomic pathways (de Kloet, 2000; Dallman, 2005) and 
recently  the  endocannabinoid  system  emerged  as  a  potential  candidate  to 
regulate some of the nongenomic actions of glucocorticoids. A single injection 
of a stress dose of glucocorticoids is known to rapidly boost up endocannabinoid 
signaling within limbic brain regions. Previous  ndings indicate that elevated 
endocannabinoid levels within hypothalamic regions are important in mediating 
glucocorticoid-induced  fast  inhibition  of  the  hypothalamic–pituitary–adrenal 
(HPA) axis (Tasker and Herman, 2011). In chapter 4, we showed that the CB1 
receptor antagonist AM251 administered into the basolateral amygdala (BLA) 
after IA training blocked the memory–enhancing e ect of the GR agonist RU 
28362. These  ndings extend previous evidence indicating that CB1 receptor 
blockade  in  the  BLA  prevents  the  memory-enhancing  e ects  of  systemically 
administered  corticosterone  (Campolongo  et  al.,  2009).  Thus  these  results 
indicate that endocannabinoid signaling within the BLA is essentially involved 
in regulating the memory-enhancing e ects of glucocorticoids. Furthermore, we 
found that a blockade of CB1 receptors in the BLA immediately after IA training 
also  prevented  the  memory-enhancing  e ects  of  a  coadministration  of  the 196
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membrane-impermeable ligand Cort:BSA. Based on these  ndings, it appears 
that the memory-enhancing e ects of glucocorticoids most likely involve the 
activation of a GR on the cell surface. Consistent with these  ndings, Tasker and 
colleagues reported that the activation of a membrane GR launches a G-protein-
dependent  signaling  cascade  that  induces  the  synthesis  of  endocannabinoid 
ligands (Di et al., 2003; Evanson et al., 2010). Collectively, these data suggest 
that the activation of the endocannabinoid system by post-training GR agonist 
infusions within the BLA might have mediated the memory-enhancing e ects of 
glucocorticoids. 
Other stress-activated response systems such as central corticotropin-releasing 
factor (CRF) are also potent modulators of memory consolidation (Roozendaal 
and McGaugh, 2011). In chapter 4, we also demonstrated that the CB1 receptor 
antagonist  AM251  administered  into  the  BLA  after  IA  training  blocked  the 
memory-enhancing e ect of concurrently administered CRF6-33, indicating that 
the endocannabinoid system is also required for enabling the enhancing e ects 
of other stress-related systems on memory consolidation. However, as we discuss 
in  that  chapter,  it  is  possible  that  glucocorticoids  interact  with  the  memory-
enhancing e ects of CRF receptor activation via an endocannabinoid-dependent 
mechanism.
Since arousal-induced noradrenergic activity is crucially required for enabling 
glucocorticoid  e ects  on  memory  consolidation  (Roozendaal  and  McGaugh, 
2011), we set out to explore interactions between the endocannabinoid and 
noradrenergic  systems  to  examine  whether  endocannabinoids  mediate  the 
rapid  actions  of  glucocorticoids  on  the  noradrenergic  system  in  enhancing 
memory  consolidation.  We  found  that  the  CB  agonist  WIN55,212-2  infused 
into the BLA immediately after an IA learning experience enhanced memory 
consolidation; however, immediate posttraining infusions of the `-adrenoceptor 
antagonist  propranolol  blocked  the  enhancing  e ect  of  WIN55,212-2  on 
memory consolidation. Conversely, the CB1 receptor antagonist AM251 infused 
into the BLA, as with a GR antagonist shifted the dose-response e ects of the 
 -adrenoceptor agonist clenbuterol such that a much higher dose of clenbuterol 
was required to induce memory enhancement. These  ndings strongly suggest 
that  glucocorticoids,  via  an  endocannabinoid-dependent  mechanism,  render 197
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the  BLA  more  sensitive  to  the  memory-enhancing  e ects  of  noradrenergic 
stimulation. 
Moreover,  arousal-induced  noradrenergic  activity  is  tightly  linked  to  an 
activation of the intracellular protein kinase A pathway and thereby leads to the 
phosphorylation of cAMP response binding element (pCREB) protein. Previous 
 ndings indicated that glucocorticoids increase pCREB activation in the BLA via an 
interaction with the noradrenergic system (Roozendaal et al., 2006b). Many  ndings 
support the view that an activation of the transcription factor CREB initiates gene 
expression important for memory formation. For example, interference with CREB 
activation through genetic or pharmacological manipulations leads to memory 
impairment,  whereas  an  activation  of  CREB  is  associated  with  an  enhanced 
memory formation (Silva et al., 1998; Bozon et al., 2003; Josselyn et al., 2004). As 
glucocorticoids are known to increase pCREB activation via an interaction with 
arousal-induced norepinephrine, we tested whether CB1 receptor antagonism 
would block the corticosterone-induced increase in pCREB expression within the 
BLA. We found that CB1 receptor blockade with a systemic injection of SR141716 
prevented the increase in pCREB expression in the BLA as well as blocked the 
memory-enhancing e ects of corticosterone. These  ndings clearly indicate that 
endocannabinoids enhance the consolidation of memory via an interaction with 
the noradrenergic system. 
Endocannabinoids have been suggested to in uence noradrenergic function via 
an inhibition of GABAergic transmission (Campolongo et al., 2009; Hill and McEwen, 
2009; Atsak et al., 2012b). CB1 receptors are abundantly present on local inhibitory 
GABAergic interneurons in the BLA (Katona et al., 2001; McDonald and Mascagni, 
2001). A recent study indicated that CB1 receptors are particularly enriched in axon 
terminals of cholecystokinin (CCK)-positive interneurons and form invaginating 
perisomatic synapses with pyramidal neurons in the BLA (Yoshida et al., 2011). 
CCK-positive interneurons have been proposed to function as  ne-tuning devices 
for the cooperation of pyramidal neurons, which are sensitive to the emotional 
and motivational state of the animal (Freund et al., 2003). Various studies have 
reported that an activation of CB1 receptors regulates long-term depression at 
inhibitory synapses and decreases GABAergic synaptic transmission (Katona et al., 
1999; Ohno-Shosaku et al., 2001; Freund and Hajos, 2003). Substantial evidence 198
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demonstrates that an inhibition of local GABAergic circuits in the BLA enhances 
memory consolidation (Brioni et al., 1989; Castellano et al., 1989; McGaugh, 2004) 
by  increasing  the  release  of  norepinephrine  from  presynaptic  sites  (Hat eld 
et  al.,  1999).  Additionally,  GABAergic  receptor  antagonists  are  known  to  act 
postsynaptically to increase the excitability of BLA pyramidal neurons (Azad et al., 
2004; Pistis et al., 2004; Zhu and Lovinger, 2005; Yoshida et al., 2011). These  ndings, 
together with the evidence that glucocorticoids and CRF enhance the excitability 
of  BLA  pyramidal  neurons  by  decreasing  the  impact  of  inhibitory  GABAergic 
in uences (Rainnie et al., 1992; Duvarci and Paré, 2007), support the hypothesis 
that nongenomically mediated actions of glucocorticoids on the noradrenergic 
system require a rapid increase in endocannabinoid signaling within the BLA to 
e ectively shut o  local inhibitory GABAergic interneurons. Such a suppression 
of GABAergic activity might then result in augmented noradrenergic signaling in 
BLA pyramidal neurons and an enhanced consolidation of long-term memory of 
emotionally arousing experiences. 
1.2. Endocannabinoids mediate nongenomic glucocorticoid e ects on memory 
retrieval
Opposite  to  the  enhancing  e ects  of  glucocorticoids  on  the  consolidation 
of  memory,  stress  or  pharmacologically  induced  increases  in  glucocorticoid 
levels exert temporary impairment of retrieval of memory of contextual/spatial 
information in rats and declarative information in human subjects (de Quervain 
et al., 1998; de Quervain et al., 2000b; Roozendaal et al., 2003; Roozendaal et al., 
2004a; Roozendaal et al., 2004b; de Quervain et al., 2009). Since the hippocampus 
has long been implicated in the retrieval of contextual/spatial and declarative 
memory (Holt and Maren, 1999; Corcoran and Maren, 2001) and expresses high 
levels of adrenal steroid receptors (McEwen, 2001), these  ndings have been taken 
to suggest that hippocampus-dependent memories are particularly sensitive to 
the disruptive e ects of glucocorticoids. An involvement of the hippocampus in 
regulating glucocorticoid e ects on memory retrieval of spatial and contextual 
information was further shown by  ndings of pharmacological studies in rats 
indicating that corticosterone or selective GR agonists administered directly into 
the dorsal hippocampus shortly before retention testing induces comparable 
memory retrieval impairment (Roozendaal et al., 2003; Roozendaal et al., 2004a; 
Schutsky et al., 2011). In Chapter 5, we reported that systemic corticosterone 199
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induces dose-dependent retrieval impairment of contextual fear memory without 
in uencing the retrieval of hippocampus-independent auditory fear memory. 
The  ndings of other studies investigating whether glucocorticoids might impair 
memory retrieval on hippocampus-independent learning tasks are consistent with 
our current observation that glucocorticoids seem to have little or no e ect on 
retrieval of auditory fear memory or other hippocampus-independent memories 
(Kirschbaum et al., 1996; Schutsky et al., 2011). Since both tasks employed the 
same behavior (freezing) as an index of memory, these results further strengthen 
the view that the glucocorticoid administration speci cally impaired the retrieval 
of memory, rather than nonselectively altering the expression of the behavior. 
Evidence    indicates    that  glucocorticoids  selectively  impair  the  retrieval  of 
emotionally  arousing,  but  not  neutral,  information  because  of  an  essential 
interaction  with  arousal-induced  noradrenergic  activation.  For  instance, 
`-adrenoceptor  antagonist  administered  systemically  or  directly  into  the 
hippocampus  blocks  the  impairing  e ects  of  glucocorticoids  on  memory 
retrieval (Roozendaal et al., 2004a; Roozendaal et al., 2004b). Similarly, human 
studies indicated that the  -adrenoceptor antagonist propranolol blocked the 
impairing  e ect  of  cortisone  on  retrieval  of  emotionally  arousing  words  (de 
Quervain  et  al.,  2007).  Overall  these  studies  indicate  an  essential  interaction 
between  the  noradrenergic  and  glucocorticoid  systems  in  mediating  stress 
e ects on memory retrieval. However the induction of noradrenergic activity 
by glucocorticoids occurs too rapid to be mediated by the classical genomic 
mechanism of glucocorticoids (McReynolds et al., 2010). Recently, there has been 
a  growing  interest  in  endocannabinoids  as  a  potential  candidate  to  mediate 
these rapid glucocorticoid e ects on noradrenergic activity (Atsak et al., 2012b). 
In chapter 5, we provide novel and convincing evidence for a critical involvement 
of hippocampal endocannabinoid signaling in mediating glucocorticoid-induced 
impairment of memory retrieval. We showed that a blockade of hippocampal 
CB1 receptors by local infusions of AM251 prevented the impairing e ects of 
systemically administered glucocorticoids on retrieval of contextual fear memory, 
whereas  the  corticosterone  induced  a  signi cant  elevation  in  hippocampal 
2-arachidonoylglycerol (2-AG), but not anandamide (AEA), levels in the same time 
course of retention test. In order to determine whether endocannabinoids mediate 
the e ects of glucocorticoids on the noradrenergic system, we further examined 200
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possible interactions between the endocannabinoid and noradrenergic systems 
on retrieval of contextual fear memory. We showed that the CB receptor agonist 
WIN55,212-2 infused into the hippocampus 1 h before retention testing impaired 
the retrieval of contextual fear memory; however, co-infusion of the `-adrenoceptor 
antagonist propranolol blocked the impairing e ects of    WIN55,212-2. Conversely, 
the CB1 receptor antagonist AM251 infused into hippocampus together with 
an impairing dose of norepinephrine failed to abolish the impairing e ect of 
norepinephrine  on  memory  retrieval.  Collectively,  these  data  indicate  that 
endocannabinoids interact with the noradrenergic system in in uencing memory 
retrieval and that the noradrenergic system appears to be located downstream, at 
least functionally, from the endocannabinoid system. Several other studies have 
reported that systemic or local administration of cannabinoid analogs increases 
the release of norepinephrine in speci c brain regions (Oropeza et al., 2005; Page 
et al., 2007; Carvalho and Van Bockstaele, 2012). Although the mechanism of 
how cannabinoids boost up the release of norepinephrine is not entirely clear, 
one possibility is a direct e ect of cannabinoid analogs on the locus coeruleus 
(LC) (Mendiguren and Pineda, 2004; Mendiguren and Pineda, 2006; Muntoni et 
al., 2006). It has been shown that the administration of the CB1 reverse agonist 
SR141716A causes a signi cant reduction of spontaneous  ring of LC neurons, 
suggesting that the LC might be under control of an endogenous cannabinoid 
tone. 
Endocannabinoids also in uence other neurotransmitter systems, for instance, 
the e ects on glutamate and GABA are well described (Hashimotodani et al., 
2007; Kano et al., 2009). Thus, another possibility is that endocannabinoids exert 
their in uence on the noradrenergic system indirectly by  rst a ecting other 
neurotransmitter systems. For instance, within the BLA and hippocampus, CB1 
receptors are predominantly located on GABAergic terminals and activation of 
these receptors decreases GABA release (Ohno-Shosaku et al., 2001; Freund et 
al., 2003; Kano et al., 2009) via a rapid inhibition of Ca2+ in ux into the terminals 
(Ho man and Lupica, 2000; Wilson et al., 2001). Furthermore, as described above, 
it has been reported that the amygdalar GABAergic system modulates memory 
consolidation  (McGaugh  and  Roozendaal,  2002)  and  that  an  inhibition  of 
GABAergic activity within the BLA enhances memory consolidation by increasing 
the release of norepinephrine (Hat eld et al., 1999). In view of this evidence, it is 201
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suggested that endocannabinoids can stimulate the release of norepinephrine 
by  binding  to  presynaptically  located  CB1  receptors  on  GABAergic  terminals, 
thereby inhibiting the release of GABA (Campolongo et al., 2009; Hill and McEwen, 
2009; Atsak et al., 2012b). Collectively, these  ndings strongly suggest that the 
endocannabinoid  system  might  mediate  glucocorticoid  e ects  on  memory 
retrieval via an in uence on the noradrenergic system.
Very few studies investigated the e ect of glucocorticoids on recall of recognition 
memory.  In contrast to the e ects seen on retrieval of declarative and contextual 
memory, these studies reported small and nonsigni cant e ects of glucocorticoids 
on the retrieval of this kind of memory (de Quervain et al., 2000a; de Quervain 
et al., 2003; Buchanan et al., 2006). Therefore, in chapter 6, we investigated the 
e ects  of  systemic  corticosterone  administration  on  the  recognition  of  two 
di erent components of information acquired during object recognition training, 
i.e., memory of the object per se and memory of the location of the object. We 
found that corticosterone, administered 1 h before retention testing, impaired 
the retrieval of both aspects of object recognition memory. Studies on memory 
consolidation indicate that these two components of object recognition memory 
are  processed  by  dissociable  memory  systems  such  that  the  representation 
of  the  object  itself  requires  information  processing  within  cortical  regions, 
particularly the perirhinal and insular cortices, whereas memory regarding the 
location of the object within its context depends primarily on the hippocampus 
(Murray and Richmond, 2001; Bermudez-Rattoni et al., 2005; Roozendaal et al., 
2010). Thus, it is possible that glucocoticoids might have impaired the retrieval 
of these two components of object recognition memory by acting onto di erent 
brain regions. However, as some lesion studies suggested also an involvement 
of the hippocampus in object recognition memory (Broadbent et al., 2004), the 
possibility that the hippocampus takes a role in regulating glucocorticoid e ects 
on the retrieval of both components of recognition memory cannot be excluded 
at the present time. Importantly, we also demonstrated that systemic blockade of 
CB1 receptors with SR141716 prevented the impairing e ects of glucocorticoids 
on retrieval of both aspects of recognition memory. These results suggest that 
the endocannabinoid system is essentially involved in regulating the impairment 
of retrieval of recognition memory, possibly by in uencing di erent memory-
related brain regions. 202
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1.3. Comparison of the two models
The  ndings discussed thus far demonstrate that the endocannabinoid system 
is  crucially  involved  in  regulating  glucocorticoid  e ects  on  both  memory 
consolidation  and  memory  retrieval.  Glucocorticoids  rapidly  launches  the 
activation of the endocannabinoid system in di erent brain regions including the 
hippocampus and amygdala (Hill et al., 2010), possibly through a nongenomic 
mechanism involving a Gs-coupled membrane-bound receptor (Di et al., 2003; 
Di et al., 2005a; Di et al., 2005b; Malcher-Lopes et al., 2006; Di et al., 2009). This 
increased endocannabinoid signaling might mediate the modulatory e ects on 
both memory consolidation and memory retrieval via rapid interactions with the 
noradrenergic system. Thus, the described models for endocannabinoid regulation 
of glucocorticoid e ects seem to be highly similar for memory consolidation 
and  retrieval.  However,  although  not  explored  in  this  thesis,  there  might  be 
subtle but important di erences. For example, depending on the brain region 
investigated endocannabinoids can a ect neurotransmitter systems other than 
GABA. Both in the hippocampus and BLA, CB1 receptors are abundantly present 
in GABAergic and into a minor extent glutamatergic cells and the activation of 
CB1 receptors can modify the release of both neurotransmitters (Katona et al., 
1999; Katona et al., 2001; Azad et al., 2003; Kawamura et al., 2006; Kano et al., 
2009). The glucocorticoid-induced fast inhibition of the HPA axis is mediated by an 
endocannabinoid-dependent inhibition of glutamatergic inputs to CRF-releasing 
cells within the paraventricular nucleus (Tasker and Herman, 2011). Since we did 
not investigate the neurotransmitter systems mediating the endocannabinoid 
e ects  on  memory  consolidation  and  memory  retrieval,  it  remains  unknown 
whether  glucocorticoid-induced  changes  in  endocannabinoid  signaling 
underlying memory consolidation and memory retrieval rely predominantly on 
GABAergic, glutamatergic or yet another neurotransmitter systems.  
Additionally,  some  studies  suggested  that  di erent  endocannabinoid  ligands 
might mediate di erent physiological processes. Thus another possible unexplored 
distinction between the two mechanisms can be the exact endocannabinoid 
ligand  mediating  the  glucocorticoid  e ects  on  memory  consolidation  and 
memory retrieval. This suggestion originated particularly from studies indicating 
that endogenous AEA and 2-AG ligands are di erently modulated by emotional 203
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stimuli  (Marsicano  et  al.,  2002;  Busquets-Garcia  et  al.,  2011).  Some  evidence 
indicated that stress and glucocorticoids might induce di erent e ects on AEA 
and 2-AG levels in brain regions like the amygdala, hippocampus and prefrontal 
cortex. For instance, a single episode of stress was reported to decrease AEA levels 
in the amygdala without changing 2-AG levels. Taking into account the anxiolytic 
e ects of inhibitors of the AEA-catalyzing enzyme fatty acid amide hydrolase 
(Kathuria et al., 2003), the decline in AEA signaling that occurs in response to 
stress is taken to contribute to increased emotional and anxiety-like behaviors 
that  accompany  stress  exposure  (Hill  and  McEwen,  2010).  However,  a  single 
glucocorticoid injection induces a di erent response pattern and rapidly elevates 
AEA levels without altering the 2-AG levels. These results are taken to suggest that 
glucocorticoids might be functioning to reinstate homeostasis after stress (Hill 
and McEwen, 2010). 
Some  studies  also  reported  that  AEA,  rather  than  2-AG,  is  implicated  in  the 
e ects  of  cannabinoids  on  memory  consolidation.  For  example,  systemic 
pharmacological manipulation of AEA tone has been implicated in regulating 
the modulatory e ects of endocannabinoids on memory consolidation (Costanzi 
et al., 2004; Busquets-Garcia et al., 2011). Moreover, rats trained on an IA task 
had higher levels of AEA in the BLA than rats that were only exposed to the IA 
context. Post-training infusions of the AEA-hydrolysis inhibitor URB597 into the 
BLA, increasing AEA levels, resulted in an enhanced memory consolidation of 
IA training (Morena et al, unpublished observation). Taken together, it is thus 
possible that AEA might be the major endocannabinoid mediating the memory-
enhancing e ects of post-training infusions of GR agonist (chapter 4). In contrast, 
in chapter 5 we reported that the administration of an retrieval impairing dose 
of corticosterone shortly before memory retrieval testing selectively increased 
hippocampal levels of 2-AG without a ecting those of AEA. Thus, such  ndings 
suggest the intriguing possibility that AEA might be predominantly involved in 
regulating the enhancing e ects of glucocorticoids on memory consolidation, 
whereas 2-AG might be more involved in regulating glucocorticoid e ects on 
memory retrieval impairment. Further, it cannot be excluded that an involvement 
of AEA relative to 2-AG in regulating glucocorticoid e ects on di erent memory 
functions is also highly dependent on the brain region investigated. 204
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2. Other Mediators of Nongenomic Glucocorticoid Actions 
The   ndings  presented  in  this  thesis  show  that  endocannabinoids,  released 
upon activation of a membrane GR, are an important regulator of nongenomic 
glucocorticoid actions on di erent memory processes. However, there are also 
other known mediators of nongenomic actions of glucocorticoids. A recent study 
reported that activation of membrane GRs evokes the release of nitric oxide, another 
retrograde messenger, from pyramidal cells in the hippocampus (Hu et al., 2010). 
This released nitric oxide di uses back to the presynaptic membrane and rapidly 
induces the release of GABA from hippocampal interneurons and hypothalamic 
magnocellular neurons (Di et al., 2009; Hu et al., 2010). Glucocortiocoids also 
enhance glutamate transmission in hippocampal CA1 pyramidal neurons in the rat 
(Karst et al. 2005). Since this rapid steroid e ect is eliminated by pharmacological 
blockade of mineralocorticoid receptors (MRs) and furthermore is lost in mice 
with a  conditional knockout of the MR in the forebrain, but not of the GR (Karst et 
al., 2005; Olijslagers et al., 2008), this rapid corticosteroid e ect is likely mediated 
by a direct activation of a presynaptic membrane-associated MR. This membrane-
associated MR has a 10-fold lower a nity than the regular MR which means its 
occupation, like of the GR, is more prevalent during stress compared to basal 
conditions (Kloet 2000). Di erent from nongenomic membrane GR e ects, this 
fast MR-mediated e ect on glutamatergic transmission has been shown to be 
endocannabinoid independent (Karst et al., 2010). 
Evidence is accumulating in support of a postsynaptically located MR mediating 
fast glucocorticoids e ects on various aspects of AMPA receptor tra cking (Groc 
et al., 2008). AMPAs are ionotropic glutamate receptors that mediate the majority 
of fast excitatory transmission in the brain. They are heterotetramers, comprised 
of a combinatorial assembly of four subunits, GluR1–GluR4, in which GluA1 and 
GluA2 are essentially linked to the formation of emotional memories (Wisden 
and Seeburg, 1993; Hollmann and Heinemann, 1994). Glucocorticoids, via an 
MR-dependent  mechanism,  have  been  shown  to  facilitate  AMPA  tra cking, 
in particular, by increasing the membrane expression and synaptic insertion of 
GluA2 subunits (Groc et al., 2008; Krugers et al., 2010; Joels et al., 2011). Moreover, 
norepinephrine also targets AMPA receptors. Considerable evidence indicates 
that norepinephrine facilitates the phosphorylation of the AMPA subunit GluA1 205
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by activating protein kinase A and calcium/calmodulin kinase II/ protein kinase 
C (Hu et al., 2007; Joels et al., 2011). It is known that phosphorylation of GluA1 
promotes AMPA-receptor tra cking to synapses and contributes to the synaptic 
strengthening and the induction of long-term potentiation (Barry and Zi , 2002; 
Song and Huganir, 2002; Bredt and Nicoll, 2003; Malenka and Bear, 2004). These 
e ects of norepinephrine on AMPA signaling have been proposed to underlie 
the  mechanism  of  how  emotions  enhance  memory  (Hu  et  al.,  2007).  Since 
glucocorticoids rapidly facilitate arousal-induced norepinephrine release, they 
can also exert indirect e ects on AMPA signaling through norepinephrine. Future 
experimentation is required to further address these questions. 
3. Convergence of genomic and nongenomic glucocorticoid e ects
Although the nongenomic e ects of glucocorticoids recently became in sight 
again (Dallman, 2005), in the classical perspective, glucocorticoids are broadly 
renowned  for  their  genomic  (delayed)  e ects.  Glucocorticoids  regulate  gene 
transcription  by  activating  MRs  and  GRs,  functioning  either  as  homodimers 
or  heterodimers,  interact  at  a  glucocorticoid-response  element  and  recruit 
corepressors or coactivators, whereas GR monomers interact with stress-induced 
transcription factors or other proteins to dampen their transcriptional activity. 
The  rst step that leads to their ultimate e ect on adaptive behavior involves 
the altered expression of responsive genes. Recently, a study performed with 
large-scale  gene-expression-pro ling  methods  identi ed  glucocorticoid-
responsive genes in the hippocampus. The activation of MRs or GRs, mimicking 
the physiological conditions, resulted in waves of gene regulation, with both 
transactivation and transrepression of responsive genes (Datson et al., 2008). 
Although GR binds to genomic DNA autonomously, recent data show that the 
binding pro le of GR is pre-determined by chromatin state and thus depends on 
the accessibility of the chromatin (John et al., 2011). These  ndings indicate that 
glucocorticoids coordinate the expression of high- and medium-abundant genes 
that underlie aspects of cell metabolism, structure and synaptic transmission and 
through these a ects many processes in di erent brain regions. 
Through  activating  GRs  and  through  rapid  interactions  with  arousal-induced 
norepinephrine,  glucocorticoids  activate  the  cAMP-dependent  protein  kinase 
(PKA) pathway and subsequently increase levels of pCREB (Roozendaal et al., 206
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2006a). As mentioned before, pCREB is highly linked to memory formation and 
changes the transcription of many genes. Glucocorticoids, via a nongenomic, 
CREB-dependent  mechanism  increase  histone  acetylation  that  leads  to 
enhanced  synaptic  plasticity  and  long-term  memory  formation  (Vecsey  et 
al., 2007; Roozendaal et al., 2010). In chapter 4, we showed that a blockade of 
endocannabinoid  signaling  by  a  speci c  receptor  antagonist  prevents  the 
corticosterone-induced pCREB activation in the BLA. These  ndings suggest that 
membrane GR-associated release of endocannabinoids activate pCREB, possibly 
via an interaction with norepinephrine, that might converge with the DNA-binding 
capacity of nuclear GRs, ultimately resulting in genomic e ects of glucocorticoids. 
Nongenomic and genomic actions can still interact or converge together even 
if they occur in di erent time frame, this eventually determines glucocorticoid 
e ects to be highly time dependent. Based on the baseline activity, which means, 
whether there is already a modi ed state by genomic actions of glucocorticoids, 
the direction of glucocorticoid e ects on certain cellular processes can be entirely 
opposite. For instance, corticosterone given immediately before the induction 
of long-term potentiation (LTP) stimulates synaptic strengthening (Wiegert et 
al., 2006), whereas corticosterone applied hours earlier inhibits the induction 
of  the  same  type  of  LTP  (Diamond  et  al.,  1992;  Pavlides  et  al.,  1993).  Thus, 
electrophysiological data suggested that after a stressful event corticosterone 
quickly  enhances  glutamatergic  transmission  in  the  hippocampus  through 
nongenomic mechanism and later on reinstates cellular activity through genomic 
GR mechanims (Karst et al., 2010). Similarly, a human imaging study reported 
that hydrocortisone desensitizes amygdala responsivity during the processing of 
fearful facial expression in a rapid fashion, while it normalizes the response slowly 
in a time frame compatible with its genomic e ects (Henckens et al., 2010).
Some evidence indicates that the outcome of interactions between glucocorticoids 
and norepinephrine can also be highly time dependent. Electrophysiological data 
suggest that if corticosterone is given together with isoproterenol (`-adrenoceptor 
agonist) as similar to the physiological condition during stress, it facilitates LTP 
in the hippocampus (Pu et al., 2007). However if corticosterone is given some 
hours prior to the isoproterenol, as it can occur in certain clinical conditions or 
with  sustained  glucocorticoid  therapy,  then  it  induces  a  suppression  of  the 207
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`<adrenoceptor-induced facilitation of LTP, possibly because genomic GR e ects 
already kick in(Joels et al., 2011). Collectively, the actual rapid signaling might 
help the organism to cope with the situation in a short time frame, subsequently 
the genomic e ects will kick in to take over and restore the activity of the circuits 
to reach to homeostasis (Groeneweg et al., 2011). 
4. Clinical relevance of the  ndings: Implications for post-traumatic stress 
disorder and phobias
Persistent  traumatic  memory,  characterized  by  intrusive  recollections  and  re-
experiencing  of  highly  stressful  experiences,  is  a  hallmark  of  stress-related 
disorders  such  as  post-traumatic  stress  disorder  (PTSD)  (de  Quervain  et  al., 
2009). Changes in glucocorticoid signaling, like increased sensitivity of the GR 
(Hauer et al., 2011) and enhanced feedback of the HPA axis (Yehuda, 2009), have 
consistently been reported in patients with PTSD. Further, a low cortisol response 
to traumatic events might re ect a higher risk for the development of PTSD 
(Yehuda;, 1997). In line with these observations, clinical investigations reported 
that the administration of stress levels of glucocorticoids following trauma or in 
patients with established PTSD signi cantly reduces re-experiencing and other 
chronic stress symptoms (Aerni et al., 2004; Schelling et al., 2004; Schelling et al., 
2006; Surís et al., 2010). Glucocorticoids also reduce retrieval of fear memory in 
patients with phobia and thereby preclude stimulus-induced fear (Soravia et al., 
2006; De Quervain and Margraf, 2008). Collectively, glucocorticoids are suggested 
to  exert  bene cial  e ects  in  diseases  related  to  memory,  at  least  in  part,  by 
impairing the retrieval of trauma-related memories, but also by facilitating the 
extinction of stress-related memories (Bentz et al., 2010; de Quervain et al., 2011; 
Atsak et al., 2012a). Despite the potential value of glucocorticoids as treatment 
for PTSD and phobias, in a clinical setting, the sustained use of glucocorticoids 
is undesirable because of the pleiotropic nature of these hormones to a ect a 
wide array of physiological functions (e.g., immune and metabolic functions). 
The  ndings presented in this thesis indicating that the endocannabinoid system 
mediates glucocorticoid e ects on memory retrieval impairment could aid in the 
development of non-glucocorticoid–based therapies for PTSD. Although clinical 
studies have not yet investigated interactions between these two stress systems, 
recent  ndings indicate that administration of the synthetic cannabinoid nabilone 208
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to PTSD patients resulted in a highly comparable reduction of treatment-resistant 
daytime  ashbacks and nightmares (Fraser, 2009). Moreover, the possible positive 
outcome of treatments targeting the endocannabinoid system in PTSD has been 
also suggested by recent data showing altered levels of plasma endocannabinoid 
levels (AEA, 2-AG and Oleoylethanolamide and palmitoylethanolamide) in PTSD 
patients (Hauer et al. unpublished observations). 
5. Conclusions and Future Directions
Glucocorticoids  enhance  memory  consolidation  for  emotionally  arousing 
experiences  and  impair  memory  retrieval  during  emotionally  arousing  test 
situations via rapid interactions with arousal-induced noradrenergic mechanisms. 
The overall conclusion of the part II of the thesis is that the endocannabinoid 
system is playing a crucial role in mediating such rapid glucocorticoid e ects on 
the noradrenergic system. However, there remain many unanswered questions. 
First,  decades  of  research  substantially  reproduced  the   ndings  of  animal 
experiments that glucocorticoids, by means of interactions with arousal-induced 
noradrenergic activity, modulate memory also in humans (Wolf, 2008; de Quervain 
et  al.,  2009).  It  is  crucial  to  perform  experiments  addressing  the  role  of  the 
endocannabinoid system in glucocorticoid-induced e ects on human memory. 
In chapter 6, we showed that systemic injections of a CB1 receptor antagonist 
prevented the impairing e ects of glucocorticoids on recognition memory in 
rats. Future experiments that employ a similar design and drug treatment will 
be invaluable to compare the role of the endocannabinoid system in regulating 
glucocorticoid e ects on memory across species. 
Second, although similarities between the mechanisms of how endocannabinoids 
mediate  glucocorticoid  e ects  on  consolidation  and  retrieval  have  been 
addressed  in  chapter  4  and  5,  future  experiments  dissecting  the  possible 
di erences between the two models will be needed. For example, there seems 
to be a possible functional distinction in the endocannabinoid ligands mediating 
the  modulatory  e ects  of  glucocorticoids  on  memory  consolidation  versus 
memory  retrieval.  As  mentioned  before,  AEA  has  been  more  implicated  in 
memory consolidation, whereas we reported in chapter 5 that 2-AG appears to be 
more linked to the e ects of glucocorticoids on memory retrieval. Future research 
explicitly addressing the involvement of di erent endocannabinoid ligands in 209
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mediating glucocorticoid e ects on di erent memory processes will be required. 
Third,  although  several   ndings  have  demonstrated  that  endocannabinoids 
modulate  noradrenergic  transmission,  it  is  unclear  whether  this  is  actually 
achieved indirectly by in uences on GABAergic or glutamatergic transmission, 
or by a direct in uence on the noradrenergic transmission. Future experiments 
examining  the  e ects  of  glucocorticoids  in  conditional  mutant  mice  lacking 
CB1 expression speci cally in glutamatergic or GABAergic neurons (Marsicano 
and  Lutz,  1999)  and  as  well  as  experiments  focusing  on  the  mechanism  of 
how manipulation of endocannabinoid signaling relates to direct changes on 
noradrenergic transmission will be essential. 
Another    crucial    question  is  the  role  of  emotional  arousal  in  regulating 
glucocorticoid-endocannabinoid  e ects  on  the  noradrenergic  system. 
Emotional and non-emotional memory seems to be di erently modulated by 
endocannabinoid system activation (Akirav, 2011) and endocannabinoids exert 
opposite  e ects  depending  on  the  baseline  arousal  level  of  the  organisms 
(Campolongo et al. unpublished observations). Moreover, in our experiments 
we only demonstrated the recruitment of endocannabinoids by glucocorticoids 
to a ect noradrenergic activity under arousing conditions, hence, it would be 
necessary to investigate whether glucocorticoids also recruit the endocannabinoid 
system under low-arousing experimental conditions. 
Although  speculative  at  this  point,  considering  the  alteration  of  circulating 
endocannabinoid levels in PTSD patients (Hauer et al., unpublished observations), 
it  would  be  interesting  to  investigate  whether  the  achieved  bene ts  of 
glucocorticoid treatment in this patient group are also mediated by changes in 
endocannabinoid signaling. And last but not least, investigating whether the 
known disturbances in glucocorticoid signaling in PTSD patients are actually linked 
to changes in the endocannabinoid system would be valuable to understand the 
dynamics between these two systems as well as to develop alternative treatments 
targeting this interaction in pathological conditions. 210
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Conclusion
CONCLUSION
Stress  can  exert  rapid  as  well  as  delayed  e ects  at  many  di erent  levels  of 
cognition.  This  thesis  explored  the  e ects  of  stress  on  social  cognition  and 
memory  in  rats. The   rst  part  investigated  the  role  of  social  communication 
between conspeci cs in stress transmission and demonstrated that the display 
of distress behavior by a rat to a stressor (footshock) can induce an immediate 
stress reaction in another, observing rat. In particular, this part pointed out that 
this emphatic response in an observing animal requires prior experience with the 
same stressor. The underlying neuronal mechanism and the sensory modality that 
conveys the information between conspeci cs and the contribution of various 
factors such as familiarity, similarity, gender of the animals and salience of the 
stimulus remains to be explored in future experiments. The second part examined 
the neurobiological mechanisms underlying the e ects of stress hormones on 
di erent memory phases. The experiments of this part demonstrated that the 
lipid-based endocannabinoid system plays a crucial role in mediating the rapid 
actions  of  glucocorticoids  on  arousal-induced  noradrenergic  activity  that  are 
necessary for enhancing the consolidation of memory as well as impairing the 
retrieval of memory for emotionally arousing experiences. Future experiments 
dissecting  the  role  of  particular  endocannabinoid  ligands  in  mediating 
glucocorticoid e ects on memory consolidation and retrieval as well as the role 
of the endocannabinoid system in regulating glucocorticoid e ects on memory 
across species, in particular, in humans will be needed.223
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Summary
Stress kan op velerlei manieren cognitie beïnvloeden. In dit proefschrift heb ik 
deze  stresse ecten  binnen  twee  verschillende  cognitiedomeinen  onderzocht. 
In hoofdstuk 2 beschreef ik dat sociale communicatie tijdens dreigend gevaar 
een belangrijke rol speelt bij het doorgeven van stresssignalen van de ene op de 
andere rat. Dit gebeurde echter alleen als beide ratten ervaring hadden met de 
stressor en niet als de observerende rat naief was met betrekking tot de stress-
stimulus. De resultaten van dit onderzoek kunnen dienen als voorbeeld voor 
het concept van stress op sociale cognitie en empathie bij ratten. In het tweede 
gedeelte van dit proefschrift onderzocht ik hoe stress verschillende aspecten 
van  het  geheugen  kan  beïnvloeden.  Het  is  algemeen  bekend  dat  stressvolle 
en  emotionele  gebeurtenissen  beter  onthouden  worden  dan  alledaagse 
gebeurtenissen,  terwijl  acute  milde  stress  juist  het  oproepen  van  eerder 
aangeleerde  emotioneel-gekleurde  informatie  uit  het  geheugen  vermindert. 
Uitgebreid  onderzoek  heeft  aangetoond  dat  beide  e ecten  het  gevolg  zijn 
van de werking van hormonen die vrijkomen uit de bijnieren tijdens stress. In 
hoofdstuk 3 heb ik een overzicht gegeven van de complexe manier waarop een 
van de belangrijkste stresshormonen, glucocorticoïden (cortisol bij de mens), het 
geheugen beïnvloeden. Glucocorticoïden komen vrij uit de bijnierschors tijdens 
stress en verbeteren de consolidatie en opslag van nieuwe informatie in het 
geheugen terwijl ze tegelijkertijd het oproepen van eerder opgedane ervaringen 
uit  het  geheugen  verminderen.  Glucocorticoïden  kunnen  op  twee  manieren 
hersenactiviteit, en dus hersenfuncties, beïnvloeden. Enerzijds is er een langzame 
weg die afhankelijk is van transcriptionele activiteit op genniveau. Het duurt 
daarom enige uren voordat deze e ecten zichtbaar worden. Anderzijds zijn er 
ook snelle niet-genomische e ecten (waarbij geen sprake is van transcriptionele 
activiteit) die al na een paar minuten zichtbaar worden. Ondanks het feit dat   
verschillende  van  deze  glucocorticoïd  e ecten  op  het  gedrag  en  geheugen 
afhankelijk  zijn  van  deze  snelle  weg,  is  het  mechanisme  daarvan  niet  goed 
begrepen. Wel is bekend dat de snelle e ecten van glucocorticoïd-hormonen 
afhankelijk  zijn  van  noradrenaline,  een  ander  stresshormoon,  dat  vrijkomt  in 
de  hersenen  tijdens  emotionele  gebeurtenissen.  Maar  hoe  glucocorticoïden 
een interactie aangaan met noradrenaline is niet bekend. Uit recent onderzoek 
blijkt dat het endocannabinoïdsysteem, een snelwerkend lipide-systeem in de 
hersenen,  medeverantwoordelijk  is  voor  het  bewerkstelligen  van  een  aantal 
van deze snelle glucocorticoïd e ecten. Op dit moment zijn meer dan twaalf 227
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verschillende endocannabinoïden beschreven maar speci eke functies voor elk 
van hen zijn onbekend. De aanmaak van verschillende endocannabinoïd-liganden 
wordt aangewakkerd door neuronale depolarisatie, een toename in intracellulaire 
calciumconcentraties,  en  activering  van  verschillende  metabotrope  en 
excitatoire ionotrope neurotransmitter receptoren. Eenmaal vrijgekomen binden 
endocannabinoïden zich aan CB1 en CB2-receptoren. CB1-receptoren zijn in zeer 
grote dichtheden aanwezig in het centrale zenuwstelsel. Stress en glucocorticoïden 
kunnen de activiteit van verschillende van deze endocannabinoiden beïnvloeden. 
Zo  is  het  bekend  dat  glucocorticoïden  endocannabinoïd  concentraties  in  de 
hypothalamus verhogen en op deze wijze de hypothalamus-hypofyse-bijnier-as 
activiteit afremmen.  Deze resultaten zijn belangrijk omdat ze het eerste bewijs 
leverden voor een rol van het endocannabinoïdsysteem in het mediëren van 
snelle glucocorticoïd e ecten. 
In dit proefschift heb ik onderzocht of endocannabinoïden ook betrokken zijn bij de 
e ecten van glucocorticoïden op de consolidatie en oproepen van het geheugen. 
In hoofdstuk 4 toonde ik aan dat endocannabinoïden een belangrijke rol spelen 
bij de e ecten van glucocorticoïden op het verbeteren van de consolidatie van 
geheugen. De voornaamste conclusie van dit onderzoek is dat glucocorticoïden 
via het endocannabinoid systeem noradrenerge activiteit binnen het basolaterale 
complex van de amygdala (BLA), een belangrijk hersengebied voor de regulatie 
van stress e ecten op leren en geheugen, beïnvloeden. Verder heb ik kunnen 
aantonen dat activiteit van het endocannabinoidsysteem noodzakelijk is om de 
e ecten van glucocorticoïden op neurale plasticiteit van het BLA te bewerkstelligen. 
Zoals reeds hierboven beschreven, kan blootstelling aan stress of de toediening 
van glucocorticoid hormonen kort voor een retentietest juist het oproepen van 
herinneringen  uit  het  geheugen  verminderen.  In  hoofdstuk  5  onderzocht  ik 
daarom een mogelijke betrokkenheid van het endocannabinoïdsysteem in deze 
glucocorticoïd-geïnduceerde verslechtering van het oproepen van informatie uit 
het geheugen. Ratten werden getraind op een contextuele angsttaak (contextual 
fear conditioning), waarbij ze leerden dat ze een electrische schok konden krijgen 
in een bepaald apparaat (= context). Systemische toediening van corticosteron, 
het belangrijkste glucocorticoïd-hormoon in de rat, een uur voor de retentietest 
verminderde het oproepen van het geheugen voor deze contextuele angsttaak, 
zonder  rechtstreeks  de  expressie  van  angstgedrag  te  veranderen.  Belangrijk 228
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is dat een blokkade van CB1 receptoren in de hippocampus dit corticosteron 
e ect  volledig  blokkeerde.  Deze  resultaten  laten  dus  zien  dat  activiteit  van 
het  endocannabinoïdsysteem  noodzakelijk  is  voor  het  mediëren  van  deze 
corticosteron e ecten op het oproepen van emotioneel geheugen. Verder vond ik 
dat de toediening van corticosteron resulteerde in een verhoging van de spiegels 
van 2-arachidonoylglycerol, een van de meest voorkomende endocannabinoiden, 
in de hippocampus. Lokale toediening van WIN55,212-2, een agonist voor CB 
receptoren,  in  de  hippocampus  resulteerde,  net  als  bij  corticosteron,  in  een 
vermindering van het oproepen van contextueel geheugen. Ook hier lijkt de 
samenhang tussen glucocorticoïden en endocannabinoïden uiteindelijk uit te 
monden in een verandering van noradrenerge activiteit. Ik heb namelijk kunnen 
vaststellen dat antagonisme van ß-adrenerge activiteit in de hippocampus door 
lokale toediening van propranolol het e ect van de CB-receptor agonist volledig 
blokkeerde.
Hoewel  de  e ecten  van  glucocorticoïden  op  een  vermindering  van  het 
oproepen  van  hippocampus-afhankelijk  ruimtelijk  en  contextueel  geheugen 
vaak  zijn  beschrijven,  lijken  glucocorticoïden  veel  minder  e ectief  te  zijn 
in  het  beïnvloeden  van  het  oproepen  van  recognitiegeheugen,  een  vorm 
van  geheugen  dat  onafhankelijk  is  van  de  hippocampus.  Daarom  heb  ik  in 
hoofdstuk 6 onderzocht of de toediening van corticosteron het oproepen van 
verschillende soorten informatie met betrekking tot een object-recognitietaak 
kan beïnvloeden. Corticosteron toediening kort voor de retentietest resulteerde 
in een vermindering van de herkenning van zowel het object zelf als de plaats 
waar dit voorwerp zich bevond tijdens de training. Dit experiment laat dus zien 
dat corticosteron mogelijk een veel algemener e ect heeft op het oproepen 
van informatie uit het geheugen dan tot nu toe werd aangenomen. Aangezien 
de  resultaten  van    hoofdstuk  5  lieten  zien  dat  het  endocannabinoïdsysteem 
betrokken is bij de e ecten van glucocorticoïden op het oproepen van geheugen, 
heb ik verder onderzoek gedaan naar de betrokkenheid van endocannabinoïden 
in de e ecten van glucocorticoïden op het ophalen van deze twee componenten 
van  objectherkenning  en  vond  dat  systemische  toediening  van  de  inverse 
CB1-agonist SR141716 1 uur voor aanvang van de retentietest de e ecten van 
corticosteron volledig blokkeerden. 229
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Stress kan dus zowel snelle als langzame e ecten uitoefenen op veel verschillende 
aspecten van cognitie. Dit proefschrift onderzocht de e ecten van stress op sociale 
cognitie en geheugen bij ratten. Het eerste deel toonde aan dat uitingen van 
angst tijdens dreigend gevaar kunnen leiden tot een onmiddellijke stressreactie 
in een andere observerende rat, maar alleen als deze ervaring had met diezelfde 
stressor. Het onderliggende neuronale mechanisme, de sensorische modaliteit 
(gehoor, reuk, zicht et cetera) dat betrokken is/zijn bij de sociale transmissie van 
angst alsmede de rol van diverse andere factoren zoals geslacht van de dieren 
en saillantie van de stimulus moeten nog worden onderzocht. Het tweede deel 
toonde  aan  dat  het  endocannabinoïdsysteem  een  cruciale  rol  speelt  bij  het 
reguleren van de snelle e ecten van glucocorticoïden op zowel de verbetering 
van de consolidatie van nieuwe informatie in het geheugen als de vermindering 
van het oproepen van bestaande herinneringen uit het geheugen. Toekomstige 
studies  zullen  moeten  onderzoeken  in  hoeverre  speci eke  endocannabinoïd 
liganden een rol spelen bij deze diverse glucocorticoïd e ecten. Verder zal moeten 
onderzocht worden of het endocannabinoid net zo’n een voorname rol speelt in 
de regulatie van stress e ecten op het menselijk geheugen.Curriculum Vitae 232
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VPRRWKO\7KDQNVWR+HVWHUIRUORQJIURQWGRRUWDONVDQGDOZD\VIRUÀ[LQJODWH
early, wrong orders for me, to Arie for teaching me many things and being so 
kind in approving my last minute submitted workprotocols, to Ester and Linda 
for spending a lot of time to provide me the information about animals. I know I 
JDYHDORWRIWURXEOHWR\RXE\DVNLQJVRPHWLPHVWLPHVDGD\KRZPDQ\DQLPDOV
used, how many left, transfer from one dec to other, it was tough for me as well 
but one reason why doing the welfare evaluation for my group was not a total 
EXUGHQZDVEHFDXVH,KDGDJUHDWVXSSRUWIURP\RX,·GDOVROLNHWRWKDQNWRRXU240
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ZHOIDUHRIÀFHU&DWKHULQH7KXULQJIRUSXWWLQJH[WHQVLYHHIIRUWLQLPSURYLQJWKH
quality of our methods and experiments as well as for her friendly attitude and 
always welcoming us whenever we had a problem or question. Thanks to all our 
animal care takers for trying to realize all our weird wishes about cage change 
time, checking time, moving the animals around and etc. I want to highlight 
Natascha, in particular for her effort in helping us for abbott experiments, we 
FRXOGQRWKDYHGRQHLWZLWKRXW\RXDQG,·GOLNHWRWKDQNWR$QQHPLHNHZKRVRUWHG
out a lot of mess regarding housing the animals, labels and etc. and to Ar for 
DOZD\VÀQGLQJWLPHWRVRUWRXWLVVXHVIRUXV
My dear friends: 
Ana, my dear, my dance buddy, my hug giver! Thanks for always having time for 
PH,DPEOHVVHGWRKDYH\RX<RXDUHVSHFLDOKHH\ZRPDQURJHUWKDW"
Peter, my weird friendly mate! Sometimes we cheer up and sometimes we keep 
TXLHWVRPHWLPHVZKHQRQHGRHVQRWÀQGPHDQLQJWDONLQJWRDVWUDQJHURQHÀQGV 
the one who transforms into a best buddy in a matter of seconds. Thanks for 
being the one who takes the one as it is, no matter how weird, how demanding 
and how ridicoulus it is!
.DWKDULQD	9LERU WKDQNV IRU KDYLQJ PH LQVLVWHQWO\ LQ WKH 6HUELDQ	&URWLDQ
parties and activities, even that meant for you guys to speak in english all day/
night to integrate me into the group. And thanks to you, Kaca, for convincing me 
that there is a life after 30! 
*RGD	2RI,DOZD\VIHOWWKDW,GRQ·WQHHGWRWDONWR\RXJX\VLQRUGHUWRH[SUHVV
myself. You offered me a great comfort, positive atmosphere and deep looks. I 
DSSUHFLDWHGDOOWKHIXQ\RXEURXJKWLQWRWKHUDNLSDUWLHV,FDQ·WWKLQNRIKDYLQJ
parties wihout you guys. And with you Goda, I think we shared one of the most 
interesting experience, though we will never know whether they will eventually 
build this student house in Groningen, if they do, we will know how it was decided 
DQGSODQQHGDOVRWKDQNVIRUJLYLQJPHSOHQW\RIKXJVNQRZLQJWKDW,QHHGLW
but I could not say it... 
Elena, we met late but you know what they say - better late than never - we 241
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compensated and will compensate more!
$VWURJURXSQR,GLGQRWIRUJHW\RXJX\V6LPRQD/HRQ5DMDW0DWWHR*LDQQL 
3DQRV/DXUDZKREURXJKWDORWRIFRORXUVLQWRP\ÀUVW*URQLQJHQ\HDUV7KDQNV
for  dinners&drinks  and  broadening  my  astrophysics  knowledge  dramatically 
LWHYHQWXDOO\VRPHKRZKHOSHGLQ1HXURVFLHQFHDQGVRUU\IRUGHVWUR\LQJ\RXU
SURIIHVLRQDOWDONVZLWKP\QHXURVFLHQWLÀFEDFNJURXQG,·GQHYHUXQGHUVWDQGKRZ
brain looks similar to a galaxy without you guys! 
Liga&Gert Jan, thanks for all the fun activities you got me into! Sushi nights, 
ice-skating, dance&music, bbq, the koffer and many other things. It has been 
great to know you guys, I really enjoyed everything that we have done together. 
To be continued in Nijmegen... 
,·GDOVROLNHWRWKDQNWR5DPRQD.DWKDULQD*RHUOLFK.DFD*HUU\0DUF1DGLU
Julien, Carlos for coloring my smoking time with enjoyable conversations.
And of course, thanks to my dear dutch teacher, Arianne, who through teaching 
dutch,  listened  to  my  life,  my  ups  and  downs,  my  hopes,  excitements  and 
desperacies! Thanks for great home-made cappuccinos and proof-reading of my 
dutch summary!  
As last but not least:
$QQHP%HQLNLPVHQLQVHYPHGLùLJLELVHYHQNLPVHQLQELOPHGLùLJLELELOHQVDQD
6LQDQ$UDIWDYHFPEüWHEXODQYHGüWHRODQWDUDÁDUÖPÖELOHQsana,
%DEDP%HQLROPDNLVWHGLNOHULPLFLQGHJLOEHQROGXùXPLoLQGHVWHNOH\HQVDQD
%HUIX+HUUHQJLPHNXFDNDoDQVHQLQGHEHQLP|GOPROGXùXQXELOHQVDQD
$ELPH+HUüH\LQEL]GHEDüOD\ÖSEL]GHELWWLùLQLELOHQVDQD
6DQHP3D\ODüPDQÖQVÖQÖUODUÖROPDGÖùÖQÖELOHQVDQD
(EUX+D\DWÖQKHUüH\HUDùPHQGHYDPHWWLùLQLELOHQYH|ùUHWHQVDQD
$UD]+HU\ROXQVRQXQXQLQVDQÖQNHQGLVLQHoÖNWÖùÖQÖELOHQVDQD
'HYULP.DED*YHQLOPHQLQVÖQÖUODUÖROPDGÖùÖQÖELOHQVDQD
+D\UL\H²0HVDIHOHULQSD\ODüÖPD\HQLOPHGLùLQLELOHQVDQD
+ÖGÖU²=DPDQLQSD\ODüÖPD\HQLOPHGLùLQLELOHQEHQJHOHPHGLNoHEDQDJHOHQVDQD
9HD\UÖFDSDDUGPGDYLPLGLùHUFDQÖPDUNDGDüODUÖP&DQ2]OHP2]DQ1DGLU242
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'HYULP2QXU(GD9RONDQ%XUFX8PXWYHVDQD.DQDWNH\LÁLDQODUX]XQVRKEHWOHU
\HPHNOHUSDUWLOHUJH]PHFHWR]PDFDSD\ODüÖPODUÖQÖ]|ùUHWLOHULQL]GHVWHùLQL]
NÖVDFDKD\DWÖPDJHWLUGLùLQL]EWQUHQNYHGHULQOLNOHULoLQPLQQHWWDUÖP
$QGP\ÀQDOZRUGVLVIRU\RXWKHRQO\RQHWKDW,HYROYHGWRJHWKHURYHUDOO
these years, the one I shared the happiness and sadness, the one who knows 
my deepest layers, the one who strenghtened me, the one that inspired me, the 
one who maybe deserves the biggest credit for this work after me. It has been 
tough sometimes but I believe, we have had great mutual support and inspiration 
WKURXJKRXUFRXQWOHVVKRXUVRIWDONVDQGORYH0DQ\WKLQJVKDSSHQHGDQGZH
have changed, our lives goes into different directions now and unfortunately 
ZHFDQ·WDGDSWDVIDVWDVZHZLVKZHZRXOGDOZD\V:KDWUHPDLQVWKHVDPH
however, is what I appreciate the most. Thank you Leonardo, particularly for 
showing me sometimes it is necessary to stand at the top of the cliff and jump 
off, and build your wings on the way down! 
Piray 
St. Petersburg/Antalya/Groningen
 August 2012243
Acknowledgment